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Abstract 
 
Oral precancer (OPC) is a collective term for a number of disorders that may precede 
oral cancer. Treatment is aimed at preventing malignant transformation however, this is 
complicated by a lack of robust evidence concerning both treatment effectiveness and 
future cancer risk. Uncertainties surrounding prognosis and treatment options might be 
expected to impact on a patient’s experience of their disease, as well as creating 
challenges for their management.  The aim of this research was to explore the 
experience of OPC through the eyes of the patient and clinician to assess the impact of 
living with oral precancer and enable the identification of opportunities to improve 
outcomes. 
 
The project comprised two qualitative studies, each employing semi-structured 
interviews.  28 patients with OPC, were recruited for study A, while 11 Oral and 
Maxillofacial Consultants were involved in study B. Data collection and analysis was 
iterative, following the principles of the ‘constant comparative’ method (Glaser 1965). 
Data collection stopped when data saturation was achieved. The data were analysed 
using thematic analysis. 
 
The results indicated that during the diagnosis and management of OPC, clinicians were 
faced with challenges.  These included: communicating a diagnosis, (particularly in 
terms of terminology), conveying risk meaningfully, meeting patients’ additional 
information needs, encouraging behaviour change and making treatment decisions.   
The patient data indicated that for some, OPC represents a devastating diagnosis leading 
to feelings of fear and uncertainty impacting significantly on the individual’s life. In 
addition, analysis also allowed a disease journey to be mapped and directly related to 
the findings from the clinician group thereby indicating opportunities where changes in 
practice may improve patient care.  These points included: the diagnosis, where 
understanding terminology and comprehending risk were problematic, following a 
diagnosis, where meeting information needs was a challenge and during the 
management and review stages when treatment decisions were made and carried out.   
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Chapter 1. Introduction and outline of thesis 
 
 
This thesis focuses oral precancer, both from the perspective of individuals who are 
diagnosed with it as well from the view-point of those who are involved in the 
management of patients with it.  The term oral precancer is used to describe a group of 
disorders that may present in the oral cavity.  The significance of these disorders is that 
they pose a higher risk of malignant transformation than healthy oral tissue.  Because of 
this, treatments are aimed at preventing cancer development; however, a lack of robust 
evidence concerning both treatment effectiveness and future malignant change means 
that there are currently no clear guidelines for clinicians to follow.  Accordingly, 
practice varies widely.  In addition, because of a paucity of literature pertaining to 
patient experience of oral precancer it is not clear how this group of patients experience 
their disease and if the lack of clear clinical guidance has an impact on their disease 
journey. 
 
The work in this thesis has, therefore, been designed and conducted with a view to 
exploring patients’ and professionals’ views and experiences of oral precancer.  
Furthermore, the research presented seeks to map out and identify aspects of a patient’s 
disease journey where implementing change may improve outcome.   
 
Following this introduction, Chapter 2 reviews the current available literature and 
includes: 
 
 An overview of oral precancer 
 Management approaches in oral precancer 
 An individual’s response to illness  
 Uncertainty in illness 
 
Following the literature review the research aims and objectives are outlined, and 
chapters 3 and 4 describe the study’s methodology and method.   
 
Chapters 5 and 6 present the results and discussion from the patient study (study A) and 
the clinical professional study (study B).  Chapter 5 discusses the varied and complex 
process of patients’ experiences of disease from symptom appraisal through to treatment 
2 
 
and discharge from secondary care.  This chapter highlights the individual nature of 
disease experience and in doing so presents a discussion of the factors that may 
influence this experience.  In this way it is now possible to understand better the values 
and influences that may contribute to these patients’ experiences.  The results may also 
help clinicians to understand why some people react differently to others even where the 
process or treatment is apparently the same.  Chapter 6 presents the results and 
discussion of the clinician-based study and specifically highlights several areas in which 
clinicians experience difficulty managing patients with oral precancer. In particular, this 
chapter explores approaches to communicating an oral precancer diagnosis and cancer 
risk, meeting patient information needs, discussing and encouraging patient behaviour 
change and making treatment decisions as well as unpicking the perceived relevance of 
the clinical set-up and doctor-patient relationship. In doing so, the clinician study results 
emphasize the differences in practice between clinicians as well as the factors which 
influence those practices. 
 
Chapter 7 presents a summary of the results.   This chapter examines the model of the 
patient journey through the health care system to focus on specific areas within this 
process where there is an opportunity to implement changes and hence potentially an 
opportunity to improve outcome.   
 
Finally conclusions are outlined and recommendations from practice and future research 
are detailed in the remaining chapters. 
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Chapter 2. Literature review 
 
Prior to conducting the research, which constitutes the main body of the work, a review 
of the literature was carried out during which the following areas were examined: 
 
 An overview of oral precancer 
 Approaches to managing oral precancer 
 An individual’s response to diagnosis 
 Uncertainty in illness 
 
The purpose of reviewing the literature with respect to oral precancer and its 
management is not only to allow a better understanding of this group of disorders but is 
also to consider why oral precancer is significant and how current evidence contributes 
to a clinician’s approach to its management. In addition, by reviewing the literature 
relating to an individual’s response to illness and the effect of living with uncertain 
illness it is possible to begin to explore the potential factors that may influence an 
individual’s behaviour both prior to and following a diagnosis of oral precancer.   
 
2.1  Oral precancer – an overview 
 
Oral precancer, also referred to in the literature as premalignancy or potential 
malignancy, is a lesion or condition in the oral cavity which is more likely to undergo 
malignant change compared to healthy oral tissue.  The significance of oral precancer is 
that it often precedes oral squamous cell carcinoma (OSCC), the most common type of 
oral cancer (Morse et al., 2007) and a disease associated significant mortality and 
morbidity (Warnakulasuriya 2009).  The fact that OSCC is often preceded by oral 
precancer has led to the hypothesis that tumour genesis may be a two-step, or indeed 
multistep process, with the development of oral cancer being preceded by oral 
precancer.  The concept of this two-step process of cancer development in the oral 
mucosa is well-established (Reibel 2003), although not universally accepted (Cowan et 
al., 2001).  Histologically oral precancers are a lesions or conditions which are more 
likely to exhibit oral epithelial dysplasia or frank malignant change when compared to 
apparently normal tissue (Brennan, Migliorati and Lockhart 2007).  The importance of 
oral epithelial dysplasia specifically is that its presence is considered to be the most 
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significant factor when predicting the likelihood of oral cancer development from 
premalignant disorders, with some suggesting that it heralds malignant change (Scully 
1995). 
 
2.1.1  Classification of oral precancer 
 
Until recently oral precancers were classified as belonging to either one of two groups: 
precancerous lesions or precancerous conditions, with each category being associated 
with a future risk of oral cancer development.    
 
Precancerous lesions Precancerous conditions 
Leukoplakia Lichen planus  
Erythroplakia Submucous fibrosis 
Palatal lesions in reverse smoker Actinic keratosis 
 Discoid lupus erythematosis 
Table 1. Precancerous lesions and conditions 
(adapted from (Kramer et al., 1978)) 
 
The definition of a precancerous lesion was put forward as ‘a morphologically altered 
tissue in which cancer is more likely to occur than in its apparently normal counterpart’, 
whereas a precancerous condition was described as ‘a generalized state associated with 
a significantly increased risk of cancer’(WHO 1973). 
 
In 2007, however, a report produced following a workshop coordinated by the World 
Health Organization (WHO) collaborating Centre for Oral Cancer and Precancer in the 
UK, subsequently recommended a change in classification of the above two groups, 
preferring the single category ‘potentially malignant disorders’ (Warnakulasuriya, 
Johnson and Van der Waal 2007). The change was put forward as it was felt that this 
single category more accurately reflected the fact that these conditions have the 
potential to develop into oral cancer rather than its development being a certainty.  It 
was also felt that it was unlikely that all tissues would behave in the same way and 
where in some instances a two-step process from precancer to cancer may take place, in 
others a cancer may develop from a clinically normal tissue site.  This concept is known 
as field cancerization.  First described by Slaughter in 1953, and supported by others 
(van Oijen and Slootweg 2000) this theory proposes that tissue change may occur in any 
area of the aero digestive tract which has been ‘preconditioned’ by a carcinogen 
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(Slaughter, Southwick and Smejkal 1953).  As such, if this concept is to be accepted, it 
can be appreciated that this process may complicate the management of oral precancer 
in that treatment aimed at targeting defined lesions may not eliminate risk of the future 
development of oral malignancy.  
 
Finally, it should be noted that although many authors favour the term ‘potentially 
malignant’ over ‘precancerous’ or ‘premalignant’, ‘potentially malignant’ is not used 
universally throughout the literature and, therefore, all of the above 3 terms will be used 
interchangeably throughout this document to indicate an oral condition or lesion which 
carries an increased risk of cancer development.    
 
2.1.2  Potentially malignant disorders 
 
Leukoplakia and erythroplakia are the most common of the potentially malignant 
disorders and this is reflected in the oral precancer literature.  However, there are a wide 
range of lesions and conditions which are considered to have malignant potential. These 
are detailed in table 2.  It is worth noting that a number of other oral disorders are put 
forward in the literature as being potentially malignant in nature, however, for the 
purposes of this review only those detailed in table 2 will be discussed as these 
constitute the disorders recognised by the WHO Collaborating Centre for Oral Cancer 
and Precancer in the UK (Warnakulasuriya, Johnson and Van der Waal 2007).  I will 
now go on to briefly discuss each in turn. 
 
Oral precancerous disorders 
Leukoplakia 
Erythroplakia 
Palatal lesions in reverse smoker 
Oral submucous fibrosis   
Actinic keratosis    
Lichen planus 
Discoid lupus erythematosis 
Hereditary disorders with increased risk 
Table 2. Oral precancerous disorders 
Adapted from (Warnakulasuriya, Johnson and Van der Waal 2007) 
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Leukoplakia is the most common of the oral premalignant disorders (Poate and 
Warnakulasuriya 2006).  Leukoplakia was until recently, defined as ‘white patches that 
carry an increased risk of malignant potential’ (Kramer et al., 1978), however, this 
definition was re-evaluated in 2007 and the following definition put forward ‘white 
plaques of questionable risk having excluded (other) known diseases or disorders that 
carry no increased risk for oral cancer’ (Warnakulasuriya, Johnson and Van der Waal 
2007).  
 
Clinically, leukoplakia presents in a variety of guises (Warnakulasuriya et al., 2010) but 
predominantly as a white patch and may be classified as either homogenous, typically 
uniformly flat and thin,  or non-homogenous.  Non-homogenous leukoplakias include 
both mixed red and white lesions (speckled or erythroleukoplakic lesions) nodular and 
verrucous leukoplakia.   The nature of lesion appears to have significance in terms of 
the likelihood of malignant transformation, with non-homogenous lesions being 
considered a higher risk for malignant transformation than homogenous (Napier and 
Speight 2008).  Within the umbrella term of leukoplakia, proliferative verrucous 
leukoplakia (PVL) is sometimes considered separately, although it is worth noting that 
the WHO workshop on potentially malignant oral mucosal lesions and conditions 
prefers to regard it as an extreme variant of leukoplakia.  The reason it is sometimes 
differentiated from other lesions is because PVL lesions are much more likely to contain 
epithelial dysplasia than other leukoplakias and furthermore, are considered much more 
likely to progress to OSCC during the first decade following diagnosis (with one cohort 
study suggesting transformation in up to 70% of those affected) (Bouquot, Speight and 
Farthing 2006).   
 
Moving on from discussing leukoplakia, erythroplakia is defined,  as ‘a fiery red patch 
that cannot be defined clinically or pathologically as any other definable disease’ (Axell 
et al., 1984).  Although not as common as leukoplakia, erythroplakia is more likely to 
display dysplastic or malignant changes (Mashberg and Samit 1989), in fact is it 
believed that over time the majority of erythroplakias will undergo malignant change 
(van der Waal 2010).   As a result of this erythroplakia is considered a high risk lesion, 
although specific annual transformation rates are said to be difficult to calculate (van 
der Waal 2009). 
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Reverse smoking is not commonly practiced in the UK, and instead is primarily seen in 
female populations in east-central India (Mehta et al., 1969).  This habit (smoking with 
the lit end of the cigarette inside the mouth) is associated with oral lesions found 
predominantly on the palate which have been shown to have the potential to exhibit 
both dysplastic and malignant change (Hebert et al., 2002).  
 
Oral submucous fibrosis is a disorder in which fibrosis of the oral mucosa is seen to 
occur.  It is observed primarily in south-east Asia where the principal risk factor of betel 
quid chewing is commonly practiced.  Mucosal atrophy is a feature of the condition 
which is believed to increase the likelihood of malignant transformation when exposed 
to carcinogens.  The malignant transformation rate is reported as being in the region of 
0.5% (van der Waal 2009), however, figures such as these are based on the findings of 
follow up studies with a very small number of participants (Murti et al., 1985). 
 
Actinic keratosis is a potentially malignant disorder affecting the lower lip.  It is thought 
to arise due to prolonged exposure to ultraviolet light.  Figures suggest that 
transformation of actinic keratosis to squamous cell carcinoma may be something in the 
region of 12%-30% over 3 years for high risk patients (Zide 2008).  However, exact 
rates of malignant transformation again are difficult to predict due to a paucity of 
studies (Thomson 2012).   
 
Lichen planus is an autoimmune disorder of unknown aetiology in which T 
lymphocytes accumulate beneath the epithelium of the oral mucosa and increase the rate 
of differentiation of squamous epithelium.  This results in hyperkeratosis and erythema 
sometimes with associated ulceration (Warnakulasuriya, Johnson and Van der Waal 
2007).  Although the subject of controversy within the literature with regard to whether 
lichen planus should be considered a potentially malignant disorder at all (van der Meij, 
Mast and van der Waal 2007), it is generally accepted that although there is evidence to 
support malignant potential in lichen planus, the risk of malignant transformation is 
difficult to ascertain due to the nature of the best available evidence (retrospective 
cohort studies and prospective incidence studies) (Lodi et al., 2005). 
 
Discoid lupus erythematosus is also an autoimmune condition of unknown aetiology.  It 
is characterised by skin involvement but may also present intra-orally as well 
circumscribed white patches with elevated borders.  They may also be surrounded by a 
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telangiectasia halo and have associated radiating white striae.  They have known 
potential for malignant transformation (Pindborg et al., 1997), however, a lack of 
evidence makes quantifying the risk of malignant transformation difficult (Wei et al., 
2011) 
 
Finally, the hereditary disorders dyskeratosis congenita and epidermolysis bullosa may 
also have an increased risk of malignant change (Warnakulasuriya, Johnson and Van 
der Waal 2007), but are rare.   
 
Although oral precancer may be considered as any of the above forms, as discussed, the 
majority of the literature focuses on the premalignant disorders leukoplakia and 
erythroplakia which represent the majority of oral precancers observed, the other 
disorders representing a much smaller proportion of precancers seen (Napier and 
Speight 2008). 
2.1.3  Incidence and Prevalence 
 
Obtaining meaningful information of the incidence and prevalence of oral precancer is 
difficult, with many studies focusing purely on leukoplakia.  However, even then 
variances in the definition of leukoplakia make synthesising the data difficult (Napier 
and Speight 2008).   
 
There are very few studies pertaining to the incidence, number of new cases per year, of 
oral precancers.  However, those that are available predominantly relate to leukoplakia 
in Indian populations and have suggested a range of between 0.2/1000 to 30.2/1000 
with the higher incidence rates being associated with high levels of tobacco use 
(Bhargava et al., 1975; Mehta et al., 1972). 
 
In contrast to incidence more is known on the prevalence, the number of cases in a 
given population at any one time, with data being available worldwide.  Survey based 
studies have reported variations in prevalence of oral precancer from between 24.8% 
(Axell 1987) to 0.2% (Mehta et al., 1969) although it is largely agreed that the realistic 
prevalence of oral premalignancy is between 1% and 5% (Napier and Speight 2008; van 
der Waal 2009).  A difference in apparent prevalence is seen when figures from 
different geographical locations are examined.   
2.1.4  Transformation rates of oral precancer 
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The transformation rate of oral precancer is defined as the frequency at which an oral 
precancer changes to become an oral cancer.  The annual transformation rate of 
precancer is thought to be in the region of 1% (Johnson, Warnakulasuriya and Tavassoli 
1996) however, some have suggested this is too high, and should more realistically be 
considered to be 0.5% (van der Waal 2009).  Differences in reported transformation 
rates appear to be as a result of a lack of high quality evidence. In particular, differences 
in study design, follow-up duration and definition of oral precancer make interpreting 
this information challenging.  
 
As by far the majority of premalignant disorders present as leukoplakias, there is a 
preponderance of literature available on the potential transformation rates of this 
disorder when compared to the other premalignant disorders (Lind 1987).  Reports 
suggest that patients with leukoplakias have a 50 to 100 times greater chance of 
developing a OSCC compared to the general population (Cawson 1975).  However, a 
wide variation in malignant transformation is documented with studies suggesting rates 
of between less than 1%– to 36% (Silverman, Gorsky and Lozada 1984).  Given that the 
prevalence of oral leukoplakia in the general population is believed to be between 1%- 
5%, this is not an insignificant finding.   
2.1.5  Risk factors 
 
As with oral cancer, the literature suggests that the two main risk factors for the 
majority of the potentially malignant disorders are tobacco smoking and alcohol 
consumption (Jaber et al., 1999), furthermore, case controlled studies have 
demonstrated an association between these risk factors and oral epithelial dysplasia 
(Kulasegaram et al., 1995; Morse et al., 1996).  
 
Focusing firstly on smoking as a risk factor for oral premalignancy, the literature 
suggests that smoking is a significant risk factor in the genesis of both oral precancer 
and oral cancer, particularly in European subjects (Jaber et al., 1999; Kulasegaram et al., 
1995) with one survey based study finding that leukoplakia is 6 times more common 
amongst smokers that non-smokers (Baric et al., 1982).  Where the majority of the 
literature focuses on cigarette smoking, it has also been put forward that cigar and pipe 
smoking significantly increase the risk of malignant change in the oral cavity (Winn 
2001) and there is evidence that chewing tobacco products also puts an individual at an 
increased risk of developing oral malignancy. Of potential significance is that 2 cohort 
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studies have demonstrated that smoking cessation is associated with the potential for 
reversal of precancer (Ramseier et al., 2010), with some premalignant lesions being 
seen to regress and in some cases resolve completely following cessation of a smoking 
habit. The most frequently cited of these is a large Indian 10 year follow up study which 
demonstrated that following smoking cessation the incidence of oral leukoplakia 
substantially decreased (Gupta et al., 1995).  In Europe a  Swedish based study found 
that leukoplakias were reversible in patients who stopped or, indeed, reduced smoking 
(Roed-Petersen 1982). Clearly, this may have implications when it comes to managing 
patients with oral precancers. However, given the strength of the available evidence it is 
not possible to state conclusively that smoking cessation is fundamental to the 
elimination of oral precancer.    
 
Although cohort studies suggest tobacco use appears to have a more significant 
association with epithelial dysplasia than alcohol consumption (Jaber et al., 1999), 
alcohol is still considered an independent risk factor (Maserejian et al., 2006) although 
it is thought that alcohol and tobacco smoking together may produce a synergistic 
effect, further increasing the risk of both oral cancer and precancer (Morse et al., 1996).  
It has also been postulated that the use of alcohol containing mouthwashes may be a risk 
factor for a small contingent of women who do not smoke or drink (Blot, Winn and 
Fraumeni 1983).  However, this is considered controversial and has been disputed in 
more recent times (Gandini et al., 2012). 
 
Morse et al., sought to discover if patterns of risk factor behaviours (smoking tobacco 
and drinking alcohol) differed for those individuals with oral cancer compared to those 
with oral epithelial dysplasia.  They found evidence that where smoking is associated 
with oral dysplasia and oral cancer equally, alcohol is more strongly associated with 
oral cancer.  Further they went on to suggest that a history of high alcohol intake in 
patients with oral epithelial dysplasia may predict cases of dysplasia at a higher risk of 
transformation (Morse et al., 2007) . 
 
Other than tobacco use and alcohol consumption, poor diet has also been put forward as 
a risk factor for oral precancer development (Zain 2001).  Although the impact of diet as 
a risk factor for oral precancer specifically is not fully understood it is believed that a 
diet rich in fruit and vegetables results in a reduced rate of oral cancer.  This is 
supported by a meta-analysis by Pavia et al., (Pavia et al., 2006). The protective effects 
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of fruit and vegetables are attributed to their antioxidant activities.  However, it is felt 
that the effects of diet are not as significant as those of tobacco and alcohol use 
(Marshall and Boyle 1996).  Furthermore it is a difficult area to study as the risk factors 
do not always appear independently. 
 
Human papilloma virus is put forward as another potential risk factor in oral precancer. 
Having been implicated as a risk factor in the wider literature (in cancer of the uterine 
cervix), a relatively recent systematic review pooling data from 39 studies concluded 
that a potentially important causal relationship exists between HPV, oral cancer and oral 
precancer (Syrjanen et al., 2011). However, the authors finish by stating that further 
work, in the form of prospective cohort studies, is required until HPV can ultimately be 
considered as a risk factor in oral precancer.   
 
Other potential risk factors are seen in the literature including: immunosuppression and 
poor oral hygiene, oral health and genetic predisposition.  However, despite evidence 
suggesting their involvement as risk factors, the level and mechanism of the 
involvement is not fully understood  
 
2.1.6  Diagnosis  
 
The diagnosis of oral precancer traditionally takes place following a visual inspection of 
the oral cavity which is subsequently followed up with a scalpel biopsy.  The resultant 
sample is then examined histologically to determine a diagnosis and to assess for 
features of frank malignancy or features of dysplastic change.   
 
Although a thorough intra-oral examination is a key constituent of assessing a patient 
for the presence of oral cancer or precancer, most authors agree the presence or absence 
of malignant change cannot be reliably determined by visual examination alone (Mirbod 
and Ahing 2000; Shugars and Patton 1997; Silverman 1988).  Although some have 
suggested that there may be some features of the examination that may arouse 
suspicion.  For example Bouquot and Whitaker have suggested that when it comes to 
clinical inspection of oral leukoplakia, an increase in thickness of the lesion correlates 
with a greater chance of finding dysplastic changes histologically (Bouquot and 
Whitaker 1994).  
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The current gold standard in the diagnosis of oral precancer is an incisional biopsy.  
This is reflected in the fact that the majority of oral and maxillofacial surgeons (OMFS) 
report taking a biopsy of lesions in patients with suspected premalignant disease 
(Kanatas et al., 2011). The purpose of an incisional biopsy is to gain a tissue sample 
which can be subsequently analysed by a pathologist with a view to determining an 
accurate precancer diagnosis.  Central to this process is the assessment of the sample for 
the presence of epithelial dysplasia which, as discussed, at the present time, is the best 
known predictor for malignant change within a lesion.  Although an important factor in 
determining the risk of malignant change, oral epithelial dysplasia is not associated with 
any specific clinical appearance (Reibel 2003). Oral epithelial dysplasia is seen to occur 
where histological examination of the tissue reveals changes in cellular maturation and 
morphology.  Criteria for diagnosing epithelial dysplasia are detailed in table 3.  
 
Criteria for diagnosing epithelial dysplasia 
Loss of polarity of basal cells 
Presence of more than one layer of cells having a basaloid appearance 
Increased nuclear-cytoplasmic ratio 
Drop shaped rete ridges 
Irregular epithelial stratification 
Increased number of mitotic figures 
Mitotic figures that are abnormal in form 
The presence of mitotic figures in the superficial half of the epithelium 
Cellular and nuclear pleomorphism 
Nuclear hyperchromatism 
Enlarged nuclei 
Loss of intercellular adherence 
Keratinisation of single cells or cell groups in the prickle cell layer 
Table 3. Criteria for diagnosing epithelial dysplasia 
Adapted from (Pindborg et al., 1997) 
 
As dysplasia is a spectrum, typically these changes are assessed by a pathologist and 
graded as mild, moderate and severe.  A diagnosis of carcinoma in situ is made where 
the dysplastic features involve all surface epithelia strata, which differs from OSCC in 
which there is evidence that the nests of epithelial cells have isolated the epithelial-
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stromal interface and invaded the underlying lamina propria and deeper submucosa 
(Brennan, Migliorati and Lockhart 2007). 
 
As previously outlined, the relevance of this histological assessment is that the presence 
of dysplasia within a lesion is thought to increase the risk of malignant change (Speight, 
Farthing and Bouquot 1996; van der Waal et al., 1997; Warnakulasuriya 2001) and in 
particular the latter grades are thought to be associated with a more substantial risk than 
the former grades (Rodrigues and Tuomainen 1998).  When this is examined further it 
can be seen that studies have reported wide variations in transformation rates.  For 
example 7% -50% in severe epithelial dysplasia (Bouquot, Speight and Farthing 2006), 
3%-15% in moderate dysplasia and less that 5% in mild dysplasia (Speight 2007).  
However, it must be appreciated that where the categories mild, moderate and severe 
are routinely used, there are no truly reproducible criteria to define these categories 
(Barnes et al., 2005).  Nevertheless, as a result of these assumptions the lesions 
displaying more severe grades of dysplasia are often treated in a more aggressive 
manner than the less severe grades.   
 
Although a great deal of significance is subscribed to the results of the histological 
report, there exists potential for variability in that the assessment of the biopsied tissue 
is considered by some to be a somewhat subjective process.  Indeed studies have shown 
a lack of standardisation in the diagnostic criteria (Pindborg, Reibel and Holmstrup 
1985) as well as a lack of inter-observer agreement between pathologists with one study 
finding inter-observer agreement of only 54% between two experienced pathologists 
grading dysplastic lesions (Lumerman, Freedman and Kerpel 1995) . However, others 
have suggested no significant inconsistencies in inter-examiner reliability between 
pathologists assessing the same tissue samples, reporting agreement when grading of 
92% (Lippman et al., 1993). As a means of reducing this potential disparity, it has 
recently been recommended that the grading of dysplasia be altered from 3 to 2 grades 
reclassifying the mild risk the category low grade and combining moderate and severe 
dysplasia into the single category high grade dysplasia (Warnakulasuriya et al., 2008), 
however, it is not yet known if this produces more consistent reports as the allocation 
into either one of these groups is still a subjective process. Given the significance 
ascribed to the histological assessment, variability at this stage may mean the difference 
between regular review and surgical intervention in terms of patient treatment options.    
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Another aspect affecting the reliability of a biopsy and subsequent histopathological 
assessment is whether the sample can be considered truly representative of the entire 
lesion from which it is taken.  This was explored in a study by Holmstrup et al., in 
which 101 surgically removed premalignant lesions where examined histologically and 
the results compared to the histology from a preoperative biopsy (Holmstrup et al., 
2007).  Their findings indicated that an under diagnosis was made in 35% of the lesions 
examined.  In other words the secondary analysis indicated a more severe diagnosis than 
the initial biopsy indicated.  Indeed in 3% of cases where the biopsies had shown no, 
slight or moderate dysplasia, carcinomas were observed in the excised tissue sections.   
 
In an effort to gain a better understanding of oral precancer at a cellular level and 
ultimately to enable us to identify the lesions which are at greater risk of malignant 
transformation, there is a growing body of research which seeks to understand 
molecular alterations in normal cellular turnover, and in particular biomarkers which 
may allow identification of abnormal processes.  This is because carcinogenesis is a 
process by which dysregulation of cell proliferation, differentiation and death 
(apoptosis) is seen to occur.  When such dysregulation occurs, the result of this 
uncoordinated process gives rise to the changes amounting to dysplasia as described 
above and potentially invasive neoplasia.  This dysregulation is thought to occur as a 
result of genetic mutations, sometimes secondary to exposure to a particular carcinogen.  
The resultant mutations can result in abnormalities in processes such as cell growth and 
survival.  However, although work is continuing in this area, at present there are no 
biomarkers which can be used in the diagnosis of oral precancer (Pitiyage et al., 2009).  
 
In summary, this section has presented an overview of oral precancer, beginning with 
classification of precancers and noting the relatively recent change in classification from 
the two groups precancerous lesions and conditions to the single group potentially 
malignant disorders.  Each disorder has been briefly described, with a recognition that 
information pertaining to oral leukoplakia accounts for the vast majority of the available 
literature.  The prevalence and incidence of the potentially malignant disorders have 
been presented along with what is known regarding their risk of malignant change.  
Finally oral dysplasia has been put forward as the current best available predictor for 
malignant change and the possible drawbacks of using dysplasia for this purpose have 
been outlined.  The following section will now go onto discuss how oral precancer is 
currently managed.  
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2.2  Management of oral precancer 
 
Since the majority of oral precancers are asymptomatic, the primary objective of their 
management is to prevent malignant transformation (Lodi et al., 2008).   
 
One of the key challenges of oral precancer management is predicting which lesions 
will go on to progress to oral squamous cell carcinoma.   Unfortunately, at the present 
time, there is no means of accurately predicting exactly which lesions are more likely to 
transform compared to others.  Currently, the degree of dysplasia present within a 
precancer is seen as the most reliable marker for malignant transformation.  Although 
discussions in the previous section have outlined the limitations of using dysplasia for 
this purpose, it is generally agreed that lesions exhibiting severe dysplasia pose more of 
a risk of malignant transformation than those with mild or moderate dysplasia (Bouquot, 
Speight and Farthing 2006).  However, some longitudinal studies have indicated that 
even mildly dysplastic or benign mucosal lesions have been shown to present a risk of 
progression (Zhang et al., 2005). Clearly this may pose a problem when it comes to 
managing oral precancer.   
 
2.2.1  Current management options 
 
At the present time there are no evidence-based guidelines available on the management 
of oral precancer.  This is because the evidence pertaining to treatment effectiveness in 
oral precancer is weak, primarily based on cohort studies.  This further complicates the 
treatment planning process, with clinicians having to rely on the current best available 
evidence alongside personal experience.  Such a situation is likely to lead to variations 
in practice and this is reflected in the literature (Epstein et al., 2007; Marley et al., 1996; 
Marley et al., 1998). 
 
 
 
 
Currently, the literature details the following possible options in the management of oral 
precancer:  
 Elimination of risk factors 
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 Surgical removal of the lesion 
 Medical management 
 Conservative management 
 
2.2.2  Elimination of risk factors 
 
It was discussed in the previous section of this chapter that tobacco use and alcohol 
consumption, and to a lesser extent diet and viral infection, are considered risk factors 
for the majority of oral precancers.  It has also been discussed that there is limited 
evidence to suggest that if these risk factors are eliminated, improvement or resolution 
of a precancer potentially may occur (Gupta et al., 1995).  As a consequence, efforts 
aimed at eliminating such risk factors often form an integral part of the management 
plan of an individual with oral precancer.   
 
If we first consider tobacco use in the UK, because of the wider impact of tobacco use 
on an individual’s health, clear guidelines exist regarding the delivery of smoking 
cessation advice and providing access to specialist services.  In the case of hospital 
practitioners, every patient contact should be utilised to promote a healthy lifestyle 
(DoH 2012a).  Specifically, in the case of patients who smoke, this should involve 
referring each patient on to a specialist smoking cessation service (NICE 2008).  
Evidence available prior to the introduction of these guidelines suggested that the 
smoking status of an oral precancer patient was not always determined during a 
consultation (Marley et al., 1998).  It would not be unreasonable to assume from this 
that smoking cessation was, therefore, not always engaged in.  It will be interesting to 
see the impact of such guidelines in future studies of smoking cessation in oral 
precancer management.   
 
Even where professionals are promoting smoking cessation, there is evidence that, in 
the long term, a high percentage of patients with oral precancer continue to smoke.  For 
example, a study by Poate and Warnakulasuriya sought to evaluate the success of 
interventions to eliminate tobacco use in a population of patients with oral precancer 
attending a UK based oral dysplasia clinic.  Their study looked at 180 patients, 83% of 
which were current users of tobacco products.  Using a combination of brief 
intervention advice, medication and referral to a specialist smoking cessation clinic, 
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their cessation success rate was only 20% (Poate and Warnakulasuriya 2006).  Similar 
results have been shown in other studies (Hamadah, Hepburn and Thomson 2007). 
 
There is much less in the literature with regard to the management of the other risk 
factors implicated in oral precancer development and progression, other than the general 
message that education regarding their relevance and interventions to promote healthier 
lifestyles should be encouraged (Reichart 2001). 
 
2.2.3  Surgical removal of the lesion 
 
Currently surgical management of precancer remains the preferred treatment of choice 
for most professionals (Marley et al., 1998; Nankivell and Mehanna 2011; van der Waal 
2009).  Surgical treatment may involve scalpel excision, laser excision or laser ablation. 
(Historically cryotherapy has also been used as a surgical option but will not be 
discussed in depth here because it is not currently recommended as a valid treatment for 
this purpose (Lodi and Porter 2008)).  Generally it is felt that scalpel or laser excision is 
preferable to laser ablation because the latter method makes it impossible to analyse the 
lesion histologically following surgery to assess for the presence of a primary neoplasm 
in an area of dysplastic epithelium (Thomson and Wylie 2002).   
 
Unfortunately, at the present time, there are no randomised control trials assessing the 
effectiveness of the surgical management of oral precancer.  This leads to doubts 
regarding its value as an effective treatment (Lodi and Porter 2008). Indeed, a Cochrane 
review assessing interventions in oral leukoplakia, the most common of the potentially 
malignant disorders, concluded that there was insufficient evidence to assess the 
effectiveness of surgical interventions preventing the future development of OSSC 
(Lodi et al., 2008).  As a result, evidence must be sought from observational studies.  As 
an example, in their retrospective study, Lummerman et al., demonstrated a 15.4% risk 
of malignant transformation for untreated dysplastic lesions compared to 6.2% in cases 
where the dysplastic lesions were excised (Lumerman, Freedman and Kerpel 1995).  
However, unfortunately, although results such as these suggest that a reduction in 
transformation rates may be possible, it remains the case that surgical intervention will 
not eliminate the potential for malignant transformation in all cases (Holmstrup et al., 
2006). 
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As the aim of surgical treatment is removal of the precancerous lesion and its associated 
risk of malignant transformation, it is interesting that the topic of width of the margin 
removed alongside the lesion has never been discussed in detail (van der Waal 2009), in 
the same way that its importance has been noted in the oral cancer literature (Nason et 
al., 2009).  This may be significant when it is considered that pathological changes in 
the epithelium may be present beyond the clinically visible oral precancerous lesion 
(van der Waal 2009).  Indeed, if we look to the work of Hamadah et al., their study 
involving 78 patients undergoing laser excision, found that of the lesions excised as part 
of the study, 45% of the excision margins showed some degree of dysplasia (Hamadah 
and Thomson 2009).  Indicating that further work in this area may be of value as an aid 
to surgical planning.   
 
An additional aspect of surgery which should be considered as part of the treatment 
planning process is that of the possible postoperative surgical complications.  An 
awareness of the potential complications will assist in the decision making process, 
particularly in an area where so much uncertainty regarding treatment effectiveness 
remains.  There is, unfortunately, very little in the literature regarding complications 
following surgical treatment of oral precancer.  Goodson et al., however, recently 
published a retrospective study involving 82 patients having previously undergone laser 
excision of a precancerous lesion (Goodson et al., 2012).  The range of complications 
reported by their group are summarised in table 4.  Interestingly they reported that all 
patients complained of at least one postoperative complication.  Further studies 
documenting potential complications may, therefore, be of benefit in planning treatment 
in that patients will be better informed when determining if the benefits of surgical 
treatment outweigh the risks. 
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Complications after laser surgery for oral precancer 
Pain 
Bleeding 
Paraesthesia of the lingual nerve 
Swallowing difficulties 
Obstructive swelling of the submandibular gland 
Tethering of the tongue 
Difficulties with speech 
Table 4. Complications following laser surgery for oral precancer 
(Adapted from Goodson et al., 2012) 
 
2.2.4  Medical management   
 
Moving on from surgical management, medical treatment is a lesser employed approach 
to oral precancer management than surgery (Marley et al., 1998).  However, the 
potential benefits of medical management are clear: firstly the opportunity to treat the 
whole of the oral cavity, rather than a specified lesion, this is of particular interest given 
the concept of field cancerization, and secondly, the less invasive nature of the 
treatment, removing the potential for the undesirable postoperative complications that 
may be seen with surgery.   
 
In order to select an adequate medical treatment, a compound must be found that is safe, 
long lasting and effective (Scully 1995). To this end, research has demonstrated a 
number of possible treatments, both topical and systemic which have shown promise in 
the field of oral precancer, but as yet a single agent has yet to be identified which can 
satisfy all of the above criteria. Table 5. lists medical treatments which have been 
trialled in the treatment of oral precancer. 
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Medical options trialled in the treatment of oral precancer 
Carotenoids and retinoids 
Vitamin C 
Vitamin E 
Topical Chemotherapy 
Polyamine inhibitors 
Glutathone S-transferase stimulators 
Immunotherapy 
Gene therapy 
Photodynamic therapy 
Table 5. Medical options trialled in the treatment of oral precancer 
(Adapted from Scully, C. 1995) 
 
The previously discussed Cochrane review on the management of oral leukoplakia, 
(Lodi et al., 2008), also reviewed the evidence for the role of medical management in 
patients with oral leukoplakia.  They noted that there were only a few randomised 
control trials of relevance and that upon examination of the evidence, concluded that, 
there was no robust evidence to suggest that any of the medical options investigated 
were effective in preventing relapse or malignant transformation.  This perhaps explains 
the apparently low proportion of UK OMFS consultants currently advocating medical 
management in the oral precancer patient (Kanatas et al., 2011).   
 
2.2.5 Conservative management 
   
An alternative to surgical or medical treatment in oral precancer is conservative 
management.  Also referred to as active surveillance, review or watchful waiting, 
conservative management is usually instituted following a diagnostic incisional biopsy 
and involves patient monitoring, typically by means of intra oral visual inspection.  
Photography may also be used as an adjunct to this process as well as repeat incisional 
biopsies to assess for pathological tissue changes.   
 
In a recent survey of UK based OMFS consultants, Kanatas et al., explored, amongst 
other things, the use of photography and follow-up in the management of oral potential 
malignancy.  In terms of the use of photography as part of the surveillance process, they 
noted that 72% of consultants photographed the lesion ‘always’ or ‘most of the time’ 
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(Kanatas et al., 2011).  This appears to represent a change in practice when the work of 
Marley et al., is considered.  In their survey, conducted 13 years earlier just 13% of the 
UK based OMFS consultants they surveyed routinely photographed potentially 
malignant lesions.  This finding perhaps indicates the value clinicians place on the 
clinical appearance of an intraoral lesion.  
 
Kanatas et al.’s survey also examined review of precancer patients.  They determined 
that 96% of the OMFS consultants surveyed would follow up patients whose diagnostic 
biopsy had contained severe dysplasia, whilst 70% would review those with moderate 
dysplasia.  Where these figures would appear to follow recommendations in the 
literature indicating a continued need for surveillance following an oral precancer 
diagnosis (Mehanna et al., 2009), they do not indicate the frequency, nor the duration of 
such reviews.  This is important if it is considered that in oral leukoplakia, for example, 
observational studies report that only 33%-42% (Lind 1987; Silverman, Gorsky and 
Lozada 1984) of those lesions which undergo malignant change, are thought to do so in 
the first 2 years following diagnosis.  This suggests that long follow up periods may be 
advisable for these patients.   
 
By exploring the possible management options in oral precancer, it can be seen that a 
lack of robust evidence may create difficulty for the professional when attempting to 
plan treatment for an oral precancer patient.  This could potentially explain the disparity 
in treatment practices (Marley et al., 1998), and although calls have been made for the 
formulation of national guidelines (Kanatas et al., 2011), little progress has been made 
due to a persistent lack of high quality evidence.   It can be appreciated therefore that 
uncertainties associated with the effectiveness of the current available management 
options may impact on decisions made in clinical practice.   
 
2.2.5  Negotiating treatment decisions 
 
Given that the evidence base for the management of oral precancer is inconclusive, it 
can be appreciated that decisions surrounding treatment options in oral precancer may 
be challenging.  Evidence previously discussed has demonstrated that management 
practices vary between units, however, at this point it is also worth considering how 
such treatment decisions are made given the difficult circumstances.   
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Making treatment decisions in a health care setting should ideally involve, as a 
minimum, a health care professional and the patient.  In the UK and indeed in many 
other countries worldwide (Legare et al., 2008) the concept of shared decision making 
(SDM) is currently felt to be the preferred model for decision making in medicine.  
(This process is commonly described as: involvement of both the patient and the doctor, 
a sharing of information by both parties, both parties taking steps to build a consensus 
about the preferred treatment and reaching an agreement about which treatment to 
implement (Charles, Gafni and Whelan 1997).  Indeed the government document 
‘Equity and excellence: liberating the NHS’ states that SDM within the UKs National 
Health Service should ‘become the norm’ (Pg. 3) (DoH 2010).  It is suggested that for 
SDM to take place, clinicians will need to spend time developing the necessary skills, 
which should be underpinned by good basic communication skills (Elwyn et al., 2012) 
and although some clinicians have expressed doubt over the effectiveness of the SDM 
process, several randomised control trials support its use (Stacey et al., 2011).  
Furthermore these studies have demonstrated the advantages of SDM, which include an 
increase in patient knowledge, an increased confidence in the decisions made (including 
an increased understanding based on accurate expectations of both positive and negative 
consequences of treatment) and more active involvement in care.  
 
In practical terms SDM seeks to enable a patient to make their own treatment decisions, 
while the clinician facilitates this process by 1) providing information and 2) supporting 
patients while they weigh up their options.   A process which sometimes involves the 
use of specially designed tools.  At present there is no available information in the 
literature relating to the process of decision making in oral precancer management, an 
area which will be explored further with the study groups.   
 
2.3  An individual’s response to a diagnosis of oral precancer 
 
So far the literature reviewed has focused on the group of disorders that may be 
considered under the umbrella term oral precancer and the possible ways they may be 
managed with the last section touching upon shared decision making during the 
treatment planning process.  The remainder of the literature review will move on to 
focus on oral precancer from the patient perspective, examining what it can mean, for an 
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individual, to experience disease.  Specifically there will be a focus on response to 
illness and factors which may affect this response.   
 
When discussing an individual’s response to oral precancer, it is important initially to 
consider the following points.  Firstly, the presentation of oral precancer in the oral 
cavity is somewhat variable, where for some people oral precancer may be accompanied 
by mild symptoms, for others it is completely asymptomatic.  Signs such as an 
unusually coloured patch in the mouth may also go unnoticed, often being discovered 
only during a routine dental intra-oral examination.  It is likely, therefore, that a lack of 
salient signs and symptoms will influence an individual’s medical help-seeking 
behaviour.  Secondly, the disease trajectory of oral precancer is somewhat uncertain and 
is accompanied by an underlying threat of disease progression into oral cancer.   For 
some patients, sometimes following an intervention, complete regression of the disease 
occurs, rendering the person disease free. However, for the remaining individuals whose 
disease neither transforms nor regresses, it assumes a chronic course.  From this it can 
be seen that it is unlikely all people diagnosed with oral precancer will respond in the 
same way.  For some oral precancer will be an acute condition of temporary 
significance, constituting a transitory and limited disruption in their lives.  Whereas for 
others, oral precancer may be thought of as a chronic illness, insofar as its disease 
course is persistent and long lasting.  The following section will explore response to 
illness taking into account the complex and unclear pathway of oral precancer, a topic 
on which there is very little to be found in the literature.   
 
2.3.1  Recognising symptoms and illness behaviour 
 
The decision to seek treatment for an illness usually starts with the experience of 
symptoms.  This does not mean that every individual experiencing a symptom will seek 
medical help, nor will they necessarily consider themselves to be ill.  The way in which 
an individual interprets and acts upon a symptom is called ‘illness behaviour’ 
(Mechanic 1962) and it is this behaviour which determines whether a decision to attend 
a doctor is made. 
 
It has long been recognised that much ill health does not reach medical attention.  This 
is known as the ‘clinical iceberg’ (Last 1963) (Hannay 1980) in which illnesses 
presented to medical professionals constitute only the tip of the iceberg.  An example of 
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this is demonstrated by the work of Scambler et al., in which a group of women were 
asked to keep a diary for six weeks, documenting any symptom experienced (Scambler, 
Scambler and Craig 1981).  Their findings indicated that although symptoms were a 
frequent occurrence, medical attention was not sought in each case.  In fact it was 
reported that on average a medical consultation was conducted for every 18 symptoms 
recorded.   Waiting until multiple symptoms have been experienced can lead to delay in 
seeking treatment which can impact on disease outcome.   
 
Although no work exists in the literature relating to oral precancer and illness behaviour 
specifically, studies looking at patients with signs or symptoms of oral cancer have 
shown that these patients often delay seeking medical attention, with some studies 
reporting delay in up to 54% of cases (Scott et al., 2006; Scott, Grunfeld and McGurk 
2006; Scott, McGurk and Grunfeld 2008).  This is significant as detecting head and 
neck cancers at an early stage is believed to be the most effective means of reducing 
death and disfigurement from this disease. (Dolan, Vaughan and Fuleihan 1998)  These 
studies were selected for review because some of the signs and symptoms of oral 
precancer are common to oral cancer, for example the presence of an intra-oral red or 
white lesion.  It is likely that if patients with symptoms of oral cancer delay seeking 
medical attention, patients with oral precancer too may delay seeking medical help.   
 
Although these and other studies have shown that people do not always seek medical 
attention for a symptom, they do not always indicate the possible reasons for this 
behaviour.  In a bid to explore what prompts an individual to seek treatment generally, 
Mechanic and Volkart conducted a study investigating the circumstances under which 
symptomatic individuals are prompted to seek medical care (Mechanic and Volkart 
1960).  Following on from this earlier work Mechanic later went on to define ten 
variables thought to affect a person’s decision to attend for a medical consultation. 
(Mechanic 1978a) (Table 6.) 
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1. Visibility, recognisability, or perceptual salience of signs and symptoms 
2. The extent to which the symptoms are perceived as serious 
3. The extent to which symptoms disrupt family, work and other social activities 
4. The frequency of the appearance of signs or symptoms, their persistence or their 
frequency of recurrence 
5. The tolerance threshold of those who are exposed to and evaluate the signs or 
symptoms 
6. Available information, knowledge and cultural assumptions and understanding of 
the evaluator 
7. Basic needs that lead to denial 
8. Needs competing with illness responses 
9. Competing possible interpretations that can be assigned to the symptoms once they 
are recognised 
10. Availability of treatment resources, physical proximity, and psychological and 
monetary costs of taking action 
Table 6. Mechanics Ten Variables 
(adapted from (Mechanic 1978a) 
 
Observing the limitations of these variables, Mechanic noted that the relationship 
between symptom experience and help seeking behaviour is complex and that the ten 
variables identified are often seen to interact with one another.  When investigating a 
person’s response to the detection of precancerous signs or symptoms, the first of 
Mechanic’s variables: visibility, recognisability, or perceptual salience of signs and 
symptoms is of particular relevance.  As discussed, one significant feature of oral 
precancer is that, for many, it is an asymptomatic disease.  This can also be true of oral 
cancer in the early stages.  Indeed, it has been shown that even when oral signs or 
symptoms are present they are often misinterpreted both by the patient and the 
professional.  This is demonstrated by the work of Guggenheimer et al., who, when 
investigating factors associated with delay in oral cancer, found that patients were 
unable to distinguish between ominous and innocuous manifestations of their disease 
(Guggenheimer et al., 1989).  They went on to suggest that patients had a tendency to 
attribute oral signs or symptoms to previously experienced common oral or dental 
conditions.  Furthermore, Guggenheimer et al., also reported that in addition to patient 
delay, professional delay occurred in around a third of cases. In other words, as a 
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separate incidental finding, once individuals presented themselves to primary care 
professionals with signs or symptoms of oral cancer, delay was noted when referring 
these patients on to secondary care.  While no additional information was sought the 
authors put forward incomprehensive examination, misleading signs and symptoms, low 
index of suspicion and lack of experience as potential explanations for this.   
 
Another of Mechanics variables may be identified when looking again at the work of 
Scott et al.,  In this study the patients saw persistence of symptoms (variable 4) as a 
significant factor which prompted the person to seek medical advice (Scott et al., 2009).  
However, attending as a result of persistent symptoms clearly relies on the person being 
able to identify the presence of a sign or symptom in the first instance which may not 
always be the case for the oral precancer group. 
 
Looking further at factors affecting medical consultation, Zola conducted a study 
investigating the importance of timing on decisions to seek medical care (Zola 1973). 
Through this work he highlighted the significance of the context in which an individual 
conducts an assessment of their symptoms.  Specifically, he identified five ‘triggers’ 
thought to precipitate a consultation: 
 
1. The occurrence of an interpersonal crisis  
2. The perceived interference with social or personal relations 
3. ‘Sanctioning’ (pressures from others to seek consultation) 
4. The perceived interference with vocational or physical activity 
5. A kind of ‘temporalizing of symptomatology’ (the setting of a deadline, e.g. if it 
has not resolved by next week I’ll make an appointment at the GP) 
 
The importance of sanctioning (trigger number 3) is seen in another of the Scott et al.,’s 
studies investigating patient delay for potentially malignant oral symptoms (Scott et al., 
2006).  This qualitative study reported that people who discussed their experience of 
symptoms with others tended to seek help soon after they developed their oral 
symptoms as a result of what was described as ‘encouragement to seek help’.   
 
Another consideration is that of gender specific illness behaviour, and the evidence that 
women consult doctors more frequently than men.  There is a longstanding view that 
women report many more of their symptoms than men (Mechanic 1978b).  This is of 
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significance in oral precancer as, despite rising levels of disease in women, males 
continue to be predominantly affected. As an example, Napier and Speight report that 
over two thirds of those diagnosed with oral precancer are male (Napier and Speight 
2008).  
 
The works described in this section highlight that the experience of a symptom alone is 
often not enough to bring about a medical consultation, but additional processes may 
need to occur before health seeking behaviour occurs.  The following section will go on 
to explore the cognitive explanations patients may use to make sense of their illness 
following symptom recognition.   
 
2.3.2  Making sense of illness – lay theories 
 
Once an individual has identified signs or symptoms as an indicator of illness, many use 
complex explanatory models in order to make sense of their illness.  These models are 
also known as lay theories.  Armstrong suggests that lay theories probably stem from 
three origins:  
 
1. Idiosyncratic – based on the patient’s own observations and experiences 
2. Popular – knowledge derived from friends and relatives 
3. Expert models of illness – information from biomedicine (Armstrong 1994) 
 
Lay theories are of relevance to the individual not just at the outset of illness but 
throughout the course of their disease.  These explanatory models may influence many 
factors including; recognition of a symptom, the decision to seek medical attention, the 
relationship with the medical professional, acceptance of diagnosis, satisfaction with 
care, acceptance of treatment, and avoidance of perceived risk factors.  It is vital, 
therefore, for the medical professional to take into account that the patient attends for 
consultation not only with signs or symptoms of disease but also with a complex belief 
system which may or may not agree with their own.  For example, in a paper examining 
lay beliefs about familial risk in common chronic diseases, Walker et al., found that 
people at risk of developing such diseases included fatalism in the mental models they 
developed to cope with and control the risk of disease development (Walker et al., 
2004).  Such a belief can have significant implications on the success of potential 
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management strategies, such as reduction of risk factors. For oral precancer this would 
be of importance as risk factor modification is often a part of the management strategy.   
 
Work by Williams proposed that a person’s belief about their illness, specifically 
thoughts regarding its cause, play an integral part in locating their disease in the context 
of their lives, through a process he called ‘narrative reconstruction’ (Williams 1984).  
Through his work, he described three individual’s accounts of their illness (arthritis) and 
noted each person’s viewpoint when recounting their explanations surrounding disease 
development.  Each interviewee attributed the genesis of their illness to a very different 
cause – working conditions, gender specific factors and God’s will.  Although the three 
individuals were experiencing the same disease process it was noted that all three used 
their opinion of disease origin to alter the social narrative accompanying their lives and 
in so doing, made sense of their present lives by giving meaning to the disruption 
caused by illness.  In Williams’ study none of the explanations provided by the patients 
accounting for disease development was seen to correlate to a biomedical explanation 
for their disease.  Williams suggests that medical professionals should consider 
differing beliefs about causes of illness as a possible explanation for the resistance of 
some patients to medical accounts for their disease.   
 
Lay theories may be used not only to help explain how individuals attribute cause to 
their particular illness, but they may also influence which individual’s present for 
advice, help and information when faced with illness (Furnham 1994).  If information 
gained from friends and family leads to a consultation with a medical professional this 
is known as the ‘lay referral system’(Freidson 1970).  The lay referral system has 
parallels to the medical referral system in that advice is sought from more 
knowledgeable individuals, and action taken based on this advice.  
 
As well as providing disease explanation and affecting help-seeking behaviour, lay 
knowledge can be used to enhance professional understanding of the relationship 
between social circumstance and individual behaviour (Popay and Williams 1996).  For 
example, in work carried out with low-income female smokers, smoking appeared to 
provide a way of coping whilst dealing with full time care of young children and 
poverty (Graham 1987). As a risk factor in a number of diseases including oral 
precancer, smoking cessation is often advised, however, factors such as personal 
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circumstance, as outlined above, must be considered when attempting to effect 
behaviour change.  
 
This section has explored how individuals make sense of illness, specifically looking at 
the influence of lay theories.  Following on from this response to illness will now be 
examined.  
 
2.3.3 Response to illness - oral precancer as an acute illness 
 
Once an individual has made the decision to seek treatment and a diagnosis is made, 
they must then try to cope with that illness. In the case of an acute illness, this may be 
straightforward as it is not expected to last, however, in the case of a chronic illness; the 
readjustment needed may be more complex.  
 
If we consider oral precancer as an acute illness then we assume that having the disease 
is a temporary state from which the patient either recovers or their disease transforms 
into oral cancer.  In acute disease, it has been suggested that a person’s ability to 
perform their normal social role is impaired, returning only when the transition is made 
from ill back to healthy.  In other words, acute illness affects not only the individual but 
also societal order. This is seen as undesirable, as Parsons states:  
 
it is clear that there is a functional interest of society…in the minimization of 
illness (p.430) (Parsons 1951) 
 
The concept of the sick role was introduced to describe the relationship between the 
doctor and the acutely sick person who is no longer able to perform normal social roles 
(Parsons 1951).  From the patient perspective there are four main aspects of the sick 
role, two rights and two obligations (Table 7.) and from the doctor’s perspective, four 
expectations and three rights (Table 8.). 
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Rights Obligations 
1. The sick person is exempt from 
their normal social roles 
1. The sick person is obliged to see 
being sick as undesirable and 
want to get well as soon as 
possible 
2. The sick person is not held 
responsible for his or her state 
2. The sick person is obliged to seek 
qualified help 
Table 7. Patients rights and obligations when assuming the sick role 
(Adapted from (Parsons 1951)) 
 
The Parsonian sick role is best illustrated with the example of a temporary acute 
physical illness.  With a physically limiting illness it is possible to see how someone 
may move away from their normal social role and put themselves in the hands of a 
medical professional, temporarily relinquishing their independence.  If the illness is not 
physically limiting however, as is often the case in oral precancer, an individual may be 
capable of carrying out normal social tasks e.g. employment, parental tasks, whilst still 
seeking professional help.   
 
Expectations Rights 
1. Apply a high degree of skill and 
knowledge 
1. Granted right to examine patients 
physically  
2. Act for the welfare of the patient 
and community 
2. Autonomy in professional 
practice 
3. Be objective and emotionally 
detached 
3. Occupy position of authority in 
relation to the patient 
4. Be guided by the rules of 
professional practice 
 
Table 8. Doctors expectations and rights in the sick role 
(Adapted from (Parsons 1951)) 
 
Further difficulties with the sick role in relation to oral precancer appear when 
considering risk factors for oral precancer.  Examples are seen in the literature where a 
person may be held responsible or blamed for their illness particularly in relation to 
alcohol consumption (Chalfant and Kurtz 1971) and smoking related disease (Chapple, 
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Ziebland and McPherson 2004), the two main risk factors in oral precancer.  In this way 
one of the ‘rights’ of the sick person are revoked (one of Parsons rights being the sick 
person should not be held responsible for their disease).  It would seem, therefore, that 
the sick role is a conceptual model that does not apply equally to all people who 
experience illness. Having highlighted difficulties in attributing response to oral 
precancer as an acute disease, response to oral precancer as a chronic illness will now be 
discussed.   
 
2.3.4  Response to illness - oral precancer as a chronic illness 
 
When considering the impact of chronic disease on an individual, the concepts of self 
and identity are especially important.  Self may be considered a coming together of 
multiple elements to constitute the individuality of a person. Self is a cognitive 
construct that is constantly being reconstructed (Kelly and Field 1996), and can 
therefore be altered by life events including illness.  Identity, on the other hand, is 
public and is a view held by others based on shared behavioural or personal aspects of 
the individual.  The two are closely related and so the umbrella term self-identity is 
often seen in the literature.   
 
Gerhart puts forward two view-points as possible explanations of the relationship 
between illness, self and identity.  She calls these the crisis model and the negotiation 
model (Gerhardt 1989).  In the crisis model, becoming ill is about identity change.  
Symptoms of body alterations lead to societal reactions which in turn lead to 
internalisation and alterations in the self. Early oral cancer and precancerous lesions are 
often subtle and asymptomatic (Neville and Day 2002).  As a result changes in the body 
are often not visible and the person may, therefore, choose to try and pass themselves 
off as normal in order to avoid these societal reactions (Goffman 1963).  In contrast, the 
negotiation model characterises chronic illness as a process of loss of self.  In this 
model, an illness, like oral precancer, does not necessarily affect a person’s outward 
appearance but affects how people perceive themselves.  
 
Outward evidence of illness can be important as it has been shown that the presence of a 
visible physical abnormality may evoke a negative reaction (Goffman 1963). Such a 
negative response is known as stigma, which was defined by Goffman as an ‘attribute 
that is significantly discrediting’ (Pg. 3) leading to a ‘spoiled identity’ for the individual 
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concerned.  People who have an illness that is not visible may still be stigmatised if 
their condition becomes apparent or the person chooses to reveal it, for example in HIV 
and AIDS where stigma is a significant problem often resulting in the discrimination of 
this group (Parker and Aggleton 2003).  Where the experience of cancer as an illness is 
associated with stigma, (Muzzin et al., 1994) it is not known if those with precancer 
experience similar social responses.  A paper by Chapple et al., however, highlighted 
the relationship between smoking, lung cancer and stigma, which was felt by the 
participants to be particularly difficult due to the perceived self-inflicted nature of the 
disease (Chapple, Ziebland and McPherson 2004).  This association between stigma and 
smoking related illness may be of significance to the oral precancer study group as the 
disease is strongly associated with smoking.   
 
Another well-established concept associated with chronic illness is that of biographical 
disruption.  If we consider Gerhardt’s views on chronic illness, this concept would fall 
into the explanations put forward by the negotiation model.  Bury (1982) describes 
chronic illness as a disruptive event which results in a change in the individual’s inner 
biography.  He suggests that chronic illness is an experience where the structure and 
form of a person’s everyday life and the knowledge supporting this form is altered.  A 
new biography must therefore be established incorporating the effects of the illness.   
 
Biographical disruption has been explored and applied to a number of chronic diseases, 
including, rheumatoid arthritis (Bury 1982) and chronic pain (Richardson, Ong and Sim 
2006).  Where these chronic diseases have a propensity to peak and trough in terms of 
their symptoms, this is not always the case in oral precancer.  As yet there has been no 
attempt in the literature to explore the process of biographical disruption with oral 
precancer or indeed oral cancer patients.  Attempts have been made, with some success, 
to apply the concept to a group of patients with prostate cancer (Navon and Morag 
2004) and a group of women with cervical precancer (Rajaram et al., 1997).  In the first 
of these two papers men’s difficulties classifying themselves into culturally available 
categories following hormonal treatment for prostate cancer is explored.  The authors 
indicate that the men were unable to consider themselves wholly male, in a cultural 
sense, post treatment.  As a result their pre-treatment relationships are affected.  This 
paper demonstrates that in spite of clinically successful treatment, significant 
disruptions to an individual’s life (in terms of their sense of self) may continue.  
Looking specifically at precancer, the second of the two studies involved women who 
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had received a diagnosis of cervical precancer.  The authors put forward the case that 
these women, whilst they did undergo biographical disruption, found that there were 
specific difficulties associated with this process.  It was felt that these difficulties 
primarily stemmed from uncertainty, especially the perceived uncertainty of the 
diagnosis.  The group had particular difficulty distinguishing between cancer and 
precancer.  As a result the meaning of their illness was often put into context by 
drawing on past personal experiences of cancer rather than precancer (i.e. cancer 
affecting a friend or relative).  It was found that a significant proportion sought 
additional medical information which in turn brought clarity to their diagnosis and 
brought about the ‘mending (of) the personal identity’(p.529) (Rajaram et al., 1997). 
 
The concept of biographical disruption was later re-evaluated by Williams in 2000.  In 
his paper, Williams reflects on the strengths and weakness of the concept of 
biographical disruption (Williams 2000).  In particular Williams highlights the 
importance of timing, context and circumstance on biographical disruption.   
Biographical disruption requires that disruptive event occurs resulting in a re-working 
of an individual’s inner biography and a subsequent change in the individuals self-
concept.  Focusing on the timing of the disruptive event, Williams states that what may 
be considered a disruptive event for some, may for others be accepted as part of normal 
everyday life.  One example used was that of disease considered to be age related and 
therefore seen as ‘normal’ or ‘expected’.  In these circumstances he suggests that 
disease is biographically anticipated rather than biographically disruptive.   
 
As we have explored by looking at the work of Bury, illness, particularly chronic 
illness, results in a change in the way a person perceives themselves.  The perception of 
self is closely associated with self-images which are developed and maintained 
throughout life through social relations (Charmaz 1983). Positive self-images are 
required for a positive sense of self, however, it is proposed chronic illness can lead to 
the ‘crumbling away’ of former self-images.  Experiences then altered by illness may 
result in positive images diminishing, being replaced by new ones framed by an ‘ill’ 
point of reference.  These new images may not be as positive and worthwhile as 
previous images.  The resultant struggle to maintain a sense of self-worth leads to a 
‘loss of self’ which can have a marked effect on an individual.  Charmaz states that this 
‘loss of self’ is exacerbated by four social psychological conditions: 
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1. living a restricted life 
2. existing in social isolation 
3. experiencing discrediting definitions of self 
4. becoming a burden 
 
Again, no work in the literature could be found pertaining to oral precancer.  However, 
a study Röing and colleagues examined patient experience of oral cancer and treatment, 
(Röing, Hirsch and Holmstrom 2007) through this work they demonstrated that oral 
cancer patients undergoing treatment for their disease experience all four of these 
psychological conditions.  As an example, in terms of social isolation, one study 
participant comments that following treatment for oral cancer he no longer received 
invitations to friends for dinner.  It can, therefore, be seen that in oral cancer the effects 
of the disease and its treatment could conceivably result in a loss of self through the 
means suggested by Charmaz. 
 
This section of the literature review has focused on an individual’s illness behaviour, 
specifically examining how people respond to the discovery of signs and symptoms and 
the processes which may take place prior to that individual seeking medical attention.  
This was then followed by an exploration of how lay theories may impact on how 
individuals make sense of their disease and finished by exploring oral precancer as 
either an acute or chronic illness.  The next and final section of the literature review will 
go on to consider the impact of uncertainty in illness.  As previous sections have 
pointed out, a number of uncertainties exist for clinicians managing patients with oral 
precancer.  I felt, therefore, that it may be possible that individuals with oral precancer 
may also experience uncertainty.    
 
2.4  Uncertainty in illness 
 
This section will focus on uncertainty in illness.  As little exists in the literature on the 
topic of uncertainly in oral precancer, this discussion will draw upon work primarily 
from the cervical precancer literature.  Although it is recognised that there are several 
important differences between cervical and oral precancer groups, there are also a 
number of common features which make reviewing this small body of literature 
worthwhile.  Specifically: both diseases are associated with the threat of developing an 
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invasive cancer (Kalliala et al., 2010; Napier and Speight 2008) both may present 
without signs or symptoms (Khan, Appleton and Turner 2008; Neville and Day 2002), 
both have the potential to regress over time (Moscicki et al., 2010; Ramseier et al., 
2010) and both currently have unclear treatment pathways (Kumar et al.,2013; 
Melnikow et al., 2002).  
 
Initial review of the cervical precancer literature, and in particular studies which address 
the patient experience of cervical precancer, highlight one finding of particular note; 
that of the uncertainty commonly associated with a cervical precancer diagnosis 
(Juraskova et al., 2007).  Further reading suggests that, for patients’, uncertainty is 
predominantly associated with ascribing meaning to their diagnosis and making 
treatment decisions (Kavanagh and Broom 1997).  This is perhaps not surprising in an 
area where, like oral precancer, robust evidence regarding treatment effectiveness is 
lacking (Melnikow et al., 2002).  Importantly, it would seem that uncertainty for many 
individuals with cervical precancer group is a negative attribute, which studies suggest 
may contribute to the confusion and increased anxiety often seen in this patient cohort 
(Gray et al., 2006; Shinn et al., 2004).   
 
This section will, therefore, go on to explore uncertainty associated with a diagnosis, 
uncertainty associated with treatment decisions and will finish by considering how 
individuals cope with and manage uncertainty.  As discussed, evidence from the 
cervical precancer literature will be sought, however, the wider literature will be 
considered to further illustrate a number of the points made. 
 
2.4.1  Uncertainty surrounding the meaning of the diagnosis 
 
For patients with cervical precancer, the point of diagnosis is often a challenging one.  
In particular, studies indicate that patients may have difficulty comprehending their 
diagnosis, which can result in confusion and, in some cases, results in patients coming 
to the conclusion that their condition has no diagnostic label (Karasz, McKee and 
Roybal 2003).  Furthermore, the impact of an uncertain diagnosis can be significant and 
may lead, for example, to difficulty seeking further information about their disease as 
well as negative thoughts surrounding the diagnosis (Fylan 1998).  
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In relation to comprehending the diagnosis, it appears that the terminology used to 
describe it is relevant (Juraskova et al., 2007).  Confusion associated with a cervical 
precancer diagnosis may be exacerbated by the terminology used, which patients often 
find inaccessible and difficult to understand.  Precancer in particular, when used as a 
diagnostic term, may be unfamiliar and misunderstood as cancer as patients draw upon 
their wider understanding of cancer to make sense of their diagnosis (Kavanagh and 
Broom 1998).  This can lead some to conclude that a precancer diagnosis will 
unavoidably result in an eventual cancer diagnosis (Juraskova et al., 2007).  The effect 
of making this link is highlighted in a study exploring women’s understanding of 
cervical precancer, in which Kavanagh and Broom report that some women, after 
linking precancer with cancer, began to have thoughts about death and dying (Kavanagh 
and Broom 1997).  In another study involving patients with cervical precancer, the 
diagnosis was seen to preoccupy daily life and was experienced negatively as a 
threatening condition (Posner and Vessey 1988). Other works support this finding and 
further suggest that individual’s may experience anxiety following a precancer 
diagnosis regardless of the level of severity of the precancer (Wardle, Pernet and 
Stephens 1995). 
 
As well as patients reporting feelings of uncertainly in association with specific 
diagnostic terms (like precancer), where the diagnosis is viewed as ambiguous feelings 
of uncertainty may be perpetuated further.  Indeed, studies indicate that were patients 
with cervical precancer interpret their diagnosis as vague, they sometimes conclude that 
there is no discernible label for their condition (Karasz, McKee and Roybal 2003).  
Difficulty with a lack of label can be seen in its most extreme form using the example of 
those with medically unexplained symptoms.  For these patients there is no diagnostic 
label. In a study by Nettleton et al, interviews were undertaken with patients attending 
UK neurology departments (Nettleton et al., 2005).  Each participant was symptomatic, 
but despite medical investigation, did not have a current clinical diagnosis.   One feature 
common to the participants’ narratives was that of chaos, characterised by confusion 
and uncertainty.  The authors describe participants as having particular difficulty with 
no clear beginning or end to their illness, with patients having ‘no route maps for a 
metaphorical journey’(Pg.206).  For these patients it is not possible to say whether they 
will improve, deteriorate or indeed to give any indication of what their outcome would 
be.  Although a diagnostic label is present in oral precancer, it is conceivable that 
uncertainty and confusion may exist where patients are in doubt over their diagnosis.  It 
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is possible that these patients may then subsequently experience difficulties 
comprehending disease trajectory. 
 
A further factor seen in the cervical precancer group which appears to be of significance 
in relation to uncertainty at the diagnosis stage is the notion that the person often feels 
well.  This may make it difficult for individuals to take on board an unexpected 
diagnosis because there is a difficulty accepting that they might be ‘ill’. Indeed 
Hounsgaard et al., have demonstrated that when feeling well, individuals with cervical 
precancer are unprepared to do anything other than confirm they are well (Hounsgaard, 
Petersen and Pedersen 2007).  This can lead to frustration at feeling apparently healthy 
when also potentially ill.  This may be of significance when considering the individual 
with oral precancer, for whom there are often no detectable symptoms.  
 
Within the context of receiving a diagnosis despite a lack of salient signs or symptoms, 
another interesting concept present in the cervical precancer literature is the concept of 
mistrust in one’s body (Juraskova et al., 2007).  For example, some of the women in 
Juraskova et al’s study describe a sense of betrayal by their body as a result of its 
inability to warn them of the disease present.  This concept was particularly felt by 
those who took care of themselves or considered themselves to be healthy (Juraskova et 
al., 2007).  Again, it may be possible that people with oral precancer feel similarly due 
to the often asymptomatic nature of the disease.   
 
2.4.2  Uncertainty surrounding treatment 
 
As well as uncertainty presenting at the point of diagnosis there is also potential for 
patients to experience uncertainty during the management phase of their disease.  This 
may be especially so for oral precancer patients in that, as discussed, given the often 
asymptomatic nature of their condition, it may be difficult for individuals to accept that 
they are ill.  It would not seem unreasonable to suggest, therefore, that this may 
potentially impact on an individual’s ability to make or engage with treatment decisions.  
However, even where individuals acknowledge that they are ill, a lack of clear evidence 
pertaining to treatment effectiveness may lead again to uncertainty; this time associated 
with the aim or perceived success of the treatment.   
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If we begin by considering treatment of the asymptomatic patient, looking to the wider 
literature, it is possible to draw parallels between oral precancer and hypertension.  In 
common with oral precancer, hypertension may be a largely asymptomatic disease 
however, it is associated with the threat of progression to something more sinister 
(although rather than malignancy the risk instead includes: stroke, myocardial 
infarction, heart failure, chronic kidney disease, cognitive decline and premature death 
(NICE, 2011)).  When considering the treatment of hypertension, the aim, much like 
that in oral precancer, is to prevent the patient from developing a more serious 
condition.  However, in hypertension, unlike precancer, treatment often takes the form 
of medical management.  In relation to this, the literature suggests that many patients 
with hypertension experience difficulty complying with a medical regimen (Crowley et 
al., 2013).  It appears that failure to adhere to medical treatment, for some, is directly 
related to individuals questioning the need for treatment at all, given their apparent good 
health (Chrostowska and Narkiewicz 2010).   
 
Although the literature on hypertension may allow us to appreciate areas of potential 
significance when managing asymptomatic disease with drug therapy, this currently 
represents the least common approach to oral precancer management with conservative 
management or surgery instead being more usual options (Marley et al., 1996).  The 
role of uncertainty in each of these management options will now be discussed. 
 
When focusing on conservative management, the wider literature suggests that 
uncertainty regarding the aim of conservative management may result in concern and 
distress.  For example, if we look at prostate cancer (in which, similar to oral precancer, 
there is no specialty agreement regarding optimal treatment), one management option 
often employed for early-stage prostate cancer is that of ‘watchful waiting’ (Donovan et 
al., 2002).  Watchful waiting, also known as conservative management, surveillance, 
expectant management, deferred therapy or active evaluating, provides an option by 
which the disease is monitored and if progression is seen surgical treatment may be 
considered.  This approach avoids the undesirable side effects of more aggressive 
(surgical) interventions. However, watchful waiting may be associated with its own 
undesirable effects, primarily associated with uncertainty regarding the aim of this 
management approach.  In particular studies have noted a number of negative responses 
to watchful waiting including: ‘living under a dark shadow’ (Hedestig, Sandman and 
Widmark 2003) ‘analogous with doing nothing’ (Bailey and Wallace 2007) or the 
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perception that watchful waiting is the equivalent of ‘watch(ing) while I die’ (Donovan 
et al., 2002).  Significantly though, Bailey et al., demonstrated that this type of 
uncertainty may be managed.  They demonstrated the effectiveness of a watchful 
waiting intervention in helping men cope with the uncertainty associated with watchful 
waiting in prostate cancer (Bailey et al., 2004).  Moving away from the prostate cancer 
literature and looking once again at the cervical precancer literature, studies also 
indicate that for people with cervical precancer ‘observation may also cause anxiety’ 
(Melnikow et al., 2002), which, furthermore, may be heightened with each review 
appointment (Hounsgaard, Petersen and Pedersen 2007).  
 
Much like oral precancer, as well as conservative management, patients with cervical 
precancer may alternatively undergo surgical treatment for their disease. Although there 
is much less in the literature on the topic of uncertainty in precancer surgery, a study by 
Meana et al., indicates that highly anxious women with cervical precancer often opt for 
surgical over conservative management (Meana et al., 1999).  Although the study 
design does not allow the reasons for this finding to be explored it is possible that these 
patients are choosing surgery in order to remove their disease and relieve themselves 
from the uncertainty associated with monitoring it instead.  A desire to obtain relief 
from uncertainty is seen elsewhere in the literature (Williams et al., 1999). 
 
2.4.3  Coping with and managing uncertainty 
 
It can be seen from the previous section that uncertainty plays a significant role in a 
number of illnesses including that of cervical precancer.  With this in mind it is 
important to consider how this uncertainty is addressed by clinician’s particularly in 
instances where uncertainty results in a negative outcome for the patient.     
 
Before considering how to manage uncertainty, Brashers states that first we should 
consider how uncertainty is viewed by patients (Brashers 2001).   He states that 
uncertainty is not interpreted uniformly, for example in the cervical precancer literature 
outlined previously uncertainty is viewed predominantly as a negative attribute and is 
liked to negative emotional responses.  However, uncertainty is not always viewed 
negatively and for some can be seen as important for maintaining hope (for example 
where long term prognosis is uncertain).  To this end, the way uncertainly is 
experienced by an individual will influence how a clinician seeks to facilitate its 
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management.  Where historically the literature has focused on uncertainty reduction, 
where uncertainty is seen as positive this may not be the most appropriate strategy.  It 
has been proposed, therefore, that rather than aiming to eliminate uncertainty, for some 
diseases managing uncertainty is more appropriate.   
 
However, uncertainty is appraised by an individual, the most important aspect of 
uncertainty management is communication (Brashers 2001).  Taking cervical precancer 
once again as an example it has been suggested that  not only is good communication 
between the doctor and patient of importance in coping with uncertainty, but that poor 
communication itself may in fact generate uncertainty (Karasz, McKee and Roybal 
2003). Associated with the genesis of uncertainty in cervical precancer are problems 
with lack of reassurance, lack of adequate consultation time or a feeling of being rushed 
and, linked with the latter, lack of opportunity to ask questions. Particularly of note in 
Karvanagh and Broom’s study was the observation that being told ‘not to worry’ did not 
satisfy most women.  Poor communication and a failure to address important concerns 
led to dissatisfaction with care and further led some women to conclude that their 
physicians were incompetent (Kavanagh and Broom 1997).  Conversely, the same 
group indicated that they appreciated doctors who expressed uncertainty about their 
own knowledge, suggesting that doctors should not be apprehensive about 
communicating their own uncertainty.  
 
Looking to the wider literature, in patients with pulmonary artery hypertension, Flattery 
identified several ways in which a group of these individuals coped with uncertainty.  In 
common with the observations of others (Brashers 2001) information seeking was 
strategy used by some of this group (Flattery et al., 2005), with the internet being cited 
as a particularly common source of additional information. However, Flattery suggests 
that as this source of information is not always reliable health care providers should 
assess available sites and refer their patients to the most appropriate and accurate 
resources.   
 
For patients with cervical precancer, studies suggest that not only do these women take 
part in information seeking behaviour, but that their information needs are not always 
met.  This may lead to women seeking advice from sources other than their treating 
clinician including the internet, leaflets, media and other clinical staff.  Clinicians 
should be aware of patients information seeking  behaviour, particularly as studies have 
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shown that while many internet sources are often not dependable, patients believe them 
to be useful and accurate (Metz et al., 2003). 
 
This section has briefly discussed the role of uncertainty in illness, beginning with the 
mechanisms by which uncertainty may occur at the diagnosis stage. It went on to 
consider uncertainty associated with management of a disease and concluded by 
considering the significance of communication and information seeking when managing 
uncertainty.  This section completes the literature review.  The following chapter will go 
onto describe the aims and objectives of the studies undertaken as part of this work.   
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Chapter 3.  Research Aims and Objectives 
 
Aim 
To investigate both patients and professionals experiences of oral precancer with a view 
to identifying opportunities to improve patient care. 
 
This will be achieved through two separate but related studies.   
 
Study A objectives 
This study will critically examine patients’ experiences and understanding of oral 
precancer through a series of qualitative semi-structured interviews.  The study’s 
objectives are: 
 
1. To gain an insight into the understanding patients have of their disease 
2. To explore what patients recall of the information they receive in relation to 
their   disease  
3. To explore their views of the medium though which information was given 
4. To explore the impact of the diagnosis on the individual’s life and health related 
behaviours 
5. To explore their views of their ongoing clinical management 
 
Study B objectives 
Study B will look at oral precancer from the clinician perspective using qualitative 
semi-structured interviews.  The study’s objectives are: 
 
1. To determine how the diagnosis of oral precancer is explained to a patient and to 
ascertain how concerns are addressed. 
2. To determine if behaviour change, specifically modification of risk factors, is 
considered an important factor in the management of oral precancer and if so 
what action is taken to assist patients with this 
3. To determine the how decisions are made relating to management options for 
patients with oral precancer.   
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Chapter 4. Methodology and Method 
 
The aim of this chapter is to explain the decisions made regarding the approach taken 
with respect to the conduct of the project. In doing so, this chapter aims not only to 
describe the specifics of the research method (the details of the process itself) but also 
the underlying methodology underpinning the research alongside the theoretical 
perspective to which the methodology relates.   
 
4.1  Philosophical assumptions 
 
Each methodological approach is informed by a set of assumptions about the 
researcher’s ontological (beliefs about the nature of reality) and epistemological (beliefs 
ways of knowing and learning about the social world) beliefs. Which in turn inform the 
research approach taken and ultimately the study design. 
 
4.2  Ontology 
 
If we begin by examining ontological perspectives, the stance taken here essentially 
describes the researchers view on the nature of reality (Nicholls 2009), which in the 
context of the social sciences refers to social reality.  The most prominent ontological 
viewpoints are realism and idealism, with realism and idealism being at either end of a 
spectrum.   In realism, it is put forward that social reality is external and exists 
independent of our human beliefs or understanding. Idealism, on the other hand, 
purports that social reality is only knowable through the human mind.  It can be seen 
therefore, that in idealism multiple realities may exist as individual human 
interpretations are subjective and therefore unlikely to be uniform.  To consider these 
two stances alone is to oversimplify things somewhat.  In between these viewpoints 
there exist a number of variants. Subtle realism is one such variant of realism which, in 
common with realism states that an external reality exists independent of our 
understanding, however, it states that reality is only knowable through the human mind 
and socially constructed meanings (Mays and Pope 2000).  This viewpoint, therefore, 
acknowledges that the researcher is likely to have an impact on the research in that their 
subjective perceptions and understandings will be involved in the interpretation of the 
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research.  It is this view (subtle realism) that I have chosen to subscribe to and will 
inform the interpretation of the research findings. 
 
4.3  Epistemology 
 
Epistemology is concerned with the way we seek to know about the world (Green and 
Thorogood 2011).  There are, in essence, two main epistemological stances that exist in 
the social sciences: 
 Positivism 
 Interpretivism 
These stances are essentially polar opposites in that positivists rely on the belief that 
there is one objective reality, that this reality can be measured and understood and that it 
remains unaffected by the researcher.  A positivist standpoint is typically associated 
with quantitative research in which a deductive approach is taken to empirically test a 
hypothesis.  Interpretivism on the other hand, takes the viewpoint that there are multiple 
ways of knowing the world because people are different and are likely to experience the 
world in different ways (Nicholls 2009). They acknowledge that the researcher 
potentially affects the research being carried out.  Interpretivism is primarily associated 
with qualitative research and is the stance that is applied to this research.   
 
4.4  Methodology 
 
Once the philosophical framework of the researcher is established, there is a vast array 
of methodological approaches which may be applied to each framework.  The approach 
taken throughout this study was a generic qualitative approach (Caelli, Ray and Mill 
2003).  This is an approach increasingly practised within the health sciences which 
utilises the core characteristics of qualitative research (the characteristics used in this 
study will be highlighted in the forthcoming paragraphs) and is an approach which is 
deemed appropriate where the study in question seeks to “understand a phenomenon, a 
process, or the perspectives and worldviews of the people involved” (p.3) (Caelli, Ray 
and Mill 2003) . 
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4.5  Research approach  
 
As the label given to the chosen methodology might suggest (generic qualitative 
research), the approach taken throughout this study was qualitative.  In terms of 
potential approaches to the study design there are two main research paradigms: 
qualitative and quantitative.  When designing a study, the approach adopted will be 
informed not only by the researches theoretical perspective, but also by the nature of the 
research question.   
 
Qualitative research seeks to understand human behaviour; it seeks to investigate the 
meanings people attach to their experiences of the social world.  The goal of qualitative 
research is to develop concepts which improve our understanding of social phenomena 
in natural, rather than experimental settings (Pope and Mays 1995).  Quantitative 
research, on the other hand, is concerned with quantification and numerical analysis and 
is often seen in conjunction with empirical research.  To fully appreciate how each may 
be applied to the same topic and using oral precancer as an example, a quantitative 
study may seek to discover how many referrals are made from primary to secondary 
care (Brocklehurst, Baker and Speight 2009b), whereas a qualitative study may seek to 
determine why  the referrals were made by exploring the rationale behind these referral 
decisions (Brocklehurst, Baker and Speight 2009a).   
 
This project is divided into two studies: study A involving individuals who have been 
diagnosed with oral precancer and study B involving clinicians (OMFS consultants) 
involved in the care of patients with oral precancer.  Initially study B was to be a 
quantitative survey seeking to determine current management strategies undertaken by 
UK based OMFS consultants. The intention was to compare this to historical data to 
determine if management strategies are changing over time.  However, following the 
patient study (study A), I felt that a more logical approach would be to investigate the 
clinicians’ perspective of areas of oral precancer management using the areas 
highlighted by the patient study group as a basis for the investigation.  Therefore, 
ultimately, both studies were qualitative in design, utilising semi-structured interviews 
to gather data.  
 
Although historically used primarily in the social sciences, qualitative techniques, and 
in particular qualitative interviewing, have been shown to play a valuable role in health 
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care research and as a result are now becoming more common place (Pope and Mays 
1995; Britten 1995; Gilbert 2008).  Although qualitative interviews are the most 
common method of qualitative data collection in the medical sciences, it is worth 
mentioning that many other forms of data collection exist in qualitative research.  
Alongside interviewing, these primarily include: observation, participation and 
analysing documents and material culture (Marshall and Rossman 2006). 
4.6  Qualitative interviewing 
 
I felt that for the purposes of this research semi-structured in-depth interviews would be 
the most appropriate form of data collection.  (Lewis and Ritchie 2003) (Lowes and Gill 
2006).  Specifically, I felt that this particular method would be best suited to achieving 
the research aims, namely exploring patients’ and professionals’ subjective experiences 
and views of oral premalignancy and the underlying understanding and beliefs that 
contribute to the formation of these views.  I will now go on to discuss this research 
method in more detail.   
 
Kahn and Cannel describe qualitative interviewing as a ‘conversation with a purpose’ 
(p.149) (Kahn and Cannell 1957). While the interview may be organized to some degree 
(in that the interviewer has in mind a broad framework of objectives, i.e. areas they wish 
to cover) it is not intended to be a formal interaction, being largely shaped by the 
responses of the interviewee.  This is important in that the purpose of the interview is to 
explore the participant’s reality, their experience of a particular phenomenon and how 
they make sense of it.  Unlike many conversations in the clinical context (which as a 
dentist I had previously been more familiar with) open ended questioning is favoured so 
that these experiences can be explored.  
 
In general terms, qualitative interviews may be semi-structured or unstructured.  
Structured interviews may also be conducted but these constitute a quantitative method 
of interviewing and by their nature do not allow for the exploration of a topic in the way 
that the other interviewing methods do.   Unstructured interviews, on the other hand, are 
much less predetermined and largely informed by the response of the participant (Pope 
and Mays 2006).  As previously mentioned, the interviews conducted for my research 
were semi-structured.  This was a decision made to ensure that specific areas of interest 
relative to the study objectives were explored with the participants.  The semi-structured 
interview is guided, to some extent, by a pre-prepared interview schedule or topic guide.  
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This allows the interviewer to cover anticipated areas of interest with all participants, 
but is evolving in its nature in that new unanticipated subject areas may be added to the 
guide as the study progresses.  In this way it was possible to ensure that the objectives 
of the study are met by focusing the discussion on defined areas, whilst also being 
flexible enough to explore additional areas of importance to the participants.  The topic 
guides for both studies were therefore informed by the aims and objectives of the study 
as well as by a review of the literature.  The initial areas selected for enquiry following 
this process are shown in Table 9.   
 
Study A Study B 
Individuals’ understanding  of oral 
precancer 
Delivery of a diagnosis 
Experience of treatment Decisions relating to disease management 
Life impact Approach to behaviour change 
Behaviour change  
Table 9. Initial topics selected for inclusion in topic guides 
 
These preliminary subject areas were then further developed to produce the interview 
topic guides, which were used at the start of the interview process and were modified as 
the studies progressed to include emerging topics.  These topic guides may be found in 
appendices G and H. 
 
As well as considering how best to guide the interview content by designing a topic 
guide to focus the discussion, a number of other factors associated with the interview 
process were taken into account as part of the study planning process.  These included: 
 
 The interview style 
 Interview location 
 Interviewing sensitively 
 The influence of the interviewer on the interview 
 The power dynamic within the interview 
 Issues associated with interviewing colleagues  
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I looked specifically at each of these factors as I felt that they had the potential to 
influence the success of the interview process and therefore the quality of the data 
generated.  Each of the factors and their relevance will now be discussed in detail. 
 
4.6.1  The interview style 
 
It was important for me to consider that although I was used to ‘interviewing’ patients 
as part of a clinical assessment, the necessary skills involved in qualitative interviewing 
are very different (McNair, Taft and Hegarty 2008).  Where clinical assessment 
interviews are often conducted with the purpose of gathering specific information 
necessary to work towards a diagnosis (in other words deductive), qualitative interviews 
seek to discover the framework of meanings an interviewee ascribes to a particular 
experience.  The researcher needs to
 
remain open to the possibility that the concepts and 
variables
 
that emerge may be very different from those that might have
 
been predicted at 
the outset (Britten 1995) (This certainly proved to be true in my case.  Specific 
examples will be given as the data is discussed in later sections). In order to acquire the 
necessary skills, interview training was carried out prior to the recruitment phase of the 
project with the Health Experiences Research Group at the University of Oxford.  
Following this training, and to ensure consistency, I conducted all the interviews.  This 
ensured that themes emerging from the interviews could be taken from one interview to 
the next in a seamless manner.   
 
Furthermore each transcript, as well as being analysed from the point of view of 
achieving the research aims, was also examined to assess the interview technique. 
Despite having an awareness of potential common problems encountered during a 
qualitative interview, such as avoiding awkward questions, jumping from one subject to 
the next  and the potential for interviewee or interviewer ‘stage fright’ (Field and Morse 
1989), it was possible for me to see from the transcripts the difficulties I was 
encountering which helped me to correct them for subsequent interviews.  For example, 
initially I found I was approaching the interviews using much too superficial an 
approach, moving on from topics too quickly and as a consequence failing to explore 
each topic in much detail.  I also noticed that in response to the difficulty I felt with 
broaching sensitive subjects I was failing to examine these areas with any great depth.  
Reviewing the interviews in this way from the beginning alongside secondary review by 
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supervisors, allowed me to refine my technique and conduct better, more meaningful 
interviews.   
 
4.6.2  Interview location  
 
For reasons which will become clear, when considering the relevance of the interview 
location, the patient and professional studies will be considered separately.  With regard 
to the patient study, a decision was made to conduct all the interviews face-to-face, 
however, as the interview location is known to affect the content of the interview 
(Elwood and Martin 2000; McDowell 1998) the participants were invited to choose a 
location comfortable for them. A choice was therefore given between an interview in 
their own home or an interview at the hospital they attended for their oral precancer.  At 
each hospital site a room was identified which was non-clinical and away from the 
clinic they usually attended.  Giving participants this option was feasible for the patient 
group not least because all the participants were located locally, within a maximum 
commute of 1 hour and 30 minutes from my base. Given this choice, the majority (19) 
of the patient participants chose to be interviewed in their own home, with the 
remainder (9) interviewed in the hospital. 
 
As I was interviewing in participant’s homes it was important to address the issue of 
interviewer safety.  To this end, standard protocol was applied in that colleagues were 
informed of my whereabouts when I was conducting my fieldwork and arrangements 
were made so that should I not make contact following the estimated interview time, 
efforts would be made to contact me and failing that the authorities alerted. 
 
The professional based interviews were conducted with a specifically selected group of 
individuals throughout the UK.  Due to the varying location of the study participants, 
carrying out face-to-face interviews, similar to those undertaken with the patient group, 
with all participants was not feasible.  The approach taken for this group was instead a 
combination of face-to-face and telephone interviews.  Where possible it was felt that 
face-to-face interviews offered benefits that telephone interviews did not, particularly in 
terms of non-verbal communication. However, the practicalities of travelling around the 
country ruled this out as a viable option.  Therefore, where distance, or participant 
preference, prohibited a face-to-face interview, telephone interviews were conducted as 
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an alternative.  This resulted in 2 face-to-face interviews and 9 telephone interviews 
being carried out with the professional group.   
 
Although telephone interviews have previously been considered most useful for a 
structured interview format (Fontana and Frey 1994), Sturges and Hanrahan have 
suggested that there are a number of instances where telephone in-depth interviews offer 
advantages over those conducted face-to-face.  Specifically, where sensitive topics are 
being explored or where the respondents are members of hard to reach groups (Sturges 
and Hanrahan 2004).  There are also the additional benefits of the interviews being of 
reduced risk to the researcher as well as being less costly to conduct.  Importantly, 
Sturges and Hanrahan, in their study comparing telephone and face-to-face interviews 
for the purposes of qualitative research, concluded by stating that the mode of the 
interview did not significantly affect the data they generated.  
 
From my experience, however, where initially I felt that telephone interviews would be 
advantageous in that they may be seen as more convenient by the professional 
participants, in practice I found that because I had no control over the professional’s 
interview location there were instances where the participant conducted the interview 
from a site which was less than ideal in that there were distractions or interruptions 
which I felt took the focus away from the interview process.  An example of this would 
be a participant taking part in an interview from an operating theatre.   
 
4.6.3  Interviewing sensitively 
 
During the study design process, consideration had to be made to the potentially 
sensitive nature of the topic.  Finding a single definition for what constitutes sensitive 
interviewing is difficult.  Sieber and Stanley define sensitive interviewing as that in 
‘which there are potential consequences or implications, either directly for the 
participants in the research or for the class of individuals represented by the research’ 
(p.49) (Sieber and Stanley 1988).  It may be argued, however, that where this broad 
definition is used, almost all interviews could be considered sensitive to some extent, or 
at least have the potential to be.  Lee and Renzetti explored the concept of sensitive 
interviewing from the standpoint of interviewing for which a ‘threat’ is posed (Lee and 
Renzetti 1993).  Defining sensitive interviewing in this way certainly provides a more 
explicit definition, which they classify in the following way: 
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Areas which are likely to be threatening: 
 Where research intrudes into the private sphere or delves into some deeply 
personal experience; 
 Where the study is concerned with deviance or social control; 
 Where the study impinges on the vested interests of powerful persons or the 
exercise of coercion or domination; or 
 Where the research deals with things that are sacred to those being studied that 
they do not wish profaned  (Lee and Renzetti 1993) 
 
Of course a subject which may be regarded as sensitive by one individual may not 
necessarily be considered so by another and indeed may vary widely across cultures and 
situations.  For example, in the context of the patient based interviews I found that 
individuals who had previous or concomitant experience of life-threatening disease 
often appeared to experience oral precancer differently from individuals who had little 
or no previous serious disease experience, in that their accounts appeared to show that 
their oral precancer had impacted on their lives less significantly than those without 
other disease experience.  In spite of this, however, I felt that the subject of oral 
precancer, had the potential to be considered a sensitive topic, particularly with the 
patient group, and gave due consideration to this.  It seemed to me that the experience of 
disease and its associated treatments is, for some at least, likely to be a private, deeply 
personal or emotive experience and therefore threatening.  Interestingly though, work 
by Lowes and Gill exploring the effect of being interviewed on an emotive subject 
(Lowes and Gill 2006) has demonstrated the potentially beneficial effect of taking part 
in a qualitative research interview.  They examine data from two studies which they 
consider to have the potential to elicit an emotional response.  When determining 
feelings about taking part in the studies some interviewees expressed that where initially 
they felt anxious or uncertain, ultimately, none expressed regret or concern about taking 
part in the process.  Indeed some went on to describe the interviews as ‘helpful’ or part 
of a ‘healing process’ (p.591)(Lowes and Gill 2006).   
 
This notion of the qualitative research interview as a therapeutic process, in the context 
of health care research, has been expressed elsewhere in the literature (Moorecroft, 
Cantrill and Tully 2004).  Lowes and Gill go on to comment that where the interviews 
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from their studies may have produced an emotional response they ‘did not cause 
distress, but were a medium through which participants expressed their distress’ (p.593) 
(Lowes and Gill 2006).  Despite this finding I felt that it was important to consider that 
the principal purpose of the interview was not one of therapy, and although not 
necessarily an unwelcome outcome I was aware that should interviewees seek therapy, I 
was not in a position to provide it.  As a result of this, adjustments were made to the set 
up of the patient study.  Specifically, the environment in which the interview took place 
was carefully considered, as outlined in the preceding section, in order to allow the 
participant to feel as comfortable as possible when discussing such a potentially 
emotive subject.  In addition, arrangements were put in place to allow referral of the 
participant to additional medical or psychological services should the need arise.   
 
4.6.4  The influence of the interviewer 
 
The nature of the interview process is such that the data produced may be affected by 
the person collecting it.  That is to say that the interviewer, as an integral part of the 
interaction, has the potential to influence the data collected, for example, by the nature 
of their background.  In my case I am a clinician but, in the context of this research, I 
am also a postgraduate student.  I felt strongly that the way I chose to present myself 
was likely to influence my data.  
 
Prior to interviewing the patient participants, particular attention was given to the 
possible influence of my professional background on the interview process.  Whilst 
coming from a clinical background and having had previous experience of working on 
similar clinics from those from which the patient participants were recruited (in a 
different hospital) I felt it was important that I presented myself as a ‘researcher’ and 
not a ‘clinician’.  This was of particular importance as I was looking to explore, in 
depth, the experiences of the individual patients including those experiences in a health 
care environment (which by its very nature will involve relationships with health care 
professionals and their influence on experience of care).  As the patient based study 
focused on the experience of disease and care I decided that presenting myself as a 
clinician would potentially discourage participants from speaking frankly, specifically 
with regard to negative clinical experiences. 
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This particular dilemma has been explored in a paper by Richards and Emslie, in which 
they consider the impact of the professional background of two researchers on their in-
depth interviews on the subject of heart disease (Richards and Emslie 2000).  In this 
case one researcher was a doctor, a general practitioner (GP), and the other a 
sociologist.  Where the authors noted some features of the interview process were 
common to both, there were also role specific interview characteristics that became 
apparent.  For the GP these took the form of the interviewees asking or assuming 
medical knowledge.  And for the sociologist, where the professional role appeared less 
well defined, time was taken by the interviewees to place the researcher.  Ultimately 
they concluded that ‘who the respondents think you are affects what you have been told’ 
(p.75).  With this in mind I decided that, for the patient based interviews, I would 
present myself as a researcher.  I felt that this approach would be more likely to allow 
respondents to talk freely about their medical care without feeling restricted by my 
clinical background.  From a moral point of view, however, I made the decision that if 
asked directly; I would have to reveal that I was also a qualified dentist, even though 
this may influence the data.   
 
The significance of my choice to present myself as a researcher, I think, was highlighted 
when a participant discussed the difference between the dynamic of the interview with 
me compared to that of the relationship he had with the clinician responsible for his 
care.  He then described how the nature of the relationship with the clinician prevented 
him from asking for further information about his condition.  I wondered if I would 
have been party to this disclosure if the participant had viewed me as a member of the 
clinical team.    
 
4.6.5  Interview dynamics 
 
The same participant mentioned above went on to suggest that the reason he 
experienced difficulty asking for further information was as a result of a power 
imbalance between the two. This manifested as a desire not to look stupid in front of the 
more knowledgeable consultant. The relationship between the interviewer and the 
interviewee is a key component of the in-depth interview and power imbalances within 
this relationship are therefore likely to influence outcome.  Just as the dynamics of the 
doctor-patient relationship in the context of a medical consultation may influence their 
outcome. 
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The balance of power between the two individuals in a qualitative interview is often 
seen as imbalanced in the favour of the researcher, in terms of the researcher defining 
the situation, introducing the topics and guiding the interview (Lowes and Gill 2006).  
However, when the researcher is asking the interviewee for an account of their personal 
experiences and opinions then perhaps they should be considered the expert and 
therefore in a more powerful position.  In line with this concept, Colbourne and Sque 
suggest that accepting the role of interviewee may cause participants to feel empowered, 
allowing them to communicate in a way not normally available to them and  in doing so 
could explain why participants are often happy to answer questions on difficult or 
emotive topics (Colbourne and Sque 2005).   
 
With this in mind, I addressed the issue of power during the interview process by taking 
care to try and make the participants feel comfortable with me prior to beginning the 
interview.  For example by chatting informally before the start of the interview and by 
explaining to participants that it was their experiences I was interested in, in a bid to 
create a power dynamic in which I was not seen as being in total control. In practice, 
when conducting the patient interviews I noticed that the majority did in fact appear to 
feel empowered.  In particular I noticed that participants were often keen to tell their 
stories regularly stating that they were eager to pass on information about their 
experiences to others, suggesting that as a consequence of their experiences they had 
assumed an expert role on the topic.  
 
Power relationships may be different again, when interviewing colleagues.  As I chose 
to interview senior colleagues, and by virtue of my disclosed status as a Clinical Fellow 
I felt that the power dynamic of interview had the potential to differ from that of the 
patient interviews.  Indeed, my decision to disclose my status as a Clinical Fellow 
during study B enabled the professional participants to easily establish my status as a 
junior colleague.  I felt, however, that there was little to be gained by presenting myself 
as a stand alone researcher to this group as some would already know me from other 
settings.  In the context of the clinical environment I am of a lower rank compared to the 
professional interviewees and I wondered whether this would affect the interview power 
dynamic.  
 
55 
 
On reflection, following the clinician interviews I felt that predominantly, although not 
exclusively, the professional interviewees sought to establish the balance of power in 
their favour.  This was accomplished largely by efforts aimed at controlling the 
interview process, for example by veering the conversation away from topics I raised, 
by seeking to test my knowledge on clinical subjects or by displaying expert knowledge 
not directly related to the research questions.   
 
4.6.6 Interviewing colleagues  
 
As well as considering specific issues relating to the interview dynamic when 
interviewing the professional participants, I felt that as a clinician undertaking the role 
of a researcher there may be other specific issues surrounding the interviewing of 
colleagues.  Chew-Graham et al., examined the effect of interviewing colleagues in two 
studies based in General Medical Practice (GMP).  Through their work they noted the 
potential for the interviewer to be seen as fulfilling one of four roles: researcher, 
confidant, expert or judge.  They went on to comment that although being interviewed 
by a fellow professional will have an impact on the data generated from the interview, 
this is not a problem in itself, rather a factor that needs to be acknowledged and 
considered when analysing the data (Chew-Graham, May and Perry 2002).  
 
This is reiterated by Coar and Sim who argue that interviewing colleagues brings up 
particular methodological issues (Coar and Sim 2006).  In their work, again with 
General Practitioners, they identified the following points which they felt were 
significant and potentially important: 
 
 The notion that the interviewee may feel that the interview is a test of 
knowledge 
 The concept that notions of professional identity appear to underlie the dynamics 
of the interview process 
Although these studies raise interesting points, in both cases the interviewee and the 
interviewer where GPs, and were therefore peers.  As a result of this they may be 
considered equals and I wondered if the issues identified above would therefore be 
applicable to my study.  With this in mind I looked to the literature concerning elite 
interviewing, as I felt that this may be more representative of my situation.  
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Study participants may be considered elite when they are seen to be located at the top of 
any stratification system.  In the case of study B; the participants are all high status 
medical professionals which I felt may be considered elite. Specific issues surrounding 
elite interviewing have been examined in the literature.  Broadly speaking, difficulties 
have been suggested around gate keeping, the ability of the elite to manipulate the 
interview process and indeed the dissemination of the results.   
 
I spent some time considering the significance of elite interviewing in relation to the 
interviews I was to conduct with surgeons for study B.  Picking up on the issue of 
gatekeepers, I found that I often had difficulty contacting the participants directly in that 
the contact details they provided were often that of their secretary.  This sometimes 
made arranging a suitable time for interview difficult, involving several attempts before 
an interview time could be finalised.  I wondered whether not having direct access to 
this participant group lead to 2 of the sample dropping out.  Additionally, I also felt that 
being an elite in is a notion intrinsically linked with power and as previously mentioned 
this manifested in the context of the interview process as the professional participants’ 
seeking to control the interview. Ultimately, I approached this by trying to establish a 
rapport with the interviewee and by waiting until I felt that the interviewee was 
comfortable with me before broaching more difficult subject with them, which proved 
successful in a number of cases.  
 
4.7  Sampling 
 
Having established the proposed interview format, the next stage in the study planning 
process was the development of the sampling strategy.  In broad terms, the approach 
taken to sampling varies according to the research paradigm under which the research 
method falls. As the approach undertaken for this study was qualitative, the sampling 
method chosen was that of purposive or criterion based sampling which is a form of 
non-probability sampling.  Sampling differs between quantitative and qualitative studies 
in that quantitative studies tend to employ probability sampling, whereas qualitative 
studies employ non-probability sampling.  The differences between the two will now be 
briefly outlined. 
 
With probability sampling, the aim is to produce a statistically representative sample, 
with each member of the defined population being of equal chance of being selected.  
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With non- probability sampling, on the other hand, participants are selected on the basis 
of their individual characteristics.  The purpose of this is twofold: firstly this approach 
allows the sample to be tailored to ensure that the chosen subject under investigation is 
explored in detail and secondly, this method also ensures diversity by deliberately 
enabling the inclusion wide range of participants (Mays and Pope 1995). In other words, 
the aim with this approach is not to represent the general population, but to select 
individuals who are likely to have experienced the phenomenon under investigation so 
that the social processes involved may be better understood (Silverman 2000).  With 
this in mind, several variables were considered prior to sampling for both the patient 
and professional participant studies.  For the purposes of study A, the patient study, all 
study participants were required to have been diagnosed with oral precancer as this was 
central to the research question.  A number of other potentially relevant factors were 
also considered and taken into account when designing a sampling strategy (Table 10).   
 
Variable  Details 
Gender Male 
Female 
Age 18 - 40 years 
40 + years 
Risk factors 
 
Smoker 
Drinker 
Smoker and drinker 
Never smoker and never drinker 
Management 
 
No active treatment (patient under regular 
review) 
Currently receiving treatment  
Previous treatment received - no further 
disease diagnosed since treated 
Previous treatment received - further   
disease diagnosed following treatment 
Location Newcastle 
Sunderland 
Table 10. Patient study sample group variables 
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I will now briefly discuss each variable and the reasoning behind its inclusion in the 
table.   
 
 Gender - Oral precancer is known to occur in both males and females, however, it is 
well recognised that males and females respond to illness in different ways 
(Scambler 2003).  For this reason the sample sought to include both genders in order 
to explore if men and women experience oral precancer differently.   
 Age - Although oral precancer is primarily a disease of individuals over the age of 
40, I felt it may be possible that younger patients may respond to illness in a 
different way compared to older patients.  As a result of this, as an ideal, I aimed to 
recruit and include patients under the age of 40 in my sample group.   
 Risk factors - The known risk factors for oral precancer are the same as those for 
oral cancer: namely smoking tobacco and drinking alcohol. Because eliminating 
these factors may improve disease outcome, part of any oral precancer management 
strategy is likely to involve an element of smoking or alcohol cessation advice.  For 
this reason, the sampling strategy included sampling patients who had active risk 
factors as well as those who did not in a bid to determine the impact of this on their 
experiences of disease. 
 Management – Alongside the elimination of risk factors, management of oral 
precancer is typically divided into those patients who are treated surgically and 
those who are treated conservatively.  I felt that the way a patient’s disease was 
managed was likely to have an impact on their experience of it.   Experience of 
disease management is of particular interest in this group given the lack of agreed 
protocols from within the specialty.  From the literature elsewhere it has been 
highlighted that patient experience of surgical treatment can often be a daunting 
experience.  However, it has also been demonstrated that conservative management 
options too can have a significant life impact. For example, some patients in a study 
by Donovan et al., interpreted ‘watchful waiting’ to mean watch ‘while I die’ 
(Donovan et al., 2002).   
 Location - I thought carefully about the potential significance of the nature of the 
clinics the sample group attended.  For this reason I chose to sample from two 
outpatient clinics.  This included clinics at two geographical locations.  Ideally the 
geographical research area would have been widened further but due to limitations 
of the project particularly in terms of time constraints, travel and financial 
implications an achievable restriction was placed on the location of the participants 
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to involve those attending clinics in Newcastle and Sunderland.  As well as differing 
locations, each of the clinics was set up in a different way: one of the clinics being a 
dedicated oral potential malignancy clinic and the other a mixed oral and 
maxillofacial clinic where people with a range of head and neck pathology may 
present.  I felt that these factors had the potential to influence experience of disease. 
 
Alongside the sampling framework, which I felt would enable a breadth of views to be 
obtained from the group sampled; a conscious decision was made to seek out ‘deviant’ 
or extreme cases.  In other words patients for whom there may be the potential to 
disprove or challenge current analytical thoughts.  In the case of oral precancer there 
exists a small group of patients who experience multifocal areas of disease.  I felt that, if 
possible, recruiting at least one of these patients would be desirable as they represent an 
unusual manifestation of the disease process and fortunately I was able to achieve this 
goal.  The make-up of the study group recruited according to the sampling framework 
may be found in appendix J. 
 
For the study B, the professional based study, a similar approach to sampling was taken 
compared to that of study A.  The criteria considered in the process are documented in 
Table 11. Again, this approach was employed to ensure a breadth of views. 
 
Criteria Details 
Gender Male 
Female 
Designation 
 
Consultant  
Specialty  
 
Oral and Maxillofacial Surgery 
 
Location Variety of locations, UK wide 
Working environment Teaching hospital, large regional unit, 
district general hospital 
Table 11. Professional group sample criteria 
 
The rationale behind the criteria included will now be explained: 
 Gender – Although the vast majority of OMFS consultants are male, it was hoped 
that it would be possible to recruit female participants too in order to explore the 
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experience of managing oral precancer patients from the perspective of both 
genders, however, in the end, none were recruited.   
 Designation/Specialty - While I recognise that there will be professionals other than 
OMFS consultants involved in the care of oral precancer patients I made the 
conscious decision to focus my study on this professional group.  I felt that since my 
patient study involved patients under the care of OMFS consultants, and that since I 
used the information gained from the first study to inform this one, that consistency 
would be maintained.  I felt that interviewing consultants in particular would ensure 
that, as the individuals had completed their professional training, participants would 
be more likely to have developed firm personal views on the topic which, perhaps, 
junior trainees would not.  It is also more likely that these individuals have 
involvement in the set up and organisation of the clinics that the precancer patients 
attend.   
 Location/Working environment – The location or the working environment may 
potentially affect the clinical set up, particularly in terms of the staff (and/or 
students) involved in the clinic, the mix of cases seen and the associated services 
offered.  I wished to examine what participants felt the significance of this was and 
if they were involved in the set up and organisation of the clinics, what relevance 
they felt their choices had to the management of the oral precancer patient.   
 
The make-up of the group of participants for study B with respect to the sampling 
criteria is documented in appendix J. Although the sampling criteria for both studies 
were designed to ensure a breadth of views were obtained, it is acknowledged that there 
may be possible bias in the self-selecting nature of these groups.  For example, in the 
professional group it is possible that those choosing to participate in the study have a 
particular interest in precancerous lesions.  
 
The final consideration in the sampling process is that of sample size.  This is another 
area in which probability and non-probability sampling differs.  Unlike probability 
sampling, in which sample sizes are determined by statistical testing, in non-probability 
sampling,  sampling is linked to data saturation which is the time at which further 
interviewing generates no new additional themes (the generation of themes will be 
further explained in the discussion on data analysis).  In other words, once data 
saturation occurs the sample is complete and only then is the final sample size 
determined.  For the purposes of this research, data saturation was seen to occur at 16 
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interviews for area 1 of the patient study, 12 interviews for area 2 and 11 interviews for 
the professional study, which is in line with the literature (Guest, Bunce and Johnson 
2006).   
 
4.8 Recruitment 
 
The patient cohorts were recruited from outpatient OMFS clinics in both Newcastle and 
Sunderland.  As outlined in a previous section, I had made the decision to present 
myself as a researcher during the patient interviews, therefore, to avoid potential 
participants associating me with the clinic I decided not to be actively involved at the 
recruitment stage.  Instead, at each clinic a lead consultant was identified to co-ordinate 
the recruitment process.  This involved identifying suitable participants, providing a 
verbal explanation of the study along with an information leaflets and reply slip.  If, 
following this, a patient wished to participate the reply slip was filled in.  Using the 
information provided on the reply slip, I contacted each potential participant following a 
7 day cooling off period.  
 
In practical terms, not being directly involved in the recruitment process made the 
process more difficult, recruitment was slower than anticipated and despite arranging 
meetings to identify and manage difficulties progress was slow.  Ultimately I applied 
for an amendment to the ethical approval to enable me to modify the recruitment 
process to include recruitment via post.  This was accepted and recruitment continued 
successfully following this amendment. However, the process took 18 months in total to 
complete.  
 
In terms of the professional study, potential participants were identified using a database 
of registered OMFS consultants on the British Association of Oral and Maxillofacial 
Surgeons (BAOMS) website.  This provided information pertaining to gender, 
designation, geographical location and working environment to be established in line 
with the sampling criteria.  Recruitment was carried out via post.  Potential participants 
were provided with a study information leaflet, including researcher contact details 
should further information be required, and a reply slip.  Once a reply slip was received 
participants were contacted to arrange a suitable time for interview.   
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Although the recruitment process for the professional study was different to that of the 
patient study, problems were also encountered.  Specifically the need to obtain research 
and development (R&D) approval from each NHS trust associated with each individual 
participant resulted in considerable delay.  Another problem involved the addition of 
gatekeepers, which had not been relevant to the patient group. In particular the 
professional participants always gave their secretaries contact details rather than their 
own.  This sometimes resulted in difficulty arranging a suitable time for an interview to 
take place and in 2 cases, despite multiple attempts; it was not possible to set up an 
interview at all.  
4.9 Ethics 
 
Following the planning process approval must be sought from the National Research 
Ethics service (NRES) before the study can commence.  NRES is part of the Health 
Research Authority, its role being to ‘safeguard the rights, safety, dignity and wellbeing 
of people participating in research’ (NRES).  To this end, I felt that the main ethical 
issues associated with the studies were: 
 Confidentiality 
 Consent/ Coercion 
 Emotional distress 
I addressed these issues by: ensuring confidentiality was maintained throughout the 
project including the anonymisation of data (including changing the participants 
names), by gaining written informed consent from each participant, by leaving a cooling 
off period between recruitment and the interview process, by making participants aware 
that they were free to withdraw at any time and by ensuring arrangements were in place 
to deal with any undue emotional distress caused by participation in the project.  
 
Following review of the submitted approval documents, within which these issues were 
addressed, and a subsequent committee meeting, ethical approval was granted by 
County Durham & Tees Valley 2 REC (Reference number 08/H0908/77) (Appendix B).  
Later, as the project progressed, two substantial amendments were made and approved 
(Appendices C and D).  The first related to change of the design of professional study 
from quantitative to qualitative and the second was to allow postal recruitment as well 
as face-to-face recruitment in the patient based study. 
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Approval was also sought, and gained, from the research and development (R&D) 
department of each NHS site involved in the research. This, unfortunately, lead to 
considerable delay.  Particularly in relation to study B which required approval from 12 
individual R&D departments.  Funding was obtained in the form of a small research 
grant from the British Association of Oral and Maxillofacial Surgeons and was used 
towards the cost of the work.   
 
4.10 Pilot interviews 
 
Prior to beginning each of the studies in earnest pilot interviews were conducted.  The 
process involved recruiting, setting up and undertaking an interview with a participant 
from each group.  The main purpose of these pilots was to test the suitability of the 
topic guide.  However, they also allowed me to identify any practical issues with the 
proposed study set up as well as allowing me to practice and develop my interviewing 
technique.   
 
4.11 Analysis  
 
I chose to analyse the data using thematic analysis, which is an approach used widely 
across several disciplines (Rapley 2010).  Thematic analysis is a process by which 
commonalties within the data are identified, reviewed and refined.  This process allows 
the researcher to not only richly describe the data but also may enable them to look for 
patterns which can help to examine or establish the underlying meanings behind the 
data content.  Where some claim that thematic analysis is merely a component of other 
types of qualitative data analysis (Ryan and Bernard 2000), Braun and Clark argue that, 
as a widely used and flexible analytical process, it should be considered a research 
method in its own right (Braun and Clarke 2006).  They go on to state that, in terms of 
qualitative data analysis, it is not so much the label applied to the analysis that is 
important, but that the process itself is clearly stated and justified.  For this reason I will 
now go on to outline the steps involved in thematic analysis (Table 12). 
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Phase Description of the process 
1. Familiarising 
yourself with 
your data 
Transcribing data (if necessary), reading and re-
reading the data, noting down initial ideas 
2. Generating 
initial codes 
Coding interesting features of the data in a systematic 
fashion across the entire data set, collating data 
relevant to each code 
3. Searching for 
themes 
Collating codes into potential themes, gathering all 
data relevant to each potential theme 
4. Reviewing 
themes 
Checking if the themes work in relation to the coded 
extracts and the entire data set, generating a thematic 
‘map’ of the analysis. 
5. Defining and 
naming themes 
 
Ongoing analysis to refine the specifics of each theme, 
and the overall story the analysis tells, generating 
clear definitions and names for each theme 
6. Producing the 
report 
The final opportunity for analysis.  Selection of vivid, 
compelling extract examples, final analysis of selected 
extracts relating the analysis back to the research 
question and the literature, producing a scholarly 
report of the analysis 
Table 12. Phases of thematic analysis 
 
I began analysis of the interview data at an early stage of data collection, using thematic 
analysis based on the ‘constant comparative method’ (Glaser 1965).  This is an 
inductive, data driven style of analysis.  By analysing the transcribed interviews as soon 
as they are produced, interesting features can be noted (or coded) immediately.  This has 
the benefit that unanticipated issues arising from the early interviews may be 
incorporated and explored with later interviewees.  In this way the interviews are not 
limited to exploring areas that the researcher thinks are important (anticipated themes) 
but are also free to explore other topics raised by the participants (emergent themes) 
(Ziebland and McPherson 2006). 
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Prior to coding, the first step in the analysis of the data involved transcription of the 
digital recordings.  The transcriptions were carried out by a professional transcription 
company and then checked through alongside the original audio recordings to ensure 
accuracy. Checking each recording in this way began the analytical process by, 
importantly, initiating familiarity with the data.  Once this process was completed initial 
coding could begin.  Coding involves carefully examining the transcripts, then selecting 
and labelling sections of dialogue.  Labelling a piece of data in this way provides, at a 
basic level, a method of indexing so that sections of data may be retrieved at a later 
date. On a deeper level, coding is an important basis for the next stage of thematic 
analysis, which involves collating codes, identifying patterns and considering 
relationships between codes so that common themes may be identified. 
 
Where traditionally this process was carried out by physically highlighting text on the 
printed out transcripts, cutting the sections out and grouping them together, computer 
packages have now been developed to aid this process.  It is important to note, however, 
that the packages do not undertake the analysis.  Rather they act as an electronic filing 
cabinet, allowing the researcher to group together sections of text into electronic files 
rather than paper based files.  Since I had used neither method before I undertook 
training in both the traditional and electronic methods of data analysis.  Ultimately I 
found that I felt more involved with the data if I used the traditional approach so this 
was the approach I employed throughout both studies.    
 
Once these themes had been assigned, I employed a technique outlined by Ziebland and 
McPherson to summarise the data (Ziebland and McPherson 2006). Essentially they 
describe a process by which one large summary document is produced.  This document 
displays the themes identified in a map style format.  This approach allows relationships 
between themes to be explored and patterns identified visually.  By including the 
respondent’s identification tag alongside each code it also enables the researcher to look 
for patterns between individuals grouped around specific themes as well as between 
themes themselves.  As initial themes were developed, transcripts were then re-analysed 
to ensure the validity of the initial themes.  By continually reviewing the data set, it was 
possible to ensure that no potentially significant information was overlooked.  This 
process continued until new interviews failed to produce any new themes, that is when 
data saturation was seen to occur.  In order to better illustrate this process, and taking 
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the patient interviews in study A as an example, Figure 1 indicates the initial themes 
identified from the coded interviews: 
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Figure 1. Initial themes and  
their associated codes 
 
It has been suggested that a potential problem with thematic analysis is a failure to 
analyse the data at all (Braun and Clarke 2006).  It is potentially possible that data may 
be superficially coded but the researcher fails to make sense of the data by searching for 
depth and meaning within it.  I was aware that as a novice researcher this was a 
potential pitfall.  Therefore, in order to avoid this I regularly discussed my findings with 
my qualitative supervisor as I sought to develop and refine codes and themes.  These 
discussions helped greatly when initially attempting to make sense of the data. Another 
activity which I found particularly helpful was attending a data analysis session from 
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another project within the institute.  It was useful for me to observe senior colleagues 
work with a data set and explain the approach taken when merging codes into larger 
themes then later, refining and searching for patterns and relationships between those 
themes. 
4.12 Limitations of chosen method 
As with all research methods, as well as particular strengths, the limitations of the 
chosen methods should be also be considered before a final decision is made with 
regard to the method undertaken.  In terms of qualitative interview based data collection 
and analysis, the following limitations were considered: 
 Generalisability 
Due to the nature of the sampling process (purposive), it may not be possible to 
generalise or apply the results of the research to other settings. However, the ability to 
transfer results to other groups is said to be enhanced by ensuring a breadth of views in 
the sample and by providing an adequate description of the research context (Malterud 
2001), both of which have been taken into account and outlined earlier in the chapter.  
 Influence of the researcher 
The influence of the researcher on the data must be considered.  This may be as a result 
of personal biases (for example professional status, see section 4.6.4) or through the 
skills of the researcher (in particular how experienced they are in relation to the research 
method, see section 4.6.1).  The potential for such bias has been outlined so that the 
reader may interpret the results with these possible influences in mind.  
 Time consuming  
Qualitative research is an often time consuming process, both in terms of data collection 
(particularly where participants are interviewed in their own homes) as well as the time 
taken to undertake the analysis itself. However, being prepared to give time to the 
research allows the researcher to gain an insight into a previously under investigated 
area.   
 
In summary, this chapter has considered not only the method but the underlying 
methodology associated with the project design.  It has examined a number of the, 
sometimes complex, considerations made prior to the start of the interview process and 
has concluded by describing the approach to data analysis.  Accordingly, the next 
chapters will discuss the results of the analysis, beginning with Study A, the patient 
based study. 
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 Chapter 5. Patient Results and Discussion:  
The patient journey 
 
5.1  Introduction 
 
The following section comprises the results and discussion of the patient based study.  It 
is organised in chronological order, that is, the order in which the patient experiences 
their disease from initial discovery of symptoms (if experienced) through to diagnosis 
and management of the condition and, where relevant, the ongoing effects of living with 
oral precancer. I believe that organising the chapter in this way provides a clearer 
narrative, allowing me to see opportunities within this pathway where interventions may 
take place. Therefore, using this structure as a basis for discussion, the results will be 
explored with particular reference to the following themes: 
 
 Perceived disease aetiology 
 Information provision/needs 
 The doctor-patient relationship 
 Precancer associated risk factors 
 Attitude to disease 
 Experience of treatment/disease management 
 Withholding concerns 
 
As it is possible for a single theme to emerge at more than one stage of the patient’s 
journey, where relevant, themes will be discussed multiple times and within the 
appropriate sections.  The discussion begins at the stage of the journey prior to the 
individual’s initial visit to a health care professional. 
 
To aid the discussion quotes from the participants will be used to illustrate points made.  
At times the interviewers questions will be given alongside the interviewees responses, 
this is to allow the reader to appreciate the context in which the responses were 
provided. Although a breadth of responses are presented, it was not possible to include 
data from each participant.  Of the 28 patient participants, 3 were not included in the 
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discussion.  This was as a result of additional oral disease or general health problems 
which influenced their responses. 
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Figure 2. Route to diagnosis – patient pathway 
 
5.2  Pre-diagnosis – An account of participants help seeking behaviour 
 
The patient’s disease journey begins with the discovery that there is an abnormality 
present in the mouth.  This discovery is made either by the individual themselves or by 
a health care professional, most commonly the General Dental Practitioner (GDP).  At 
this early stage it is possible to divide the study group into two, those for whom 
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symptoms alerted them to the abnormality and those without symptoms.  Although, in 
the long run, both groups end up in specialist care, the route and therefore the 
experiences of each group at this stage are very different.  Figure 2 is constructed to 
provide a visual illustration of this journey for both patient groups.  It can be seen from 
Figure 2 that once an abnormality has been detected and acted upon a pathway follows 
which ultimately leads to a diagnosis.  However, the precise route and duration of this 
pathway will be largely dependent on the presence or absence of symptoms and, where 
symptoms are present, the actions taken upon their discovery.  With this in mind, the 
data will now be discussed from the point of view of the symptomatic individual and 
will begin by exploring their health seeking behaviours.   
 
5.2.1  Health seeking behaviour – the symptomatic patient 
 
Symptomatic individuals who seek medical help quickly are more likely to be 
diagnosed and managed rapidly.  This is particularly relevant when it is considered that 
some of the signs and symptoms of oral precancer are the same as oral cancer, a disease 
that if treated at an early stage may not only result in a higher chance of survival for the 
patient but could be less of a financial burden on health care services.  Yet, examination 
of the data revealed that the experience of oral symptoms often did not result in prompt 
health seeking behaviour.  A participant, for example, was aware of the presence of oral 
lesions, however, she attends her dentist for treatment following trauma, which she sees 
as a more urgent problem: 
 
I got these lumps in my mouth and I was seeing my dentist (for something else) 
and he said oh, I think you should go to the hospital about this so he made an 
appointment. 
Betsy (Age 74, Participant 9, Area 2) 
 
Her account suggests that although she is aware of an abnormality in her mouth, for 
some reason this in itself is not enough to prompt her to seek medical help.  In light of 
this, the data was analysed with a view to determining the factors that may affect health 
seeking behaviour in the symptomatic patient.   
 
Whilst it is certainly the case that symptoms have a bearing on many people visiting a 
health care professional, assuming that individuals seek medical advice as a direct 
response to the initial discovery of signs or symptoms does not reflect the true, 
somewhat individual, complexity of this process. As an example, this study participant 
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recalls that he noticed a white patch but states that he did not discuss it with the dentist, 
perhaps feeling reassured by the dentist’s apparent failure to pick up on it at an earlier 
stage: 
 
I: And when your dentist was referring you to the dental hospital were you 
surprised that was happening? 
IV: Well actually I’d been to the dentist a few times before that and he’d never 
mentioned owt but I noticed it about a year before that. 
I: Oh, so you’d seen it yourself before? 
IV: Aye, but I didn’t think nowt of it1 
Bob (Age 48, Participant 10, Area1) 
 
Looking at the dental literature, in general, there is little specific information in relation 
to what factors prompt people to seek care in oral health.  This is perhaps surprising 
given that the experience of oral symptoms in the general population, ‘toothache’ in 
particular, is not an uncommon occurrence (Pau, Croucher and Marcenes 2000) with the 
1998 adult dental health survey finding that 51% of dentate adults surveyed reported 
that they had been affected in some way by their oral health (Nuttall et al., 2001).  
Examination of the sparse available literature, however, suggests that there may be 
numerous, varied reasons that act as a barrier to an individual seeking health care advice 
or treatment once signs or symptoms of disease have been recognised (Fox 2010). 
Looking specifically at oral signs and symptoms in relation to care seeking in oral 
cancer, (which as explained, are sometimes similar to those in oral precancer) the 
literature confirms that where symptoms do have a role to play, their presence alone is 
not always sufficient to warrant a visit to a health care professional (Scott et al., 2009).  
In particular, a study by Scott et al., demonstrated that up to 30% of patients delay 
seeking help for up to three months following self-discovery of the symptoms of oral 
cancer (Scott et al., 2009), a finding replicated by my patient study group. 
 
As well as quantifying patient delay in oral cancer, Scott et al.,’s study also went on to 
explore delaying and motivating factors in health related care seeking with this patient 
group. Table 13 summarises their findings: 
 
 
 
                                                 
1
 In the context of the quotes used thought out this document, the letter ‘I’ will be used to indicate the 
interviewer and the letters ‘IV’ the interviewee 
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Triggers to seeking care Barriers to seeking care 
Change in symptoms Beliefs regarding oral symptoms 
Persistence of symptoms Factors relating to the health care 
professional 
Pain Factors relating to circumstance 
Presence of another reason for visit  
Desire an early diagnosis  
Need to resolve uncertainty  
Worry/concern over symptoms  
Dislike of symptoms  
Advice of significant others  
Table 13. Triggers and barriers to care seeking in patients with potentially 
malignant oral symptoms  (Adapted from Scot et al., 2009) 
 
As a number of commonalities appear to be shared between this and the study group, a 
number of these factors will be explored alongside the study data.  
 
5.2.2  Barriers and triggers to seeking care in the symptomatic oral precancer 
patient 
 
With reference to barriers to seeking care, this participant also spoke of his delay 
seeking help for his oral symptoms: 
 
I mean I hate the dentist, I hate anybody touching my mouth, anything like that, 
so it was a case of it had been left and left and the pain had basically got that bad 
that as I say I was at work, me and the kid I worked with at the time, and I said 
‘listen just get us there [to the emergency dental clinic] and you’ll have to drive 
us’. 
Andy (Age38, Patient participant 11, Area 1) 
 
In contrast to the previous patient, Bob, who was regularly attending a general dental 
practitioner, the participant above, Andy, attended a dental emergency clinic for acute 
dental pain, where mucosal abnormalities were observed as an incidental finding.  
Although his symptoms were unrelated to his oral precancer, his experience is 
significant in that it highlights a delay seeking help for oral symptoms, he describes that 
it is only when the pain is persistent and changes in severity that care is sought.  As well 
as Scott et al.’s study, parallels may also be drawn between this behaviour and the 
75 
 
findings of Pau et al.  Through their work they sought to explore care seeking 
behaviours in patients with ‘toothache’.  In relation to toothache, a positive relationship 
was demonstrated between the intensity of the toothache pain experienced and the  
likelihood that an individual will seek health care services (Pau, Croucher and Marcenes 
2000).   
 
Another interesting finding demonstrated by Andy’s passage is the influence that his 
perception of the dentist has in delaying him seeking care.  As it is often the dentist who 
is involved in the process of recognising signs of oral precancer, it can be seen that for 
individuals with dental anxiety and signs or symptoms of oral precancer, a significant 
barrier to accessing appropriate services exists, resulting in increased delays and 
potentially more advanced disease in this patient group.  This finding is also seen in the 
dental literature.  For example Schuller et al., reported that patients with higher levels of 
dental anxiety visited the dentist less frequently than those with low dental anxiety and 
experienced more extensive disease (Schuller, Willumsen and Holst 2003). Armfield et 
al., take this concept further by examining the influence of dental fear on oral health and 
service utilisation using  the model of ‘the vicious cycle of dental fear’ (Armfield, 
Stewart and Spencer 2007). They use this model to analyse their data with a focus on 
dental fear and its relationship to dental visiting patterns.  They sum up by concluding 
that for individuals with high levels of dental fear, delay seeking treatment is greater 
than for those with low levels of dental fear.  This in turn leads to more extensive dental 
problems and erratic symptom driven attendance patterns which serve only to 
exacerbate the individual’s fear and reinforce care avoidance patterns.  Applying this to 
precancer patients it may be seen that barriers to seeking care for their oral precancer 
may be influenced by previous experiences of dental treatment. 
 
Continuing with a focus on barriers to care seeking in the symptomatic individual, the 
patient study data also demonstrates that beliefs regarding oral symptoms could 
influence a person’s decision to seek treatment, a finding also discovered in research by 
Anderson and Thomas investigating why people seek emergency dental care (Anderson 
and Thomas 2003).   They found that an individual’s past experience of oral symptoms 
could result in that person attributing their current symptoms to other, sometimes less 
significant oral conditions which may be amenable to self-care.  
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The findings of Anderson and Thomas’s study are emphasised when considering one of 
the major themes to arise from the data; that of patients’ perceived aetiology of their 
oral condition, where symptoms were commonly misinterpreted as being attributable to 
more frequently occurring, less serious oral conditions such as oral ulceration, trauma, 
burns from hot food or drink or symptoms of dental origin, ‘toothache’. 
 
The Sunday morning when I woke up, I’d been out the night before to the pub 
for a drink with the wife and woke up the next morning and felt my tongue was 
just a bit sort of rough round the edges if you like.  It just had this sort of feeling 
to it.  And it was only when I sort of looked in the mirror, the bathroom mirror, 
and looked at my tongue and I saw this what appeared to be like a sort of white 
area and it was very sort of rough to touch and it sort of threw me a bit because 
it wasn’t there the day before and then all of a sudden it was there the following 
morning, which I found very strange.  And at first I thought it might have been 
due to a drink I’d had at the pub, it may have been a dirty glass and it may have 
been an infection of some description that I picked up from having a drink in the 
pub out of a glass. 
James (Age 61, Patient participant 4, Area 1) 
 
It started with a tiny little white patch on the roof of my mouth which to be 
honest I thought I had just burnt it because I always drink black coffee and it 
used to be very, very hot.  I thought I had just scolded it. 
Lily (Age 58, Patient participant 12, Area 1) 
 
The disadvantage of attributing symptoms to minor oral disease is that patients’ are 
more likely to believe that they may be self-resolving or responsive to self-treatment.  
However, it has been shown that in patients with symptoms of oral premalignancy, if 
these symptoms fail to resolve individuals may then undergo a process of symptom re-
appraisal.  In some cases this prompts health seeking behaviour, but in others alternative 
coping strategies are adopted instead, leading to further delay (Scott et al., 2006), a 
finding also seen within the patient study data: 
 
It wasn’t a question of being frightened of what it was, I think that might apply 
to some people...it was just; oh this is bloody awkward, I wish it were...oh I’ll 
buy some more pastels or I’ll put some more isolating fluid or whatever they call 
it and its just to get to that thought; wait a minute, I've been doing this six 
months. 
Frank (Age 63, Patient participant 11, Area 2) 
 
Another common thread passing through the data was the general belief that a lack of 
pain meant a lack of significance even when other oral changes were present: 
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I didn’t attach much importance to it…I didn’t think it was anything because 
there was no pain, could hardly see anything and I didn’t really worry about it 
Archie (Age 72, Patient participant3, Area 1) 
 
This was a finding again explored by Scott et al, in another study investigating delay in 
patients  presenting with potentially malignant oral symptoms.  They found that patients 
with both benign and malignant disease often delayed seeking treatment, but contrary to 
other studies involving health seeking for oral symptoms, they found that magnitude or 
type of symptom did not impact on patient delay (Scott, McGurk and Grunfeld 2008). 
 
Further analysis of the data also demonstrates that beliefs relating to oral symptoms 
were sometimes guided by knowledge of oral precancer or indeed oral cancer itself. 
 
I mean I’d never really heard, thought or heard much about mouth cancer... I’d 
never really been aware of mouth cancer, never really thought about it.  I know 
the dentist examined for it as part of this annual check-up but the 
consequences... hadn’t been aware of them. 
Archie (Age 72, Patient participant 3, Area 1) 
 
This is significant when we consider that Dubayova et al., have found that knowledge is 
an important factor for decision making, stating that those with knowledge of specific 
medical conditions and their associated symptoms are more likely to present to health 
care providers, seeking treatment, should symptoms occur (Dubayova et al., 2010).  
However, the above patient’s account highlights the notion that public knowledge of 
oral cancer is poor.  A finding supported by a survey commissioned by the Health 
Education Authority aiming to determine public awareness and knowledge of oral 
cancer in the UK, which demonstrated that oral cancer was one of the least well known 
cancers compared to those affecting other body sites, with only 56% of the survey 
participants being aware of it (Warnakulasuriya et al., 1999). 
 
Given this lack of awareness of oral cancer in the general public previous knowledge of 
oral cancer and precancer was also explored with the study group: 
 
They didn’t know exactly what it was because I don’t know myself to be honest. 
Betty (Age 80, Patient participant 2, Area 1) 
Talking about discussing her condition with her family 
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It was observed that a lack of awareness of oral cancer and precancer affected not only 
the individual’s ability to seek care, but also impacted at later stages of the disease 
journey, as seen above, where Betty had difficulty explaining her disease to her family. 
 
As well as the experience of previous oral disease, patients’ experience of other illness 
was also seen to influence their response to oral symptoms.  This is a phenomenon 
which is not exclusive to oral precancer patients.  Looking at the wider literature, a 
pattern of delay in people with previous disease is repeated throughout a number of 
medical disciplines.  For example, studies involving patients with breast cancer show 
that women who have previously experienced benign forms of breast cancer delay 
longer in comparison to women without a history of benign disease (Caplan and 
Helzlsouer 1992).  
 
Where the study referenced above demonstrated that those with a history of benign 
disease delayed seeking help, examination of the data revealed that those with history of 
malignant disease (at other body sites), often reacted by assuming that an oral lesion 
was likely to be malignant too: 
 
I: So when the dentist suggested referring you to hospital, what did you think at 
that point? 
IV: I had a panic… because I have I’ve had a couple of histories of cancer, but 
survived. 
I: So was that you’re first thought then… that there might be a cancer in your 
mouth? 
 IV: Oh yeah 
Wilma (Age 64, patient participant 7, Area 2) 
 
Furthermore, this reaction did not appear to occur exclusively in those with a personal 
experience of cancer.  Where patients had experience of someone close to them having 
or experiencing cancer, the association between their oral condition and cancer was 
made more readily: 
 
I was very, very worried.  I had a member of staff whose daughter had had quite 
serious mouth problems, cancer of the mouth, and she’d obviously been very 
troubled and very worried, you know, she had a grandchild and I supported her 
through that.  So I was really very worried, I didn’t think...I was hoping it wasn’t 
as serious as all that and you look for reassuring things.... 
Jackie (Age 51, Patient participant 13, Area 1) 
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As well as physical health, the impact of mental health can affect symptom appraisal 
and health seeking behaviours. In addition to the well documented influence of 
depression and anxiety disorders causing delay in patient presentation (Kugaya et al., 
2000), the influence of stress has been shown to affect patient interpretation of signs or 
symptoms of illness with individuals having a tendency to attribute these to the stress 
rather than to the presence of an illness, resulting in delayed care seeking (Cameron, 
Leventhal and Leventhal 1995). Although stress was mentioned as a subtheme, the 
study data did not appear to support stress as a factor influencing presentation, rather the 
influence of stress appeared when participants reflected on their perceived aetiology of 
their condition: 
 
IV: it may possibly have been stress related… 
I: Is that something that was mentioned? 
IV: I’m only thinking that myself.  That possibly it could have been stress 
related….not that I’m always stressed but I seem to be always stressed, but I’m 
not as stressed as I was back then. 
James (Age 61, Patient participant 4, Area 1) 
 
Returning to Dubayova et al.’s paper, they also suggest that psychological factors may 
impact on patients’ health seeking behaviour.  Specifically, they state fear or anxiety has 
a significant effect on patient behaviour, particularly in relation to seeking treatment.   
Through their systematic review they concluded that an individual’s fears of 
discovering the cause of their symptoms, as well as fear about the consequences of 
diagnosis and treatment, were often associated with delay seeking help. 
 
Fear of the cause of the signs or symptoms alongside fear of the consequences of 
diagnosis and treatment were evident in the study participants’ accounts, however, these 
fears did not cause delay seeking help.  Instead, concerns of this nature were usually 
apparent at a later stage of the disease journey.  Dubayova et al., go on to state that fear 
can be a motivating as well as a delaying factor in seeking help, dependant on the cause 
of the fear and the way people react to it.  In particular, they noted that where patients 
react to their initial discovery of symptoms with panic or alarm this may prompt that 
individual to seek help very quickly.   
 
With this in mind, looking at the patient data, when this participant discovers a white 
patch in his mouth he is prompted to seek treatment from his GP immediately, and 
when the wait for referral to a specialist is expected to take three months he describes 
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how he felt the need to seek private health care in order to speed up the referral process.  
He later explains his fear in relation to oral cancer and its consequences: 
 
IV: it wasn’t going away and it was there and the GP had said you know she was 
alarmed sufficiently to want us to see a specialist 
I: Had she mentioned what she thought it might be or what she was worried 
about? 
IV: Well she didn’t say it might be cancerous but by inference I mean she was 
saying that. 
I: So it’s a long time to wait then with that hanging over you really isn’t it? 
IV: Yeah because frankly the idea of cancer on the tongue worries me more than 
prostate cancer. 
 I: Why is that? 
 IV: I can’t imagine what life would be like if you can’t talk 
Bert (Age72, Patient participant 8, Area 1) 
 
Given that interpretation of symptoms varies with the individual, it is not surprising that 
contrasting response to a single factor may occur.  This highlights the fact that patient 
perception is an individual process and is dependent on individual appraisal and 
interpretation of symptoms. 
 
Alongside the patient’s personal evaluation of symptoms, they may also seek help with 
interpretation through non-professional sources, typically friends or family (Anderson 
and Thomas 2003).  However, the lay information gained from these sources will not 
necessarily correspond with that of medical professionals and may also result in delay in 
presentation.  On the other hand, Rozniatowski et al., report a positive relationship 
between high involvement of a spouse or partner and early presentation in head and 
neck cancer (Rozniatowski et al., 2005).  They found that close interpersonal 
relationships appeared central to facilitating patients in recognising the significance of 
their symptoms.   
 
One of the male study participants described his experience of discovering lumps in his 
mouth, initially his thoughts turned to the possible causes: 
 
Well I couldn’t think of anything else that would grow like that in your mouth 
like.  I suppose it’s possible to get a wart in your mouth I don’t know but I just 
thought what am I going to do now? ...you just think well at the time there was a 
lot of cancer going around and things like that and that's what it could be. 
Arnold (Age 71, Patient participant 6, Area 1) 
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When asked about information he shared with his wife he reveals his wife’s reaction 
when he told her about his oral lesions: 
 
It was right on the end when I took to the dentist, I told the wife like and she 
seen it and she... blew her top like, you know 
Arnold (Age 71, Patient participant 6, Area 1) 
 
These data appear to suggest that although this participant was aware of a change in his 
mouth it wasn’t until his wife had seen and reacted to the lumps that he sought medical 
attention.   
 
Rozniatowski’s team also reported that for those living alone, lacking stable family 
situations, there appeared to be a correlation with longer periods of delay.  Where it was 
not possible to make that association on the basis of the study results, there was 
certainly evidence of the impact of a stable relationship on health behaviours within the 
data set:  
 
As I say I was living by myself, [then] I met my partner that I’m with now.  You 
still have your good times, I mean, well, all the times are good if you like, a lot 
better than they were, but …I've settled down a lot more, where you would 
never see me drinking a cup of coffee put it that way you know (laughs). If I was 
by myself I would have been in the pub so now I'm at home and that's it you 
know......just life and growing up...whereas when you’re living by yourself 
you’ve got to – I mean the only priority you’ve got is yourself if you like, 
whereas obviously if you’re in a relationship there’s a lot of people to consider  
Andy (Age 38, Patient participant 11, Study 1) 
 
Moving on from the influence of friends and family, the final consideration in health 
seeking behaviour for the symptomatic individual is the influence of the health care 
professional.  The influence of the dentist specifically has been briefly covered earlier in 
this section when fear of the dentist was mentioned as a barrier to seeking help, 
however, there are other factors involving the dentist or other health care professional 
which may too be of relevance. 
 
Smith et al.’s review in relation to patient delay in cancer presentation explored 
individuals’ help seeking experiences in patients with several types of cancer.  They 
focused on fear, describing two distinct forms of fear that may impact on individual 
behaviour: fear of cancer and fear of embarrassment (Smith, Pope and Botha 2005).  
Where fear of cancer has also already been discussed, fear of embarrassment has not.  
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Fear of embarrassment has long been echoed in the work of others (Aitken-Swan and 
Paterson 1955) where there appears often to be a feeling of reluctance by patients to 
seek advice for seemingly trivial symptoms.  Although this did not come through in the 
patient data at the initial presentation stage, fear of embarrassment was discussed in 
relation to a reluctance to ask questions during consultations with secondary care 
clinicians:  
 
I don’t know if I'm just blooming stupid or what but it’s all over my head what 
they tell you. 
Phil (Age 58, Patient participant 15, Area 1) 
 
In the case above, a reluctance to ask questions about his diagnosis results in the patient 
seeking further information elsewhere.  This issue will be further discussed in later 
sections. 
 
A further potential barrier to seeking treatment may be access to a health care 
professional.   Simply getting to a hospital in order to access services may prove 
difficult and even once help is sought, can remain a significant problem for some: 
 
IV: I had to continue going to the clinics with us still smoking to keep an eye on 
it, which was very difficult because I've either had to get a friend to go with us 
or I've had to get me son to take us because I haven’t been able to... because its 
three buses to hospital A 
I: Is it? So it’s quite far way. 
IV: ...from here.  And I just can’t travel that far with taking panic attacks and 
that.  So it was quite difficult.  
Brenda (Age 53, Patient participant 7, Area 1) 
 
She later comes back to this as if to re-emphasise the importance the issue of access is 
for her: 
 
That’s the only thing about travelling so far.  I just wish services were local 
rather than having to go so far for treatment.  I just wish there was like a local 
surgery just for people who were having check-ups.  I mean I know people have 
to go over there for any treatment, but I just wish there was probably a local 
surgery for... just for check-ups and things 
Brenda (Age 53, Patient participant 7, Area 1) 
 
This section has demonstrated that for symptomatic patients with oral precancer, a 
complex process surrounds the period between symptom discovery and presentation to a 
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health care professional.  This will centre on the patients appraisal of their symptoms 
and may be influenced by factors such as: past experience of disease (both in general 
and oral disease specifically), knowledge of oral disease and information gleaned from 
friends and family.  Other than symptom appraisal factors including dental anxiety and 
difficulty accessing services may prevent or delay patients seeking help.  
 
5.2.3 Health seeking behaviour – the asymptomatic patient 
 
However, one of the key features of oral precancer is that it is often asymptomatic in its 
presentation.  This was reinforced through the patient narratives, during which mucosal 
abnormalities were frequently observed during a routine dental check-up or on 
presentation at the dentist for another reason: 
 
I went to the dentist, just for my normal check-up and he said I’m concerned about, 
it was down behind my lower teeth at the back, behind your gums, behind your 
teeth, and he said I had this white, I’ve forgotten the name of it…eluci something or 
other 
Molly (Age 82, Patient participant 10, Area 2) 
 
I only visit the dentist once a year for a routine check-up and he does a quick oral 
examination, that’s it usually.  Until this year in, sorry, last year, in June he noticed 
a white patch on the base of my mouth 
Archie (Age 72, Patient participant 3, Area 1) 
 
Well I went to see for some dentures to start with, and the dentist says, there, well if 
they fit alright, leave them, just leave them and I said oh alright, but she says how 
about this on your tongue, and I knew nothing about it 
Beryl (Age 77, Patient participant 4, Area 2) 
 
As symptoms are often central to an individual’s understanding of what illness is, a lack 
of symptoms can later lead to difficulty when it comes to patients understanding and 
making sense of their illness.  In some cases, asymptomatic conditions may lead 
patients struggling with how to define their state due to a lack of a perceived clarity over 
being ‘ill’ or ‘healthy’ and a feeling that they don’t legitimately fit into either category.  
(Kavanagh and Broom 1998).   Issues surrounding confusion with their disease will be 
explored in a later section.  
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5.2.4 Transition from primary to secondary care – all patient groups 
 
Following presentation, either through self-directed health care seeking or via a visit to 
another health care professional, the next stage in the process is referral of the patient 
from primary to secondary care, the most common route being via the GDP to an 
outpatient oral and maxillofacial department.   
 
The significance of this transition on patient experience has been noted in the wider 
literature, where even the referral itself can be seen as unsettling, particularly if patients 
are inadequately informed about the reason for referral (Jackson et al., 2006).  Also 
coupled with this transition phase,  Preston et al., outlined the importance of progress in 
association with the journey from primary to secondary care (Preston et al., 1999).  
Following their study they concluded progression through the health care system may 
signify not only progress towards recovery but, for those with chronic conditions 
especially, adjustment to an altered health state.   
 
In the UK, targets set by the Department of Health now state that patients’ who are 
referred for consultant led treatment should be seen for treatment within 18 weeks and 
those with suspected cancer should be referred urgently and should expect to be seen by 
a specialist within 2 weeks (DoH 2012b).  Furthermore, legislation has now made these 
targets a legal right (2006).  Where the drive behind these targets originates with a 
desire to diagnose and treat patients at an early stage in their disease, it is important too, 
to consider the psychological effect of waiting, as demonstrated by this patient:  
 
So for the initial couple of weeks while I waited for the appointment I got meself 
really worried, really worried about it 
  Brenda (Age 53, Patient participant 7, Area 1) 
 
A study investigating the ‘2-week rule’ in suspected breast carcinoma demonstrated the 
significant distress experienced by this patient group during this wait. However, whilst 
patients were unaware of the 2-week initiative they stated that they valued a quick 
referral to provide assurances that they did not have cancer (Cornford, Harley and 
Oswald 2004). 
 
The influence of speed during the transition from primary to secondary care was 
discussed with the patient study groups.  Where there was a feeling, as with the 
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suspected breast cancer group, of a quick referral being important in terms of alleviating 
anxiety there was also a sense of the duration of the wait indicating the seriousness of 
their undiagnosed condition.  It became apparent that participants felt short referral 
times indicated urgency and therefore a potentially more serious diagnosis: 
 
I think the length of time always helps you, because you think well if it had been 
that dire they would have had you in immediately.  Maybe that might not be 
right.  Maybe there’s just a big waiting list. But you keep thinking that don’t 
you? 
Molly (Age 82, patient participant 10, Area 2) 
 
I think the thing was, because they didn’t see it straight away, I didn’t think it 
was that serious.  It couldn’t have been that serious or they would have done 
something quicker. 
Aida (Age 65, patient participant 8, Area 2) 
 
In some cases, even the need for referral itself involving specialist opinion was enough 
to prompt feelings of anxiety: 
 
IV: She said but I would like you to go to the dental hospital. And it just all 
started from there. She said you’ve got what we call white patches 
I: Right 
IV: And I thought oh god, you know 
Betty (Age 80, Patient participant Area 1) 
 
The GP said ‘I’ll have to send you to see a specialist’ so I thought...well quite 
often you think ‘Oh it could be something nasty’ you know 
 Bert (Age 72, Patient participant 8, Area 1) 
 
 
Once the referral has been made, the individual then makes the transition from primary 
to secondary care, where their journey continues.  The following section of this chapter 
will therefore go on to focus on the patients initial experiences of secondary care, 
including their first encounter with the doctor, their experience of the hospital 
environment and their reaction to the need for further investigations (biopsy). 
5.3  Initial consultation 
 
5.3.1  Beginning of the doctor-patient relationship  
 
The transition from primary to secondary care heralds the beginning of the relationship 
between the patient and the hospital practitioner.  At this initial stage this relationship 
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may not be as established as the one with the primary care practitioner and may 
therefore be viewed as more impersonal and of potentially limited duration.  This may 
impact on the confidence of the patient and have a negative influence on patient 
experience at this juvenile stage of the relationship.   
 
Where the idea of attending a hospital was, for many, an anxiety provoking experience, 
one factor that appeared to benefit patients at the initial consultation stage was that of 
the notion of the secondary care clinician, usually a consultant, as an expert.    
 
He just knew the ropes, didn’t he?  And that made me feel quite… it gave me a 
confidence to keep going back… Yeah, it was essential to see somebody that 
had obviously a deep understanding of his job. 
Wilma (Age 64, Patient participant 7, Area 2) 
 
However, this concept of the consultant as the expert appeared to be of particular 
importance to those patients’ who later recognised in themselves the desire to almost 
remove themselves from the decision making process: 
 
 IV: I put myself in the hands of the professionals, they know what to do 
I: So did you have any questions at the time for any of the doctors or people that 
you saw? 
IV: Not really, no.  I just went and got the treatment and got an examination 
whatever they wanted. 
Arnold (Age 71, Patient participant 6, Area 1) 
 
At the initial consultation stage the significance of free communication between patient 
and doctor is a crucial one.  Specific barriers at this stage appeared to include the power 
dynamic between the patient and their doctor within the consultation. 
 
This power dynamic sometimes appeared imbalanced, the power resting with the 
doctor.  This resulted in difficulty requesting further information from the consultant 
(usually due to a fear of embarrassment) and subsequently puts up a barrier to the 
patient expressing concerns or asking questions about their disease: 
 
I think looking back, I mean if I was at ease as I am with you I could have said 
hang on a minute, just go over it again, I think its professionalism…I don’t want 
him to think that this stupid boy here, hang on, what do you mean by…I felt as if 
I was belittling myself, probably wrong, well it would have been, he’s a 
smashing fella but you don’t want to look stupid. 
Phil (Age 58, Patient participant 15, Area 1) 
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As well as creating the potential for uncertainty with regard to their diagnosis, this 
difficulty in communication may lead to patients feeling a lack of involvement in their 
care.  This situation could be seen as being at odds with the government white paper 
‘equity and excellence. Liberating the NHS’ which states that the intention is that 
patients are put at the heart of the NHS (DoH 2010). 
 
As patients progressed in their journey through secondary care, continuity in relation to 
the individual seeing the same clinician is seen as important.  Further it is put forward 
that the ‘continuity could facilitate the progress of the treatment’ (p.19) (Preston et al., 
1999) due to the professional having sufficient background and knowledge of the case 
(Preston et al., 1999).  Examining the accounts of the patients in this study it can 
certainly be seen that consistency in terms of seeing the same health care professional is 
preferred: 
 
My only concern about going there is that, yes, most of the time I have seen Mr. 
X, and other times – and I know they’re all doctors and they’ve got a job to do, 
but I mean sometimes I see different people and when you’re seeing different 
people they’re not exactly up on what’s happening.  I mean they’re only going 
off notes, and I think personally it would be better if you were seeing the same 
person all the time, and they’re going to have a look at your mouth and see 
exactly if there’s any changes without reading the notes, because they’ve seen it 
before, they know exactly... 
Andy (Age 38, Patient participant 11, Area 1) 
 
Furthermore, patients express concern or panic when access to a specific individual is 
not possible, even when the person seen as an alternative behaves in a professional and 
satisfactory manner: 
 
It’s better to see the same person.  But I do get in a panic if I don’t see him.  It 
was like when I didn’t see him in the clinic because you just expect he is going 
to be there.  When he wasn't there and I saw Mr Y and Mr Y was lovely, don’t 
get me wrong, he was really lovely, but you just think, it was like being left at 
school for the first time by your mother, I thought this isn't right.  
Lily (Age 58, Patient participant 12, Area 1) 
 
The significance of a good relationship between the health professional and the patient 
was seen throughout the course of the patient journey.  Patients’ opinions of their 
clinicians became central with themes relating to faith, trust and confidence in their 
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clinicians presenting strongly throughout all stages of diagnosis, management and 
follow-up. 
 
 
 
5.3.2  Impact of the environment 
 
As well as the impact of the clinician on a patient’s experience of care, the hospital 
environment itself may also have an impact. Although not an especially prominent 
theme, for some the experience of being in a hospital setting was an anxiety provoking 
experience in itself: 
 
I don’t like going to the hospital, it’s horrible.  I don’t like any of it but I'm pleased 
we’ve got it. 
Wilma (Age 64, Participant 7, Area 2) 
 
Where Wilma demonstrates a general dislike of the hospital environment, the following 
participants find the maxillofacial outpatient clinic itself a difficult environment to be 
in, directly relating the impact of the surroundings to their personal situation: 
 
People are on top of each other.  People who are poorly and worried and goodness 
knows what, they want space around them, they want air to breathe, you're all sitting 
here like sardines and it was very much like that...it was like the black hole of 
Calcutta, you were on top of each other all the time.  And there were some quite 
nasty disfiguration cases sitting around which sort of took your breath away...it 
certainly made me uneasy...your eyes were drawn to it.  I think the only down side 
was, the worry was, that dear me, could I end up like that?  
Frank (Age 63, Participant 11, Area 2) 
 
When I was in the clinic, I used to get frightened seeing some of them, you 
know...there was half their faces missing and...you know deformed, like, lumps of 
their jaws taken away, and you think, that could be you pal, you know.  And you do 
tend to; I think I do tend to be a bit more careful, that's why I check it all the time 
you know, this little thing... I don’t know, there probably is different, but you think 
bloody hell... I mean I've still got my face, some of these poor guys I've see, women, 
men, they don’t have that...it does tend to frighten you...as far as I'm concerned I've 
been lucky. 
Mark (Age 62, Participant 5, Area 2) 
 
Interestingly, although participants from both study areas commented generally on the 
effect of the waiting room environment, only those from area two spoke specifically 
about the effect of sharing a waiting room with others with facial disfigurement, making 
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them consider their own situation and the likelihood of their own disease resulting in a 
similar outcome.  The difference in findings between the study groups may be explained 
by examining the differences in the set-up of the individual clinics in each area.  Where 
area one has a dedicated dysplasia clinic, area two does not and patients are seen on a 
mixed maxillofacial outpatient clinic.  As a result it is much more likely that precancer 
patients from area two will come into contact with patients who have obvious signs of 
facial surgery or disfigurement than those seen in area one.  
 
5.3.3  Inference of the need for biopsy 
 
Moving on from the impact of the hospital environment and the clinician involved, one 
final significant aspect of the initial consultation itself will now be considered; biopsy of 
the lesion.  This aspect of the patient journey will occasionally take place at the initial 
consultation visit, although it is more usual that it is mentioned at this time and the 
patient returns for this investigative procedure.   For some patients even the suggested 
need for a biopsy to establish a diagnosis was enough for the individual to make the 
assumption that they had cancer:  
  
IV: When they just mentioned about the white patches [I thought] ‘ah nay 
bother, they’ll just go away’...and obviously when I’m going to a biopsy I’m 
thinking ‘hold on, they’re not that sure about that’, so it was worrying if you 
like, and I don’t know, I think you get yourself a bit down and depressed with 
things like that don’t you, but as they say life goes on and you’ve got to get on 
with things.  Cope with things the best you can, simple as that.  That’s what life 
is isn’t it. 
I: When they mentioned to you, when you had to have a biopsy, what did you 
start thinking about at that stage 
IV: Basically cancer.  You do don’t you? I mean have I? Haven’t I? Have I got 
it? Have I not? And if I have got it, how bad is it? 
Andy (Age 38, Patient participant 11, Area 1) 
 
Where the patient above demonstrates that they associate biopsy with a serious 
diagnosis, this theme was not confined purely to the initial consultation stage and was 
often also seen as a significant event for those patients who were monitored long term: 
 
 If I did have another biopsy that means it must be getting worse 
Chris (Age 65, Participant 6, Area 2) 
 
Where you might suppose that, being a minor investigative procedure, a biopsy may be 
considered innocuous by a patient; this was often not the case.  Patients frequently 
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described the biopsy itself as an unpleasant and at times disturbing procedure even 
prompting some to adhere to modification of lifestyle factors primarily to ensure further 
biopsies were not carried out: 
 
 
 I: And what was having the biopsy like? 
IV: It was horrible.  They took a piece out, the back of the teeth, and, of course, 
it was awful.  Not very nice at all. 
Aida (Age 65, Patient participant 8, Area 2) 
 
Patients who were dissatisfied with their biopsies occasionally complained that the 
person they were seen by was less experienced than expected and this seemed to have a 
negative impact on their experiences as Wilma explains when asked about her 
experience of having a biopsy: 
 
[the experience was] quite poor actually...I suspect it was probably one of the 
first he’d done and he was dead anxious...he kept complaining about my 
inquisitive tongue... And he said ‘if I've got to do another one, I’ll put you to 
sleep.’ And I said ‘oh you wont’...I did survive, but I was in for ages. 
Wilma (Age 64, Patient participant 7, Area 2) 
 
The notion of faith in the clinician’s abilities is a common thread throughout the course 
of the patient journey and will be discussed further at each relevant stage.  Where a lack 
of faith existed, patients spoke negatively about individuals: 
 
I think I saw three different... maybe they were Dr Xs minions, anyway I saw 
these people...oh dear, really, they weren’t all that... impressive. 
Betty (Age 80, Patient participant 2, Area 1) 
 
However, like the experience of disease, it would appear that biopsy itself is an entirely 
subjective experience.  Where for one person it is a disturbing, anxiety provoking 
encounter, for others it is something that is easily tolerated and quickly forgotten: 
 
 I: And how did you find having the biopsy? 
IV: Oh, it was champion. It was just a wee nick that was all, it wasn’t painful or 
nothing like that. 
Beryl (Age 77, Patient participant 4, Area 2) 
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Following the biopsy there is a delay, during which the tissue sample is processed, 
before the results of the investigation become available.  During this time patients 
reported experiencing a period of worry or stress in association with this wait: 
 
The worst time is the waiting really...the last thing you want is to have this 
worry on the back of your mind all the time. 
Archie (Age 72, Participant 3, Area 1) 
 
In keeping with these findings Risberg et al., investigated the psychological impact of 
diagnostic delay on patients with suspected malignancy, noting a positive correlation 
between total diagnostic delay and psychological distress (Risberg et al., 1996). Poole et 
al., broke the process down further examining specifically anxiety associated with what 
they termed the peri-diagnostic interval, that is the interval between a diagnostic 
investigative procedure and receiving a definitive diagnosis.  They found that for those 
who demonstrated anxiety this was sustained throughout the period between the 
procedure and the results (Poole et al., 1999). A factor which has been suggested by 
some to be a reason in itself to minimise such diagnostic delays (Neal and Allgar 2005).  
Interestingly, Poole et al., also found that where patients believed the outcome of their 
investigation would be a cancer diagnosis, the patient went through a ‘preparatory 
period’ during which they psychologically readied themselves for the prospect of a life 
with cancer.  
5.3 Diagnosis 
 
Following biopsy, a diagnosis is usually made, or confirmed.  It is at this point that the 
patient will be given a label to apply to their oral lesion, which is something they are 
often seeking: 
 
And of course naturally you're keen to know what it was...what it actually is 
James (Age 61, Patient participant 4, Area 1) 
 
Although an explanation of the diagnosis will be provided at this stage, this does not 
mean that it will be understood or interpreted in the way the professional providing the 
explanation intended.  There will be a number of factors which influence interpretation 
of diagnosis, which will now be discussed: 
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5.4.1  Understanding the diagnosis -  the role of communication and patient 
response 
 
When considering how patients’ make sense of their diagnosis it is worth initially taking 
into account the terminology used during the diagnosis.  Lerner et al., discuss the 
importance of the terminology used in medical communication in their paper 
concerning patients’ understanding of common medical terms (Lerner et al., 2000).  
They found that even frequently used medical terminology is often poorly understood 
by patients. As an example, 78% of their sample group did not recognise that broken 
bone and fractured bone were analogous terms.  This highlights the importance of the 
wording used when providing medical explanations to patients.   
 
In this study, the patients from both sample groups described their recollection of the 
terms used by their clinicians when delivering their diagnosis.  Descriptions such as 
white patch, unstable cells, abnormal cells, hot spots, dysplasia, leukoplakia and 
precancer were the terms most commonly recalled by patients. Although frequently able 
to remember the label which had been given, and in some cases, speak authoritatively 
regarding this label, upon further questioning it often became clear that patients 
accepted the label without a true understanding of its meaning or consequences: 
 
IV: There were some unstable cells 
I: And what do they mean by unstable cells 
IV: I don’t know. Pass. 
James (Age 61, Patient participant 4, Area 1) 
 
Furthermore, there often appeared to be a reluctance to seek clarification where a lack 
of understanding existed: 
 
 I didn’t really ask I don’t think I knew what it meant 
Dot (Age 61, Patient participant 5, Area1) 
 
The significance of this lack of understanding as a consequence of terminology used is 
discussed in a small body of work within the field of cervical precancer.  This work has 
revealed that patients with the diagnosis of cervical precancer are frequently confused 
by the terminology used by medical professionals.  This, in turn, can lead to 
misinterpretation of the diagnosis given.  Kavanagh and Broom discuss the relevance of 
patient understanding in patients with abnormal cervical smear test results (Kavanagh 
and Broom 1997).  They note that the use of terms like abnormal and precancer can 
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result in the patient believing that they in fact, have cancer. Something that was 
sometimes seen with the study group: 
 
 Basically it was cancerous cells, that's what they are. 
Andy (Age 38, Patient participant 11, Area 1) 
 Discussing his interpretation of his diagnosis 
 
As well as the direct effect of the confusion caused by difficulty interpreting 
terminology, there is also the potential for further misinterpretation when such terms are 
used by patients to seek further information.  A specific example of this was seen when 
patients used terms such as white patch to seek further information via the internet.  
This will be explored in more detail in a later section. 
 
As well as providing a label to apply to their disease, the conversation during which the 
diagnosis of precancer is delivered may also involve a discussion regarding risk.  The 
diagnosis of a potentially malignant disorder carries with it risk, specifically the risk 
that the lesion will transform into an oral malignancy.  Living with this risk will be 
discussed in a later section, however, as a component of delivering the diagnosis, the 
health professional will, on occasion, use statistics as an aid to convey this risk: 
 
...he said eight out of ten times its cancer 
Chris (Age 65, Patient participant 6, Area 2) 
 
Although the patient data often made reference to the use of statistical information, the 
values recalled by the participants were never the same.  Perhaps this is because 
communicating risk to patients is an inherently difficult task.  The subject of risk 
communication has been explored extensively in the literature.  For example, Bogardus 
et al., discuss potential difficulties encountered when discussing risk with patients 
(Bogardus, Holmboe and Jekel 1999).  They begin with a quote from a patient 
considering risks of prostate surgery to illustrate the point: “You tell me the chance of 
becoming incontinent from this surgery is 5%.  What does that mean?  If I get it, its 
100% for me, right?” (p. 1037). 
 
Following their discussion of the challenges associated with risk communication 
including the difficulty surrounding interpretation of numerical data, they put forward a 
proposal for effective risk communication.   They identify three primary formats via 
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which risk may be presented to patients: qualitative, quantitative and graphic, and 
suggest that the more recently adopted approach of presenting information graphically 
may help to overcome difficulties some patients have with interpreting quantitative 
data.   
 
The efficacy of risk communication is also explored in a paper by Lipkus.  In it he 
details the following potential effects of effective risk communication: engagement in 
recommended behaviour, paying attention to the message, acquisition of factual 
knowledge, effects on emotions, judging perceived risk and evaluation of the message 
(Lipkus 2007).  Given the wide ranging potential effects it is important that methods 
other that quantitative approaches to risk communication are considered as effective risk 
communication needs to be tailored according to the individual needs. 
 
Following delivery of the diagnosis, there were primarily two opposing responses 
noted: one of relief and the other of distress: 
 
Once they said, after the biopsy, it’s not cancerous; I thought that will do me 
Ted (Age 69, Patient participant 12, Area 2) 
 
 
[When] he said everything was okay, it’s a relief and you don’t realise until you 
come and you... the feeling of joy you get 
Graeme (Age 43, Patient participant 14, Area 1) 
 
For those who were worried about the possibility of cancer, they were often looking for 
what was frequently termed a ‘negative’ result.  Once the diagnosis was given, as long 
as it was not cancer, this was seen as a positive.  It appeared that patients were more 
likely to be distressed by the results of biopsy where they associated their results 
directly with cancer: 
 
Then I got the news, devastating news really, that they'd only just caught in time 
what appeared to be a very unstable lesion.  More or less precancerous. 
Archie (Age 72, Patient participant 3, Area 1) 
 
 
When they said it was like a precancer, I just went, you know, down, you know, 
I was pretty down 
Mark (Age 62, Patient participant 5, Area 2) 
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This anxiety appeared heightened where the participant had been unconcerned prior to 
the investigation.   
 
Looking again at the cervical precancer literature Karasz et al., demonstrated that 
patient response to the diagnosis of an abnormal cervical smear  test is shaped by what 
they term the individuals illness representation (Karasz, McKee and Roybal 2003).  
They explain that each participant’s illness representation is composed of their beliefs 
surrounding illness, which are frequently informed by a combination of biomedical and 
folk models of illness.  Applying this to the distress experienced by some cervical 
precancer patients following their diagnosis, they noted that individuals who perceived 
themselves as being at risk, for example due to persistent symptoms, experienced 
significant distress, whereas those who did not feel personally at risk, for example as a 
result of no family history of cervical precancer, were unconcerned by the test results. In 
this way it can be seen that the reaction to diagnosis will be shaped not only by the way 
in which the doctor chooses to present the diagnosis but is also determined by the 
preconceptions of the patient which will vary with each individual.   
 
This section has considered the diagnosis of oral precancer from the patient perspective 
with a focus on interpretation of the terminology used by the doctor to describe their 
disease, the risk associated with the diagnosis and the factors influencing an individual’s 
response to this information.  I will now go on to consider how the patient participants 
addressed their information needs following diagnosis, specifically by considering the 
role of their doctor, friends and family and internet as further sources of information. 
 
5.4.2  Patient Information needs – seeking additional information  
 
As discussed, alongside the diagnosis, the clinician will provide the patient with 
information about their disease. Where for some this is all they require, for others there 
is a need for further information, largely as a means of understanding their diagnosis. 
 
When considering information sources at this stage of the patient journey, an obvious 
source of further information would be the health professional delivering the diagnosis.  
Indeed studies would suggest that medical professionals are often viewed as the most 
important information resource (Norum et al., 2003).  However, accessing information 
in this way does not always appear to be straightforward.  When considering utilising 
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the health professional as a source of further information, it is impossible to exclude the 
significance of the relationship between the patient and the health care professional 
(usually the doctor).  This relationship has been explored in the literature over a number 
of years.  
 
Historical work by Parsons examined this relationship when he examined the sick role 
(Parsons 1951).  This role described the roles and obligations of the patient and doctor 
and can be viewed largely as a similar relationship to that of parent and child.  The 
nature of this relationship means that there is a power imbalance in favour of the doctor.  
Demonstrated here by this participant who categorises her clinician as an ‘authority 
figure’: 
 
IV: ...mind you, by the that time I was in floods of tears. 
I: Why was that? 
IV: I'm a weeper. Some people are.  I just weep. I'm sure it’s something to do 
with authority figures. 
Wilma (Age 64, Patient participant 7, Area 2) 
 
Over time, however, the literature has demonstrated a change in the doctor-patient 
relationship with some patients looking to adopt a more ‘active’ role (Hack, Degner and 
Dyck 1994).  In their study investigating the information needs of breast cancer patients, 
Hack et al., suggest that so called active patients not only look for greater levels of 
information in relation to their diagnosis but also expect a greater role in treatment 
decisions. Decisions surrounding treatment will be considered in a later section.  
Continuing to focus on patients’ information needs, Raspe et al., explored this topic, 
finding that patients fall into one of three categories: those who do not wish any detailed 
information, those who would like to know more but do not ask and those who ask and 
succeed in obtaining further information.   
 
Looking at the patient data, it is interesting to note that many of the patients fell into the 
category of patient who do not wish any detailed information, and instead are keen to 
maintain a passive role, for example this patient describes how he actively avoids 
seeking further information about his disease, when asked about information seeking 
habits he replies: 
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I just never bothered, I thought they know what they're doing, I just let them 
get on with it...I just let the professionals get on with it and trust them, yeah. 
Mark (Age 62, Participant 5, Area 2) 
 
Furthermore, it would appear that as a result of a desire to maintain a passive role and 
need to ‘put their faith’ in the doctor, a barrier to accessing further information is 
created. 
The doctors get paid to diagnose, they know what the score is 
Bob (Age 48, Participant 10, Area 1) discussing why he did not feel the need 
to seek any further information about his condition. 
 
I'm just one of these people that go along and leave it up to the doctors to tell 
me what's happening. 
Wilma (Age 64, Participant 7, Area 2) 
 
Wilma also explains how at one review appointment the doctor she saw mentioned a 
possible need for surgery; she then describes how she reacts to this new information: 
 
Well, obviously, head in the sand, let’s not talk about it if we don’t need 
to 
Wilma (Age 64, Participant 7, Area 2) 
 
For patients like Wilma, clearly it may be challenging for professionals to encourage 
patient involvement in care, which has been demonstrated to have a positive effect on 
quality of life and experience of disease (Hack et al., 2006). 
 
For those patients adopting a more active role, it was seen that although some felt that 
they wanted additional information, barriers existed which made accessing this 
information from the doctor difficult: 
 
I suppose it’s the North East, you're supposed to be a hunky, brutey man and not 
have concerns.  Get on with it. 
Frank (Age 63, Patient 11, Area 2) 
 
For example, Frank seems to suggest that asking questions may translate as showing 
weakness. Other barriers including feeling ridiculous and feeling that the doctor is short 
of time have also been put forward as specific barriers in the literature.  However, even 
for those who were able to ask for and obtain additional verbal information, there was 
an acknowledgment that understanding or taking in this extra information at the 
diagnosis stage, could be difficult: 
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People don’t always hear, as I'm sure you know, people don’t always hear 
what's being said to them. 
Jackie (Age 51, Patient participant 13, Area 1) 
 
Where many patients recognised that retaining information was difficult, some put 
forward potential solutions to this problem: 
 
I know it would take loads of work, but if they could write it out and send it 
back to you so then you could, then you would probably remember.  But 
that's maybe just me, that I don’t take it all in. 
Aida (Age 65, Participant 8, Area 2) 
 
Looking again at work carried out with patients diagnosed with cervical precancer, 
parallels may be drawn with their patients and my patient study group (Kavanagh and 
Broom 1997).  Patients in their study also recognised that additional information 
provided at the time of diagnosis may not be absorbed.  They reported this is as a direct 
result of either distress following the diagnosis or the technical language used.  Factors 
which were also common to my study data.  
 
After professionals, friends and family are the next common source of medical 
information (Norum et al., 2003),  with some taking the process a step further: 
 
 My wife and I compared tongues... 
Phil (Age 58, Patient participant 15, Area 1) 
Describing the action he took following his dentists discovery of a white patch on his 
tongue 
 
My sisters an ex nurse, and I take it down to her and I say right, put this into 
English for me please...I like to know 
Beryl (Age 77, Patient participant 4, Area 2) 
 
This quote also reiterates the point that medical terminology can prove somewhat 
inaccessible to patients, to some it is seen as a different language requiring translation.   
 
As well as family and friends, the internet was mentioned by some as a source of further 
information, as in this case, following delivery of the diagnosis: 
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When I got home I looked it up on the internet... [I found] all sorts of information, 
the people most likely to get it and pictures and what have you... I didn’t even know 
the name, I just said it was a lesion, unstable white lesion, unstable white cells, a 
lesion. 
 
Arnold (Age 71, Participant 6,Area 1) 
  
As well as demonstrating that some patients use the internet as a resource, this 
participant also highlights the importance of the choice of search term used when 
accessing this resource.  A paper by Alcaide-Raya et al., on internet use, sought to 
examine the quality of information available in relation to potentially malignant 
disorders (Alcaide-Raya, Hughes and Warnakulasuriya 2010). They conclude by stating 
that the information available is of satisfactory quality.  It is important to note that their 
study relies on the use of medical terminology when conducting the search.  However, it 
has been discussed that patients are often given lay labels for their disease, such as 
white patch or unstable cells. An internet search via popular search engines using terms 
such as these will reveal less specific, confusing and at times alarming, information.  
Something that was picked up by one of the participants: 
 
The trouble with the internet though is you can end up more worried, you've just got 
to be really careful.  It’s like reading medical books isn’t it, you can read them and 
think oh my god and by the time you've convinced yourself you've got Blackwater 
fever or something, you know what I mean? You've just got to be so careful.   
 
Jackie (Age 51, Patient participant 13, Area 1) 
 
 
I just put in white patch and dear me, grotesque 
Phil (Age 58, Patient participant 15, Area 1) 
 
Whilst there was evidence of internet use amongst the participants, this was certainly 
not a source explored by the majority of the study group.  One possible explanation for 
this may be found in the work of Norum et al., who, when examining internet use by 
oncology patients, found that internet use as a source of medical information  was 
positively correlated with young age (Norum et al., 2003).  As oral precancer is most 
commonly seen in older patients perhaps the internet will prove to be a more significant 
source of information for future patient groups.   
 
5.4.3 Influence of others at the time of diagnosis 
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Moving away from information needs, the significance of other people at the diagnosis 
stage will be explored by first considering briefly the role of the doctor and then 
discussing the importance of friends and family. 
 
Although the influence of the professional at the time of diagnosis has been explored in 
relation to communication and information seeking, it is also important to state that 
there was a general feeling put forward by the study group that the experience of the 
professional delivering the diagnosis was important.  This notion appeared to feed into 
participant feelings that confidence, trust or faith in the doctor is significant and if a lack 
of any of these factors was present there was a significant negative impact on the 
doctor-patient relationship.  The perception of being seen by people at the core was 
important. The consultant was frequently considered as being at the core of the medical 
team and as a result was often seen as being the expert which, in turn, inspired 
confidence and trust: 
 
Well I suppose if you're not seeing the top man it means that you're not terribly 
important 
Molly (Age 82, Participant 10, Area 2) 
 
This concept will be examined further in a later section. 
 
As well as the influence of the patient’s clinician throughout their disease journey, 
participants chose to involve friends and family to varying degrees.  Interestingly 
though, when attending the outpatient clinic, although a number of participants 
discussed their desire to bring someone with them for support, it was not uncommon for 
the person accompanying the patient to stay in the waiting room.  In this way it 
appeared that these patients appreciated having someone with them as a personal 
support (indeed bringing someone along was always viewed as positive), but also 
preferred to keep the interaction between themselves and their clinician private: 
 
I just like to go in myself, I can talk easier that way, you see, and then when I 
come out, they say, what's he say, what's he been doing, and then of course I 
repeat it to them and they know what's been going on...and everybody’s 
informed 
Beryl (Age 77, Patient participant 4, Area 2) 
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One possible explanation for this behaviour may be found when participants’ accounts 
are further explored.  In doing so it was observed that participants often chose to modify 
the information they provided to their friends and family: 
 
I minimised it, I minimised how worried I was because, well you don’t do that to 
your family do you so I said luckily they’ve identified these things really early 
because I go to the dentist every six months and therefore, I’m sure everything 
with be fine 
Jackie (Age 51, Patient participant 13, Area 1) 
 
Similarly this participant described how he found it really comforting to have his 
daughter with him at the hospital (although she didn’t go into the consultation itself), 
despite this he also goes onto describe how he chooses to withhold some of the details 
surrounding his diagnosis from her: 
 
IV: Actually the lads that I work with know more than my kids.  I've had quite a 
lot of support from them, it’s a big help.   
I: So you're quite happy to discuss it with people at work 
IV: Yeah, strangers 
I: Do you think it’s easier that way 
IV: Well you don’t want the family to worry.  At least I didn’t. 
Mark (Age 62, Participant 5, Area 2) 
 
In this way there appears to be a desire, by some patients, to maintain control over the 
nature of the information passed on to friends and particularly family in a bid to protect 
them from what is seen as potentially upsetting information.  Unfortunately,  the 
literature would suggest that shielding information from loved ones in this way, known 
as protective buffering, may ultimately lead to increased levels of distress over time 
(Suls et al., 1997).   
 
5.5  Management 
 
Once a diagnosis has been established a treatment plan is formulated.  This will usually 
involve advice regarding removal of risk factors, if present, alongside either surgical or 
conservative management.  The patient’s experience of each of these aspects will now 
be discussed beginning with issues surrounding risk factors. 
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5.5.1  Risk factors associated with oral precancer 
 
There is an established link between smoking and drinking alcohol and the genesis of 
oral cancer and precancer.  As a result, efforts aimed at reducing or eliminating the 
presence of these risk factors often forms part of a patient’s treatment plan.  One of the 
potential barriers in this process occurs where patients appear not to accept the 
significance of the risk factors put forward by their clinician.  Where this occurs it is not 
necessarily because patients do not hear the message (that tobacco and alcohol may be 
implicated  in their disease), but more that their views of disease aetiology, or their lay 
beliefs surrounding illness, may not be consistent with that of the health professional 
putting forward the risk factors.  If we use the data to consider patient perception of 
disease aetiology for example, it can be seen that study participants frequently attributed 
their oral lesions to a number of different factors: 
 
Well personally I thought it was the inhalers that gave me it 
Dot (Age 61, Participant 5, Area 1) 
 
I believe myself the thing was caused first by my bad teeth because I had… I 
hated dentists and I didn’t want to go and they were rotting and they were jagged 
and were catching my gum and you know the side of my mouth and I think that.  
I though that’s what had caused it like 
 
Arnold (Age 71, Participant 6,Area 1) 
  
At the beginning when I saw these white patches, I thought it was the toothpaste 
I was using.  I thought it could be that. 
 
Violet (Age 90, Participant 2, Area 2) 
 
It can therefore be appreciated that if patients assign the cause of their disease to reasons 
other than known risk factors, the motivation to modify these health related behaviours 
is reduced and this can therefore be a barrier to following treatment plans.  
 
A clear explanation of disease aetiology was not always present within each of the 
patient accounts and when discussing the potential causes of their condition, patients 
frequently reported the cause of their disease as unknown. This was seen to occur even 
when patients were aware that professionals were implicating smoking and drinking in 
their disease process: 
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Well it’s like a lot of the doctors blame smoking for everything don’t they, no 
disrespect or anything but I just think it’s the easy option really, you know but I 
do believe a lot of doctors and people do blame smoking for a lot of things, I 
think there's other things that contribute 
 
Gladys (Age 62, Participant 1, Area 1) 
 
It doesn’t matter what you go into hospital for... they ask you how much you 
drink…and do you smoke?  And it doesn’t matter. 
Betty (Age 80, Patient participant 2, Area 1) 
 
This response is perhaps not surprising when we consider the work of Lowry and 
Craven. They examined awareness of oral cancer within a cohort of smokers and 
drinkers.  Through this work they demonstrated that there was a dramatic lack of 
perceived association between drinking alcohol, smoking tobacco and an increased risk 
of oral cancer development, despite these two factors being the primary causative agents 
(Lowry and Craven 1999).   
 
This participant later goes on to describe her reaction to a clinician questioning her 
about her alcohol consumption: 
 
And I did have a little bit of a do with a Mr Z.  I don’t drink any more than 
anyone else.  And I said my husband and I used to have what we called our 
nightcap, we had a nightcap at night before we went to bed and I mentioned this 
and he said how much alcohol did you have? And I said well I suppose we had 
one sort of drink.  And he said but how big was the drink? And he went on and 
on about the alcohol.  And I'm afraid at the finish I said, look if you're trying to 
say I'm an alcoholic I'm not...I wasn’t having that. So I ended that conversation. 
But just in case alcohol had anything to do with it I haven’t had one single drink 
since then. 
Betty (Age 80, Participant 2, Area 1) 
 
The participant in this case demonstrates a reaction of anger when being questioned 
about her alcohol intake.  It appears that she accepts alcohol as a risk factor because she 
chooses to modify this behaviour; however, this is not what she literately reports.  
Instead it is likely that she feels a sense of guilt that she may have contributed to her 
oral condition and is reluctant to accept it.   
 
This reaction may be explained if we consider the role of stigma and disease with 
particular regard to self-inflicted conditions.  Cancer in general is often considered a 
stigmatised disease, but if we take the example of lung cancer where there is frequently 
a strongly perceived association with smoking the stigma may not only be associated 
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with the disease but also with the notion that the sufferer has caused the disease through 
their actions.  A qualitative study by Chapple, Ziebland and McPherson explored this 
topic. Through their work they found that although the majority of patients 
acknowledged the stigma associated with their cancer and smoking habit, some sought 
to resist blame and associated stigmatisation by attributing alternative factors such as 
diesel fumes, carbon monoxide, spray paint, asbestos, pollution, diet, stress, and 
bereavement to the cause of their disease (Chapple, Ziebland and McPherson 2004).   
 
Within my patient study groups, smoking was by far the most widely discussed risk 
factor.  As part of the discussions on smoking, the topic of smoking cessation was often 
brought up, usually because smoking cessation formed or was recommended as part of 
the patient’s treatment plan.  When talking about attempts at stopping their smoking 
habit, participants often started by drawing a distinction between smokers and health 
professionals: 
 
So you always go and think oh god, here we go, smoking can be brought into it.  
In my experience, not everybody, but lots of people in the medical profession do 
have a sort of view, a sort of very strongly held view  that why are these people 
smoking when it’s so bad for their health so they feel very strongly about it.  
You can see why they can’t understand it but then, you know, it’s got to be a 
very addictive thing for you to spend that much money ruining your health, do 
you know what I mean? 
Jackie (Age 51, Patient participant 13, Area 1) 
 
As part of this process participants sometimes tried to ascertain my smoking status.  
Although the exact purpose of this was not clear from the discussion following these 
enquires it is hypothesised that the stigma associated with smoking and a potentially 
self-inflicted condition may have had a role to play. 
 
When discussing attempts at behaviour change, it appeared that patients were more 
motivated to undertake a lifestyle change when they believed it would impact directly 
on their current situation: 
I think I realised that Mr X wasn’t saying to me you’ve got to give up smoking 
the way doctors, you know, go in with an ingrown toenail and they say you've 
got to give up smoking.  I know they're coming from a health viewpoint but this 
was a very serious ‘you’ve got to give up smoking’ and it wasn’t said nastily or 
exasperatedly or whatever, he just said it in a very serious manner. He said ‘you 
really must give up smoking’, you couldn’t miss it and you knew it was meant 
for your benefit. 
Jackie (Age 51, Patient participant 13, Area 1) 
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Where the patient above felt stopping smoking would have a direct effect on her 
prognosis in relation to her oral lesion, the following patient stopped smoking as a result 
of another motivating factor: 
 
IV: I’ll tell you what it was.  I was having plastic surgery on my eyes, and they 
said that I need to stop smoking and that's what made me do it.  I stopped just 
like that. 
I: So was that a bit later on from the white patches? 
IV: Huh-huh. Yes I think it was. 
I: Did they say at the hospital, say that if you stopped smoking that would mean 
the white patches would go away? 
IV: They said it would reduce the chances of it becoming cancerous. 
Aida (Age 65, Patient participant 8, Area 2) 
  
There were a number of participants in both study groups who continued to smoke 
following their precancer diagnosis.  This was sometimes seen to occur even when a 
clear association between the patient’s current disease, smoking status and potential 
progression to oral cancer were understood: 
 
They basically said that eventually it would turn to cancer, it would.  If I kept on 
smoking it would turn to cancer eventually... 
Brenda (Age 53, Participant 7, Area 1) 
 
In order to understand why Brenda and other participants continued to smoke despite 
the known association with cancer, the data was analysed with respect to barriers to 
smoking cessation.  Other than the belief their disease is caused by another factor, as 
previously discussed, it became evident that a further significant barrier to smoking 
cessation existed where participants adopted a fatalistic approach to disease: 
 
I've smoked since I was 14 you know: I'm 62 now... I've known people that 
don’t smoke and they are in a hell of a sight worse state than me...and you know, 
you just; well you take your chances don’t you, well I do anyway. 
Mark (Age 62, Participant 5, Area 2) 
 
He later goes on to describe in length the smoking cessation services he has accessed 
and reports a reduction in his smoking habit from 40 to 20 per day, however, when 
asked directly if he felt that he would eventually be able to give up smoking he answers: 
 
 Yeah, when I'm dead 
Mark (Age 62, Participant 5, Area 2) 
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Thereby, making his true intentions clear.  This point of view was seen in relation to 
alcohol consumption as well as tobacco smoking: 
 
I don’t think it does us any harm because I mean my father’s ninety-four, [and he] 
has a whisky and orange every night. 
Arnold (Age 71, Participant 6, Area 1) 
 
Such attitudes have been defined in the literature as ‘cancer fatalism’ (Lewis et al., 
1989), with one UK based study finding that 43% of the participants believed that 
whether a person developed cancer or not was a matter of chance and therefore was 
unavoidable (Warnakulasuriya et al., 1999).  Cancer fatalism is a concept characterised 
by an individual believing that they have no influence over their health status, the 
likelihood of disease development being purely down to luck.  It can therefore be seen 
that such an attitude poses particular difficulties when it comes to attempting to 
influence patients’ risk factor related behaviours.  Although behaviour change can be a 
challenging process much work has been carried out in relation to facilitating this 
process.  To this end it has been suggested that the individual involved in facilitating 
this process can have a significant effect.  Work by Lowry et al., has shown that the 
attitude of the health professional can be perceived by patients as a barrier to behaviour 
change, specifically a lack of enthusiasm.  Their group found that social marketing can 
be used successfully to overcome this, and other barriers, to elicit smoking related 
behaviour change (Lowry et al., 2004). 
 
5.5.2  Experience of treatment – surgery 
 
Many of the study participants had undergone a surgical intervention on at least one 
occasion, usually involving either laser or scalpel excision.  Earlier in the chapter the 
impact of the hospital environment during the transition phase from primary to 
secondary care was discussed and it was demonstrated that for some being in an 
outpatient department alone can be a daunting experience.  When patients undergo 
surgical treatment the clinical environment changes again and they may face another 
new environment for the first time.  For example, this patient recalls her experience of 
surgery where she had surgical treatment in a theatre environment under local rather 
than general anaesthetic: 
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It is quite scary.  It’s the first time I can remember being in a theatre, and you sort of 
stand there and look and there not going to like this but there was a lot of people and 
all in masks and goggles and goodness knows what, they looked as though they 
came from another planet to be honest. Mars comes to mind. And I just sort of 
thought oh, my god.  And to be honest how I got through it I do not know. But I was 
told I did very well.  But I didn’t feel as though I coped very well.  But I found it 
frightening. I did find it frightening.  
Betty (Age 80, Participant 2, Area 1) 
 
Where a number of patients’ accounts echoed that of Betty, finding the experience of 
surgery frightening, for others the concerns were a little more trivial: 
 
 
It was, like, what I looked like.  I mean I had no teeth in, I  had to take teeth out, I 
had the goggles and he wrapped us up so just me nose and eyes, I thought, my god, I 
hope nobody’s watching, taking a photograph, what a sight. 
Gladys (Age 63, Participant 1, Area 1) 
 
However, fear of the surgery was not a universal experience: 
 
I mean I've had so many operations especially when I had the leukaemia, I had 
four Hickman lines in so that was under general anaesthetic and I’d had 
the…eyes for Glaucoma before that under general anaesthetic...I mean by 
comparison the laser treatment was no big deal 
Bert (Age 72, Patient participant 8, Area 1) 
 
It can be seen here that Bert’s anxiety levels are reduced apparently as a result of 
previous experience of illness.  A theme also observed during other aspects of the 
patient journey.  
 
Expectations of surgery were explored with the study groups where, at times, patient 
expectations did not match the surgery itsself: 
 
I actually just thought they were going to zap it with a laser beam...it  wasn’t until 
the day I come into hospital he explained to me that he was going to take a piece out 
and there was going to be a big black hole there. 
Graeme (Age 43, Patient participant 14, Area 1) 
 
This theme (meeting expectations) became more prominent when it came to 
investigating patients experiences of post-operative effects: 
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Afterwards I was quite shocked at how much they cut away actually.  I thought I 
would just be a small patch.  I didn’t even expect any of my tongue to go, but he cut 
a lot off the tongue as well. 
Archie (Age 72, Participant 3, Area 1) 
 
And I thought oh, I’ll just look in the mirror. And I lifted my tongue and I thought       
crikey me, where’s my tongue gone? 
James (Age 61, Participant 4, Area 1) 
 
Now still, 18 months after, the tip of my tongue is still as dead as a dodo...I didn’t 
know that was going to happen.  
Betty (Age 80, Participant 2, Area 1) 
 
These data suggest that there is a barrier in communication preventing these patients 
from fully appreciating the possible consequences of surgery.  When the data were 
further explored, in comparison to communicating the diagnosis, it was found that 
explanations surrounding surgery were often provided by junior members of hospital 
staff.  This is interesting when the professional data is also examined in relation 
communication.  Where the vast majority of professionals stated that they felt it was 
important that a senior member of staff, usually a consultant, communicated a pre 
malignant diagnosis, this was not always found to be the case when it came to 
communicating the procedural details and consequences of surgery.   Where it is not 
possible to establish a link on the basis of the data obtained, it is certainly concerning 
that patient expectations are not being met, particularly if we consider the following 
patient’s account: 
 
IV: I wish I’d known if it was going to turn cancerous then fair enough I would 
have had the operation, but without it, without knowing it was definitely going 
to turn cancerous I wish I hadn’t had the operation. 
I: Why is that? 
IV: Because of the way my mouth is now 
Ruby (Age 51, Participant 9, Area 1) 
 speaking about her regret at her decision to have surgery after being unexpectedly left 
with permanent paraesthesia in her tongue 
 
Living with the potential side effects of surgery will be further explored in the final 
section of this chapter. 
 
5.5.3  Experience of conservative management 
 
An alternative to surgical treatment is that of conservative management, often preferred 
for patients who are considered to be at a low risk of malignant transformation.  
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Conservative management usually involves multiple visits to the hospital on a regular 
basis so that the oral lesion can be monitored for change.  The way in which this option 
is presented to the patient is important.  If we consider the previously discussed work by 
Donovan et al., involving patients with prostate cancer, the presentation of the option of 
watchful waiting was frequently interpreted by patients as no treatment leading some to 
believe clinicians would simply ‘watch while I die’ (p.768) (Donovan et al., 2002).  The 
study went on to suggest that the terminology used when explaining the concept of 
conservative management is key.  They found that by redefining the term ‘watchful 
waiting’ to ‘active monitoring’ a more proactive style of management was inferred, 
thereby inspiring greater confidence in this management option.  
 
Going back to the patient data it was seen that although for many conservative 
management was a source of deep comfort, for others these visits were seen as an 
inconvenience.  This appeared to be the case where ambiguity existed over the purpose 
of the visit and in such instances there appeared to be a sense of patients feeling lost: 
 
I mean I had no idea what was going to happen, just went to find out.  I must 
admit I was a bit sick of going up to the hospital every six months  
Ruby (Age 51, Patient participant 9, Area 1) 
 
Again, it appears that communication is central to patient understanding and acceptance 
of this option.   
5.5 Review/post treatment phase 
 
Following surgical management patients will subsequently attend a maxillofacial out-
patient clinic for regular review.  This will take a similar format to those who are being 
managed conservatively.  In both cases the time between review appointments and the 
overall review period is variable and in the absence of any clear guidelines is dependent 
both on patient factors and clinician preference, but can last several years.  As an 
extreme example, one participant in the study had been undergoing review for nine 
years.  There are a number of themes associated with this review phase.  In most cases 
these themes were evident in other areas of the patient journey.  However, they will now 
be discussed with particular reference to this aspect of the patient experience. 
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5.6.1  Uncertainty  
 
Uncertainty was a theme associated with many aspects of the patient journey.  One of 
the uncertainties associated with precancer is the uncertain disease trajectory in that it is 
possible both that the disease may progress to cancer, but also that it may regress and 
resolve altogether.  For example, at the diagnosis stage there was often a sense of relief 
seen in response to the results of the biopsy where cancer was not observed: 
 
Well I mean there’s always a doubt...you think it could be [cancer] but no, it 
turned out that wasn’t so...it was [a relief] it’s always a relief when you get good 
news 
Gladys (Age 63, Participant 1, Area 1) 
 
This relief may be partly explained if it is considered in terms of the participant being 
relieved or unburdened of their uncertainty over the looming diagnosis.  The concept of 
wanting ‘relief from uncertainty’ is seen in other areas in medicine, for example in the 
case of conditions with a genetic predisposition where individuals undergo genetic 
testing to ascertain the likelihood of developing a specific disease (Williams et al., 
1999).  However, rather than responding with relief, this participant’s reaction is more 
typical of the study group.  Although, in common with the previous participant’s 
account, she expresses that she is relieved that she has not been diagnosed with oral 
cancer, it is clear that her uncertainty in relation to the nature of her condition persists: 
 
Worried about it, because it shouldn’t be there should it. I'm worried about it.  I 
don’t know what it is.  He said the two biopsies I had it wasn’t nasty so I was 
relieved at that. But I just don’t know what it is. 
Glenda (Age 66, participant 1, Area 2) 
 
It is often documented that uncertainty results in anxiety and as a result there has 
historically been a focus on ‘anxiety reduction’ in medicine in relation to diseases with 
uncertain outcomes (Brashers 2001).  If we consider the work of Juraskova et al., it is 
clear that negative responses including anxiety are often seen for those who are 
diagnosed with cervical precancer (Juraskova et al., 2007). However, as Brashers states 
it is important to consider that individuals’ cognitive responses to uncertainty are not 
uniform.  Where it is certainly possible for some that uncertainly is an anxiety 
provoking experience, for others uncertainty can be positive in that it allows the 
individual to maintain hope, for example within this group a positive response to 
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precancer was seen in those who voiced hope that the oral precancer will regress.  As 
this participant demonstrates: 
 
Oh positive, without a doubt.  It wasn’t cancer.  To me precancer... the earlier 
you catch it the better chance you have. 
Frank (Age 63, Participant 11, Area 2) 
 
Earlier, in the literature review, it was argued that oral precancer may be viewed as 
either an acute or chronic illness.   This is significant when we look at uncertainty.  For 
those with disease that is discovered, treated and resolved the uncertainty may be short 
lived, for example uncertainty associated with a surgical procedure: 
 
 
I mean the main thing was getting put to sleep and frightened of not waking 
up...that was more of a worry than anything else 
Bob (Age 48, Participant 10, Area 1) 
 
As this participant demonstrates, his uncertainty is associated with surviving his 
operation which will clearly no longer exist following the treatment.  However, for 
many oral precancer patients their management will not result in complete resolution of 
their condition and it is not unusual for these patients to undergo extensive periods of 
follow up (in either primary or secondary care).  For these patients there was often 
uncertainty regarding the course of their disease: 
 
IV: I think it will gradually go...just take its own time...leave it to its own course 
...as long as they don’t cut off a bit of my tongue 
I: Did they mention to you that might happen 
IV: No, [but] you never know. 
Beryl (Age 77, Participant 4, Area 2) 
 
Not only does this participant demonstrate her uncertainty with regard to disease 
outcome but she also voices unresolved concerns about possible future surgery. 
 
For those with ongoing disease, the literature would suggest that the nature of the 
uncertainty can also be seen to vary over time particularly as individuals become 
accustomed to their disease state (Mishel 1999).  Where this was not especially evident 
from the data in the way Mishel describes it, there was evidence of a change in the 
levels of uncertainty the individuals experienced as time elapsed.  An unusual example 
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of this comes when we consider Violet’s account.  In this case she misinterprets 
information provided by her clinician at one of her review appointments, resulting in an 
increase in uncertainty.  She had been attending an outpatient department for review 
over several years following a surgical intervention.  She adopted a passive role 
throughout the course of her management, choosing to rely on the doctors in charge of 
her care as her sole source of information:   
 
IV: Yes, white patches, it’s all I remember.  Yes, well of course it was all new to me 
then, I didn’t understand it, but as the years have gone by well I’ve understood more 
about it. 
I: What extra information have you picked up over the years about it? 
IV: Well recently Dr X did mention cancer and that was the very first time, but I 
didn’t think it was cancer that was the only thing. 
I: So was he saying that you that you did have cancer in your mouth before? 
IV: ...well yes, because he said the cancers returned sort of thing... 
I: ...so how did you feel when that came up just quite a number of years later? 
IV: Well I was just surprised really 
Violet (Age 90, Patient participant 2, Area 2) 
 
She later goes on to describe how she re-evaluates her past disease on the basis of this 
new information, stating that she believes now that she had a type of cancer that didn’t 
spread and was therefore easier to treat.  Examining Violet’s transcript it could be 
argued that this process of re-evaluation resembles the process of biographical 
disruption described by Bury whereby an individual’s inner biography is renegotiated  
following a significant event (Bury 1982).  
 
For those whose treatment involved surgical intervention there were a number of 
possible side effects of surgery including pain, bleeding, paraesthesia, scarring or, less 
commonly, as the following participate demonstrate,  xerostomia.  Participants often 
reported uncertainty relating to the duration of these surgical side effects: 
 
IV: you know, there’s no saliva in the mouth and it just sort of sticks to 
everything 
I: And is that going to come back? 
IV: I'm not sure...I mean obviously it must vary from person to person, or where 
the actual treatment was, so I'm just waiting and holding on and keeping my 
fingers crossed  
Mark (Age 62, Participant 5, Area 2) 
 
This patient describes his experience of xerostomia, however, he appears unsure 
regarding its duration apparently relying on hope rather than seeking additional 
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information to provide clarity.  Although the majority of patients who undergo surgical 
treatment for oral precancer report minimal adverse effects, even for those without any 
persistent undesirable post-operative side effects, there was still the potential for 
uncertainty when it came to disease recurrence:  
 
I mean I knew nothing at the time what the success rate was, how many people it 
did come back.  I still don’t really know how many times people do have to 
come back, how often it reoccurs.  When it reoccurs, does it lie dormant for 
another year or two.  I don’t know anything like that, even now.   
Archie (Age 72, Participant 3, Area 1) 
 
5.6.2  Fear  
 
Linked with this often persistent uncertainty, some patients reported fear in relation to 
their disease.   The topic of fear was examined as a significant factor earlier in this 
chapter when patients’ initial seeking help behaviour was explored.   At that early stage 
it was shown that fear could be either a motivating or delaying factor when it came to 
patients presenting to a health care professional.   
 
When looking at fear during the review or post treatment phase, its possible effect on 
patient behaviour can again be seen.  In some cases there was evidence of participants’ 
fear that their disease may progress to cancer including the associated potential for 
extensive surgery and its consequences, including death.   Examining the data further it 
could be seen that this fear often manifested in the individual avoiding seeking further 
information about their disease and its prognosis: 
 
I: Did you go and look for any information yourself 
IV: No, I didn’t, no. 
I: Was there a reason for that 
IV: Frightened. Best ignore it. 
Betsy (Age 74, Participant 9, Area 2) 
 
On the other hand, a number of participants, reflecting on the potential consequences of 
disease progression to oral cancer reported a positive experience.  These individuals 
described how they felt they were the lucky ones and were often grateful to the dentists 
or doctors involved in their care for the roles they played in avoiding a more serious, 
life threatening condition: 
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I was very grateful to the dentist for finding it and referring me on...and people 
say things about dentists and all that, but they do a good job really, when you 
think about it, they do a good job.  So, I know I filled in a study for, the NHS 
often sends me studies out, I filled in a study about dentists and whether I 
thought they were good value for money or whatever.  I said if they hadn’t 
noticed that patch I probably would have got cancer.  
Brenda (Age 53, Participant 7, Area 1) 
 
The following participant is reminded of the potential for disease progression through 
her interactions with another patient in the waiting room at the outpatient clinic: 
 
[in the waiting room] there was this gentleman there with his wife and I was a 
bit, because he had something wrong with his nose, like a cancer type thing, and 
I hadn’t ever thought about this in my life, but he actually [had] a false nose.  
And it really shocked me, he lifted it off to show me.  I mean I was a bit taken 
aback... and I thought oh, at the time I'm thinking oh, cancer in the mouth and 
the face must be dreadful, I remember thinking that...I kept thinking, oh you're 
lucky 
Molly (Age 82, Participant 10, Area 2) 
 
As well as the specific fear of cancer, some patients who had been treated by surgical 
intervention reported a fear of further treatment.  This is perhaps surprising when we 
consider that the majority of professionals who participated in the second study stated 
that they felt surgical interventions for a patient with oral precancer to be minor 
particularly in comparison to the often more radical surgery required in many cases of 
oral cancer.  While it is certainly true that, when comparing one with the other, surgery 
for precancer may be considered less radical with shorter recovery periods and less 
associated undesirable consequences than surgery for oral cancer, it must be also be 
considered that the individual patients will not have cancer surgery as a reference point.  
For example, this patient had opted for laser excision of her premalignant lesion as part 
of her overall treatment plan.  However, she had been unsuccessful in reducing her risk 
factors (smoking).  When another oral lesion was subsequently discovered she believed 
it occurred as a direct result of her continued smoking habit.  She used her fear of 
further surgery as a motivating factor to successfully aid her smoking cessation efforts: 
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But I think what made me quit this time, I didn’t, it didn’t register when they said I 
had precancerous cells, it didn’t really, it didn’t really frighten me, but this time 
when he said the patch had come back, the thought of having the laser treatment 
again, that's been a big thing, because I don’t think I could stand having the laser 
treatment again...but it’s funny that how the thought of getting cancer didn’t affect 
us but the thought of [further surgery did], that's because I’d had the laser treatment 
and I knew the pain involved, whereas I hadn’t had the cancer.   
Brenda (Age 53, Participant 7, Area 1) 
 
 
5.6.3  Reassurance 
 
The review/post treatment phase of management often involves sequential appointments 
at the same clinic.   One of the most striking findings arising from the data when 
exploring the experiences of patients attending for review was that of the apparent 
therapeutic effect of the review appointment itself.  In addition to this it appears that 
some patients become reliant on the review appointment reporting panic if it is changed 
or there is a possibility of discharge: 
 
       So I always feel quite good if I've got six months reprieve. 
Lily (Age 58, Patient participant 12, Area 1) 
 
I find it very reassuring.  I find going very reassuring, I feel like, you know, passed 
again sort of thing so I find that very reassuring and knowing that things are ok. 
Jackie (Age 51, Patient participant 13, Area 1) 
 
The second participant here later goes further, and describes how she feels following a 
missed appointment: 
 
IV: I didn’t realise until I got the did not attend (letter) and I was absolutely 
mortified, that I’d wasted somebody’s time... I was actually quite panicky.  I tried 
ringing up and you can’t get through, you really, really can’t get through at all... 
I: When you got panicky, why was that? You mentioned wasting time, was it 
because of that... 
IV: It was because it wasn’t being monitored.  I was panicked as well, you know, I 
did feel awful that I’d missed an appointment and didn’t know, so I even rang up the 
next day.  But it wasn’t being monitored, that really worried me. 
Jackie (Age 51, Patient participant 13, Area 1) 
 
What Jackie demonstrates is a dependence on the review appointment to satisfy her 
need to know her disease status.  This finding is also seen in the work of Gibson et al., 
in their study examining regular dental attendance.  They further go onto compare the 
behaviours of a regular dental attender (an individual who attends the dentist at six 
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monthly intervals for a dental ‘check-up’) to those with chronic illness, observing 
similarities between the two.  In particular they state that dental patients ‘may take on 
the sick role and become dependent on the dentist for their dental health’ (Pg.10) 
(Gibson et al., 2000).  This apparent dependence on a clinician will be examined further 
in the next section.   
 
Although many of the participants interviewed reported a desire to maintain a regimen 
of regular review appointments as a means of reassurance, there were also a great 
number who were keen to progress towards discharge.  It appeared that the significance 
of being discharged was that it was seen as an end of the disease process allowing the 
person to be released from the labels of both patient and precancer.     
 
I think that I just have to go back one more time.  I'm hoping I’ll just have to go 
back one more time.  And that would be me cleared altogether. 
Betty (Age 80, Participant 2, Area 1) 
 
For these patients there was no concern regarding future disease or disease progression 
and interestingly this desire for discharge was seen both in those with no ongoing 
disease or risk factors as well as those with persistent lesions and risk factors.  
 
Previously when the patient data surrounding referral to secondary care was examined it 
was found that patients placed particular significance on the length of time between 
referral and consultation appointment, with a shorter wait indicating a more urgent 
problem.  The influence of time is seen again when the data is examined with reference 
to the time left between review appointments, for example here the change from a two 
monthly to a three monthly review is viewed in a positive light: 
 
He said we’ll keep a very close [eye] on you anyway.  The fact he's now made it 
three months is encouraging.  
Archie (Age 72, Participant 3, Area 1) 
 
This participant interprets a greater length between appointments as a signal that his 
condition is less serious and he is closer to being discharged, something which he also 
views as positive.  
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5.6.4  Influence of doctor-patient relationship at this stage 
 
Throughout the patient journey in secondary care there was a strong sense of the 
importance of what was described as trust, faith or confidence in the doctor in charge of 
their care: 
 
He was very reassuring.  I had confidence in him which means a lot to a patient.  
My wife was happy with him too, he explained each time.  Yeah, if the health 
service was staffed by a lot of Dr X’s it would be very good 
Frank (Age 63, Participant 11, Area 2) 
 
This feeling of trust was often coupled by a belief that the clinician was being 
transparent: 
 
 
Dr X, he’d obviously done a lot of it and seen a lot of it and I just put my faith in 
him really...I thought, well he's got to be genuine, he didn’t try to make light of 
it which I would imagine some doctors do when you get something, trying to 
hide, but he came out with it straight away. 
 
Archie (Age 72, Participant 3, Area 1) 
 
The notion of having faith in the doctor in charge of your medical care is not a new 
concept (Becker and Maiman 1975) and is seen as being particularly important when it 
comes to communicating uncertain conditions such as precancer (Juraskova et al., 
2007). However, the data suggested that where patients had established a rapport with a 
particular clinician and felt confident in their abilities, due to the nature of the repeated 
need for a review appointment, continuity in terms of seeing the same individual at each 
appointment was also desirable:  
 
It’s about the continuity of you know, that person, I'm sure people draw 
diagrams or measure it in some way, do you know what I mean, otherwise 
there’d be no bloody point.  But it’s also about seeing it and knowing you and 
you know he's seen it the last time and maybe opening the file refreshes their 
memory or whatever but I think that gives you confidence, that it is being seen 
and it is being taken very serious and I find that helpful. 
  Jackie (Age 51, Patient participant 13, Area 1) 
 
Some patients go further, expressing distress at the thought of not having that 
continuity: 
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And I do worry because he knows the case so well.  I just keep hoping, because I 
think he’s possibly a lot younger than me, so I think well at least you’ll not retire 
before I've...see I'm anxious about that, how sad is that?  You think well if 
something happens and he moves away.  I've told him I’ll track him down 
Lily (Age58, Patient participant 12, Area 1) 
 
This participant’s account, like the next, also demonstrates an apparent dependence on a 
specific individual.  Where this was seen it was always the consultant who was 
involved: 
 
I’d be disappointed with somebody else...it’s just I think you feel comfortable 
with a person, you can talk better to them and you just seem to understand what 
they are saying more. 
 Beryl (Age 77, Patient participant 4, Area 2) 
 
Although the majority of patients expressed a preference to be seen by the same 
clinician, there were one or two patients for whom consistency did not appear to be of 
concern: 
 
Well Dr X is in charge, but sometimes I do see other people.  They do the same 
procedure... look in your mouth... make notes and two or three times I've had 
photographs taken, so they go by the notes.   
Violet (Age 90, Participant 2, Area 2) 
 
Going back to where an attachment with a particular clinician was observed, there was 
sometimes a feeling by the participants that they had personally let their clinician down 
when, following surgical treatment to remove a lesion, their disease returned:  
 
I was going every six months for a check and then they found the patch had 
come back again.  And I felt really terrible, I felt like I’d let Dr. X 
down...because I think like he did a very good job.  And he was very, very nice 
to us and all that and then when the patch come back I just felt I’d totally let him 
down really...I wondered what he felt. 
Brenda (Age 53, Participant 7, Area 1) 
 
This section has focused on the factors affecting patients in the post-operative or review 
phase of their management.  In doing so it has been possible to highlight the persistent 
uncertainty and fear that some patients describe in relation to their disease at this stage.  
In addition, it  has also been possible to observe that where some patients report a need 
for discharge as a means of signifying the end of the disease process, others rely on the 
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review appointment for reassurance and comfort and in some cases are seen to become 
dependent on not only the review process itself but also the clinicians themselves.   
 
5.7  Ongoing effect of diagnosis/living with precancer 
 
This final section of the patient results and discussion chapter will focus on the ongoing 
effects of living with oral precancer which will be dependent on the patient’s appraisal 
of their disease.  As previous discussions have suggested, this is a multi-factorial 
process often involving patient factors (their knowledge, previous experiences), their 
social resources (typically the views of friends and family) and the influence of their 
health care professionals. 
 
5.7.1  Attitude to disease 
 
The individual’s attitude to disease will be formed as part of the process of disease 
appraisal.  The following themes demonstrate the attitudes the participants felt towards 
their disease: 
 
 A devastating diagnosis 
 View of oral precancer relative to other health related factors 
 Attitude shaped by a fatalistic viewpoint 
 Stigma felt in association with risk factors 
Each of these factors will now be discussed in turn.   
 
A number of participants found the diagnosis of oral precancer deeply distressing: 
 
Then I got the devastating news really, that they’d only just caught in time what 
appeared to be a very unstable lesion.   
Archie (Age 72, Participant 3, Area 1) 
 
A finding which has long been demonstrated within the cervical precancer literature 
(Kavanagh and Broom 1997).  Also consistent with the findings of this study, Kavanagh 
and Broom state that where associations with precancer and cancer were made, 
participants reported profound effects, particularly where the possibility of death was 
considered.  This type of acute negative reaction was most frequently observed at the 
time of diagnosis.  Where for some, the initial effects of devastation felt at the time of 
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diagnosis diminished over time, for others the ongoing negative effect of living with 
precancer was evident: 
 
I remember having reflective moments at work when you suddenly come to put 
the pen down thinking what the devil am I doing here? ... I was on my own... 
there was more time to reflect at work than there was at home. 
Frank (Age 63, Participant 11, Area 2) 
 
Frank later goes onto reiterate this ongoing effect: 
 
There were times I must admit you think oh dear, I’ll stay in bed today.  No 
doubt about that.  I think having a caring wife...helps.  Even if I didn’t talk to 
her.  But it helped, she was there. She knows. Just always being around and 
being helpful without telling me she was being helpful. Difficult for a single 
person I would think.  More difficult.  To go home and just have the four walls 
surrounding you, things closing in, too much time to think.  
Frank (Age 63, Participant 11, Area 2) 
 
As well as demonstrating the extent to which his disease affected his life, making him 
feel that he wanted to stay in bed, this quote also reveals the importance Frank attaches 
to the support of his wife as a means of helping him cope with this difficult diagnosis. 
 
The impact of other significant factors and in particular the influence of other disease in 
the patients’ lives has been discussed elsewhere in this chapter.  When considering the 
ongoing effects of living with oral precancer, there was often a comparison drawn by 
participants between their oral disease and their experience of other disease.  Patients 
frequently evaluated the significance of their oral precancer on the basis of previous or 
concurrent disease experience.  Where their oral precancer was judged to be less 
significant than previous or current illness, the ongoing effects of living with oral 
precancer were less pronounced.  For example, a number of patients reported personal 
experience of cancer.  Where this was seen the precancer was evaluated as a lesser 
disease and the effect of it on the individual was less.  
 
The impact of previous or ongoing illness was also seen in relation to associated 
hospital visits.  Patients frequently compared surgical experiences between one disease 
and another.  For some, even the experience of simply going to hospital was seen to be 
influenced by other disease experience: 
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Well as I said, I've been a diabetic since I was two years old, I've got 49 years 
behind us and I've been in and out of hospital for all sorts of things to do with 
that, so hospital holds no fear for me 
Ruby (Age 51, Participant 9, Area 1) 
 
The disease experience of others, particularly if they were close relationships, also 
impacted on the patient experience:  
 
We’ve got a granddaughter...at the same time she was having trouble.  And it 
was the dentist that told me that she was referring her to the hospital and she had 
a tumour. Had cancer. 
Betsy (Age 74, Participant 9, Area 2) 
 
This experience of oral cancer within the family resulted in Betsy having a higher 
degree of suspicion when it came to evaluating her own oral condition.  Where she felt 
that she too may have cancer when it transpired she did not, she viewed the diagnosis in 
a positive light, counting herself lucky not to have been affected by the same 
devastating diagnosis as her granddaughter. 
 
When exploring patients’ attitude to their disease, a strong theme to emerge from the 
discussions was that of fatalism.  A fatalistic attitude has already been covered when 
possible barriers to behaviour change were examined.  The belief that illness occurs 
simply as a matter of chance was frequently put forward by the study participants. 
When discussed in the context of their attitude towards their illness this approach 
appeared to be strongly linked to the age of the participant.  For example, the youngest 
participant, Andy, consistently demonstrated a fatalistic attitude towards his disease: 
 
Life’s for living at the end of the day and it’s going to deal you out the cards that 
you're going to have  
Andy (Age 38, Participant 11, Area 1) 
 
However, where Andy saw his diagnosis as an opportunity to make the most of his life, 
others seemed to suggest their life was almost complete, with some expressing 
satisfaction in the life that they had experienced: 
 
...and of course you see I'm old now, it doesn’t really matter, so it’s not as though 
I'm a young person... I've had my day 
Violet (Age 90, Patient participant 2, Area 2) 
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God I'm 69, I've had a canny innings.  I've seen my son grow up, my grandson, so I 
could go tomorrow...no I've had a canny life.  I've had two heart attacks and a brain 
haemorrhage and an operation on my toe, so I think that I'm fortunate still to be 
here: He doesn’t want us yet... 
Ted (Age 69, Patient participant 12, Area 2) 
 
Alongside fatalism, stigma was another factor which was seen to impact on an 
individual’s ongoing attitude to their disease. The theme of stigma was most commonly 
seen in relation to participants’ smoking habits.  The vast majority of smoking patients 
were able to recall that their clinicians had advised them of the association between 
smoking and oral precancer. Alongside this there was, at times, evidence of a difficulty 
coping with the knowledge that their oral disease was in some way potentially self-
inflicted.  Where this has been discussed alongside the topic of smoking cessation, in 
addition, there was an undercurrent of shame present in some of the transcripts 
particularly for those who continued to smoke: 
 
I don’t know, having something in me mouth, I don’t know, I feel like unclean 
somehow with something in me mouth.  I don’t know why it just...I tend to want 
to clean me teeth more, things like that. Because its something oral rather that 
like something on me arm…you know.  That's the only thing I feel about it. 
Brenda (Age 53, Patient participant 7, Area 1)  
 
 
5.7.2  Withholding information/protecting family and friends 
 
Where a supportive family unit can helpful during illness, it has been shown that there 
was often a need, especially initially, to withhold information from family and friends.  
This appeared to be related to the perceived relative severity of the oral condition: 
 
I was really worried, I was really, really worried.  I was so worried that I didn’t 
mention it to my husband for some time, until I actually got the letter for the 
appointment, or to my daughter.  That's usually indicative of how worried I am, 
if  I’m not worried then I say such and such has happened or whatever but the 
more worried I am, the more I tend to keep things to myself.  It’s almost like that 
sort of thing if you mention it, it makes it more real. 
Jackie (Age 51, Patient participant 13, Area 1) 
 
As well as withholding information altogether, even when topics such as referral, 
diagnosis or treatment were discussed with loved ones, the information provided by the 
concerned individual was often tailored in an effort to play down the perceived 
seriousness of the situation: 
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I really told [my wife] very little...I liked to keep most things to myself during 
the course of what was going on.  I don’t know why.  Yes, certainly the thought 
of I don’t tell her she doesn’t know, she doesn’t have to worry.  But then again 
you think well, there wasn’t much to tell her for her not to worry about.  But I 
don’t know, I think most men are like that.  Very inward, keep things to 
themselves.  Until it all goes wrong and you break down and the poor woman 
has got to pick the pieces up. 
Frank (Age 63, Participant 11, Area 2) 
 
The same participant also describes the support he felt he got from his mother despite 
the fact that he chose to conceal his illness from her: 
She was the most wonderful, lovely person but not sort of academically gifted.  
She had no idea.  My dad did but he didn’t say anything to her.  I used to get a 
lot of support from my mum, my mum bless her, she didn’t know but just by 
being there with her. She was always jolly and humorous and didn’t know what 
was happening. 
Frank (Age 63, Participant 11, Area 2) 
 
Interestingly there was also evidence that patients’ loved ones withheld their true 
feelings from the participants: 
 
I did talk to me son and daughter about it and I think me daughter was very 
worried about it...they tend not to tell me very much.   Me daughter, I've been 
told by other people she worries about us but she never tells me herself.  
Brenda (Age 53, Participant 7, Area 1) 
 
As discussed, shielding information from loved ones may also be termed ’protective 
buffering’.  A study by Suls et al., examined coping strategies employed by men 
following myocardial infarction, they revealed that men employed this approach of 
protective buffering as a means of shielding information from their wives, but they also 
found that the men’s wives likewise withheld information from their husbands.  Whilst 
the intention of both groups was to protect the other, in the end the effect was instead 
the opposite leading to increased levels of distress over time (Suls et al., 1997).   
 
5.7.3  Practical impact of precancer on everyday life  
 
In terms of a practical impact on a person’s day to day life, multiple participants 
reported a regular routine of self-checking the oral cavity: 
 
I: Do you keep an eye on your mouth? 
IV: Aye...every day...I check it every morning 
Mark (Age 62, participant 5, Area 2) 
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I'm very conscious of what's happening in my mouth now.  Obviously at one 
time – I brush my teeth a hell of a lot more, whereas sometimes it was once a 
day, now its three times a day, and the mouth wash and things like that...I mean I 
had an abscess not long ago behind one of my teeth... I went straight up to the 
hospital…I was genuinely quite panicky about it.  I mean I didn’t know it was 
an abscess. 
Andy (Age 38, Participant 11, Area 1) 
 
The impact of risk factor reduction (primarily smoking cessation) was ever present for a 
number of people for whom lesions persisted but attempts at risk factor reduction had 
failed.  However, where the individual attributed their disease to other causes there were 
examples of unusual behaviour changes which, in some instances had a profound 
impact on that person’s lifestyle: 
 
And they couldn’t really say why it had happened.  Now I’d been putting it 
down to eating and drinking very hot things which I used to do...now I put cold 
water in everything...I don’t eat, well, I try not to eat anything hot.   
Lily (Age 58, Participant 12, Area 1) 
 
Not only did this participant describe an extreme change to her eating habits she also, 
following an unpleasant surgical experience, took the decision to resign from her job:  
 
It started to worry me that they were having to take supply nursery nurses in and 
that worried me because I know it’s a more expensive route to take.  And I 
thought it might be better if I didn’t have that worry so I actually gave up work. 
Lily (Age 58, Participant 12, Area 1) 
 
Where this was not a typical example of the impact of oral precancer, it does 
demonstrate the powerful effect that this condition can have on an individual. 
 
This chapter has explored the patient experience of oral precancer by following the 
patient through their disease journey, from the point at which initial signs or symptoms 
are discovered, through the diagnosis stage, management of their condition and the 
ongoing effects of living with oral precancer. The next chapter will go on to present and 
discuss the results of the clinician based study.   
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Chapter 6. The Clinician study: Results and discussion 
 
The study based on clinical professionals’ views and experiences formed the second 
phase of the overall project.  Initially it was proposed that this study would take the 
form of a paper based postal questionnaire focusing on management choices in oral 
precancer.  However, following the results of the patient based study it was decided that 
a qualitative approach would be necessary in order adequately to explore the complex 
decision making process involved in the management of oral precancer patients.  In 
addition I thought it was important that themes uncovered in the patient study were fed 
into the professional study. As a result the areas of communication and behaviour 
change were specifically discussed with the professional group.   
 
The next section presents and discusses the results following analysis of the clinicians’ 
study data.  It begins by discussing the intricacies of delivering a diagnosis of oral 
precancer and patients’ information needs, it then goes on to outline the challenges 
faced when addressing risk factors and formulating treatment plans and finishes by 
examining a number of specific difficulties that may be encountered when managing the 
oral precancer patient.   Although a range of views are presented, it is acknowledged 
that data from participants 8 and 11 account for a larger proportion of the presented data 
than the other participants.  This may be because both are consultants who identify 
themselves has having a specific interest in the field of oral precancer.  As both have 
developed and set up dedicated oral precancer clinics as well has active involvement in 
undertaking research in the area it is conceivable that they may have more developed 
ideas than the other participants. 
 
6.1 Communicating with patients (delivering a diagnosis)  
 
Communication was a prominent theme that ran throughout the interviews obtained 
from the professional study.  Perhaps this is not surprising if the impact of good 
communication between the doctor and patient is considered.  As Ong et al., have noted, 
good communication between the clinician and their patient can potentially influence 
patient understanding of their disease and shape the decisions patients make about 
investigative procedures and treatment.  Furthermore, the success (or otherwise) of free 
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communication between clinician and patient has the power to impact the level of 
patient distress, satisfaction with care and compliance with treatment (Ong et al., 1995).   
 
For the purposes of this section, communication will be discussed primarily in relation 
to the delivery of a diagnosis.  Whilst good communication is important at every stage 
of the patient journey, the diagnosis stage has been chosen as the focus of this section as 
it contains a number of different relevant aspects of the communication process 
including: the significance of the terminology used during the consultation, the specific 
difficulties that may arise when communicating possible cancer risk to a patient and the 
desire to deliver a positive message. 
 
6.1.1  Significance of the terminology used 
 
When focusing on oral precancer diagnosis it is worth reconsidering how oral 
precancers are defined and how they are related to oral cancer, in this way the message 
that the study participants are trying to convey to their patients may be better 
understood. Briefly, oral precancers are not cancers but are lesions which are more 
likely to contain dysplastic changes (cytological and architectural changes in the 
epithelium) than normal oral tissues. Significantly, they are also statistically more likely 
to progress to oral cancer (squamous cell carcinoma) than normal tissue.  
 
In order to begin to explore how clinicians communicate the concept of oral precancer 
to their patients, the clinician study group were asked to describe how they would 
approach discussing a precancer diagnosis with their patients.  To this end, the 
participants often spoke of their choice of terminology and a desire to provide their 
patients with a clear message. Discussing their views, the participants tended to 
distinguish between lay and technical terminology with some using what they 
considered to be lay terminology alone whilst others opted for a combination of the two.  
For those who chose to use lay terminology only, there was often a belief that using 
technical language posed a barrier to patient understanding: 
 
I think we don’t actually talk about the term or mention ‘dysplasia’ much, 
because I think that’s a difficult concept to grasp, or is that a bit patronising?  
But I think changes, ‘changes in the cells’ is a term that I would use rather that 
‘dysplasia’. 
OMFS Cons 7 
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[I] just explain it in simple terms and just say that, you know, the cells are 
starting to misbehave… 
OMFS Cons 9 
 
IV: I just tell them they’re unstable. 
I: Right, ok.  And do you give them any further information? 
IV: No 
OMFS Cons 6 
 
Terms such as unstable cells, cells behaving badly, and abnormal cells were commonly 
used to explain the difficult concepts of oral precancer and dysplasia in a bid to provide 
explanations to patients that were unambiguous. However, the literature suggests that 
using non-medical terminology alone may lead to uncertainty surrounding a diagnosis.  
For example, Chapman et al., as part of a larger study, explored the effect of cancer 
euphemisms such as ‘lesion’, ‘growth’ and ‘dark spot’, on lay understanding of a cancer 
diagnosis (Chapman et al., 2003).  They concluded that a substantial portion of their 
sample did not understand such terms.  Confusing patients and creating barriers to their 
understanding of oral precancer was clearly not the intent of the study group: 
 
It’s absolutely crucial to be clear with patients what we’re talking about 
OMFS Cons 11 
 
However, some participants had reservations that their chosen terminology was fit for 
purpose: 
 
I do try and use what I think is lay terminology.  Now obviously it’s difficult, 
because sometimes even though you think you’re using lay terminology, you 
can end up using language that people don’t quite understand. 
OMFS Cons 2 
 
This participant makes an interesting point, where he states that he thinks that he is 
using lay vocabulary he also suggests that despite duly considering the language he uses 
he is not always able to assess if his chosen language has been understood.  The ability 
to provide clear explanations of medical conditions in modern times is complicated by 
the frequent use of ‘medical’ terms in the media.  However, whilst people may hear or 
read about medical terms they may not fully understand them.  This is highlighted in the 
work of Chadha and Repanos who conducted a study exploring individuals’ 
comprehension of a number of commonly employed medical terms used to describe 
‘lumps’ (Chadha and Repanos 2006).  Alongside comprehension they also investigated 
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the influence of each word on a person’s level of anxiety. Among their findings they 
noted a significant misunderstanding of some of the terms used to describe lumps.  
Specifically, the word carcinoma was among the terms which were not well understood 
whereas the words malignant and tumour were reported as being the most threatening.  
 
The concept of threatening or anxiety provoking language was examined further, for 
example when exploring the terminology used by the participant below: 
 
I tend to avoid the word dysplasia, l tend to use precancer. Rachel, I assume, and 
maybe wrongly, that people understand what I’m talking about when I say 
precancer, I don’t know. 
OMFS Cons 10 
 
Where this participant queries the effectiveness of the terminology he uses, in addition 
he chooses to use the word precancer.  This is perhaps surprising when it is well 
documented that the word cancer is an anxiety provoking term.  Indeed cancer has been 
described as ‘the most feared of modern diseases’ with some reporting that even the 
threat of such a diagnosis evokes a sense of fear (Clarke and Everest 2006).  If we then 
look specifically at the term precancer, Kavanagh and Broom in their study exploring 
women’s understanding of abnormal smear test results found that many of their 
participants mistook the word precancer for cancer, which, not only led to a 
misunderstanding of their diagnosis, but in turn also led some to thoughts of death and 
their own mortality (Kavanagh and Broom 1997). 
 
Analysis of the data also revealed that in contrast to those who used either lay or 
medical terminology in isolation, some participants chose to use a combination of both 
lay and technical terms: 
 
I do make a point of telling people what the proper term is, but then explaining 
what that means. 
OMFS Cons 11 
 
In many cases there was a definite reason for this: 
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Well I would explain that diagnosis as a precancer or potentially precancerous 
condition.  If we’re talking about dysplasia…the ones where you’ve got 
moderate or severe dysplasia, then I do explain that as being a precancerous 
condition that if left untreated or unmodified by lifestyle factors, it could well 
progress to the development of a cancer…I would use [the term dysplasia] but 
then explain what it meant, because the point is, a lot of patients I think want to 
go and look things up. 
OMFS Cons 9 
 
In the quote above the participant uses the diagnosis consultation as an opportunity to 
explain the link between oral precancer and cancer.  However, it appeared that some 
participants were not as explicit in their explanations: 
 
For more severe dysplasia I tend to, sort of, talk about cancer in waiting, that’s 
probably a phrase I use quite a lot.   
OMFS Cons 2 
 
This participant is much more ambiguous in his explanation of the diagnosis using the 
phrase ‘cancer in waiting’ which could potentially be wrongly interpreted as a lesion in 
which cancer progression is inevitable rather than one in which there is a risk of future 
cancer development. 
 
6.1.2  Desire to be positive 
 
Where participants spent time outlining the association between precancer and cancer 
with their patients, the message was usually closely followed up by the accompanying 
information that the diagnosis presented an opportunity to reduce the likelihood of 
cancer occurring, on the proviso that tobacco use and alcohol consumption were 
discontinued.  The concept of the diagnosis being an opportunity went alongside the 
frequently expressed desire to provide a positive message:   
 
I tend to stick to more positive things like, as you smoke 20 cigarettes per day, if 
you reduce that, we know…that when people stopped smoking, two years later 
some of the genes revert to normal. Mutations do resolve…some genetic 
damage is repairable, so I focus on things like that.   
OMFS Cons 11 
 
This was, clearly, an easier approach to take where patients presented with modifiable 
risk factors: 
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It’s very helpful, oddly, if they are a smoker because then we can start talking 
about, ‘there are things we can do which might help reduce the risk’. 
OMFS Cons 11 
 
Conversely, participants often had difficulty providing a positive explanation of a 
patient’s disease where they presented without any apparent modifiable risk factors: 
 
There’s nowhere to go really…if you’ve got something to give up then you 
perhaps reduce your risk status, if you’ve got nothing to give up, you’re relying 
on your genetics and there’s obviously a problem with them in the first 
place…yeah, they are more difficult to manage when there aren’t any risk 
factors. 
OMFS Cons 3 
 
A desire for a positive message at the diagnosis stage was often seen alongside a need to 
minimise the potential for distress or anxiety: 
 
What I try to do is to deliver a message that there’s an important and significant 
problem here but not in a way that’s overly…try not to be overly threatening or 
overly dramatic in giving that information.   
OMFS Cons 8 
 
First thing, I think, is always to say things in the positive because they are often 
frightened when they are at the clinic 
OMFS Cons 11 
 
This was approached in different ways by the participants, in some cases the risk of 
inducing anxiety was thought to be reduced by minimising the apparent severity of the 
situation: 
 
I play it down…I would say ‘there’s showing some abnormal cells but it doesn’t 
necessarily mean that it’s going to give rise to anything of concern. 
OMFS Cons 5 
 
The above examples illustrate the types of conversation the consultant participants had 
with their patients in association with cancer risk which is an important, but inherently 
difficult, task as although the literature provides convincing evidence that precancerous 
lesions are more likely to progress to a malignant lesion than normal oral tissue, figures 
on the incidence of malignant transformation are not consistently reported within the 
existing literature base.  This creates a situation which can be challenging to address 
with patients: 
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‘And it’s rather difficult’, although I often say we’re working on ways of trying 
to do this, ‘but it’s very difficult to predict to anybody what is going to happen 
to that patch’ 
OMFS Cons 8 
 
Where the participant in the example above chooses to broach the fact that a precancer 
prognosis is somewhat uncertain, others expressed concern that focusing on potential 
cancer risk may well evoke feelings of fear or anxiety. 
 
A balance has to be struck between telling them the gravity of the situation that 
they’re in and in some way providing them with a degree of risk assessment, but 
not making them very frightened or anxious.  
OMFS Cons 11 
 
6.1.3  Risk communication 
 
The participant above introduces the concept of risk assessment.  There is a great deal in 
the medical literature on the subject of risk assessment and corresponding risk 
communication, with a particular focus on communicating risk in a format that patients 
can understand.  In general terms, information concerning risk may be provided in a 
quantitative (usually in the form of statistics), qualitative (usually using descriptors such 
as frequently or rarely) or graphic format (Bogardus, Holmboe and Jekel 1999).  
Evidence of qualitative and graphic risk communication was limited within the clinician 
data set.  On the other hand, providing risk information using numerical values was a 
popular topic of discussion from the participants: 
 
I do sometimes give patients statistics.  I think it depends personally, I think it 
depends on the patients…and I will say to patients, look I can give you a 
statistical thing, but actually at the end of the day, statistics don’t apply to 
individuals, they apply to populations, and if I tell you there’s a 90% chance of 
something not happening, and yet you happen to be in the 10% where it does 
happen, then the relevance to you is you know, sort of, what. 
OMFS Cons 9 
 
Although it was not always a practice that was favoured: 
 
I don’t think [the use of statistics is] helpful at all…I don’t like quoting 
percentages to people because I can never remember them and anyway, in real 
terms, in terms of this, they’re pretty meaningless 
OMFS Cons 8 
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I don’t ever quote statistics to patients because I think they’re very unhelpful…if 
they’re ok in five years it didn’t help them that four out of five people were dead 
and they’re either completely alive or completely dead, so I hate it when medics 
and anybody starts quoting figures at people because they are meaningless. 
OMFS Cons 3 
 
This participant later takes it further by suggesting that clinicians may use statistics in 
situations where they may find personal difficulty synthesising risk information into a 
format which is accessible to patients: 
 
I think sometimes clinicians hide behind it because I think… I  hear some of the 
juniors quoting statistics at people and that’s because they’ve been reading up 
for exams and they’re sort of almost showing off their knowledge and actually I 
don’t think it helps anybody and I think what the patient wants to know is how is 
this going to affect me. 
OMFS Cons 3  
 
This initial section has shown that communicating with patients is not always a 
straightforward task and, in particular, the results presented here have demonstrated that 
within the theme of communication, the terminology used in the process of delivering a 
diagnosis of oral precancer to a patient can often be seen as crucial, with the choice of 
the terminology having the potential to both produce uncertainty and impact on patient 
anxiety.  In addition, the results discussed have explored the practicalities associated 
with communicating the increased risk of oral cancer with patients which, amongst 
other things, has also highlighted the desire of some to provide a positive message by 
outlining to patients the opportunity such a diagnosis presents to modify behaviour and 
reduce cancer risk. 
 
6.2  Addressing patients’ information needs  
 
Patients with oral precancer will receive information about their condition at several 
stages of their disease journey.  Such information will often be provided verbally by 
their clinician, and may include: a description of a diagnostic investigation, an 
explanation of their disease or a discussion of a treatment option.  However, it should be 
appreciated that this is not the only source of information that will be accessed by 
patients.   
 
When we consider ways of addressing patients’ information needs it is impossible to do 
so without also considering communication.  Where the doctor is an important source of 
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information, the literature demonstrates that patient information needs will not 
necessarily be met through verbal information alone and although it is always the case 
that some degree of information will be provided verbally by a clinician, it is 
acknowledged that patients will often look for additional sources, frequently finding 
them more accessible.  Such alternatives  include: other health care professionals, other 
individuals such as friends and family, other patients, persons associated with the 
patient’s faith as well as various forms of media including the internet and written 
material (Rutten et al., 2005).  
 
The challenge of addressing oral precancer patients’ information needs was explored 
with the clinicians and is discussed in the following section.  This includes the 
approaches and limitations of verbal information provision from a consultant; it also 
explores the use of other methods of conveying key information such as the provision of 
written material.   
 
6.2.1  Approaches and limitations of verbal communication 
 
When discussing their patients’ information needs, some clinicians felt that many of 
their patients were satisfied purely with the information provided by them: 
 
I don’t think they do [look for further information]…I think people are probably 
used to talking about [precancer] in terms of cervical malignancies, sort of CIN
2
, 
when people talk about the changes in the cervix, and I think people understand 
that concept because it’s been around for a longer period of time. 
OMFS Cons 7 
 
This participant seems to be suggesting that the general public, and as he later clarifies, 
women in particular, are familiar with the concept of precancer as result of a greater 
public awareness of cervical precancer.  This belief, however, is certainly at odds with 
the cervical precancer literature, which indicates that many women find cervical 
precancer a confusing and, as a result of an ambiguous diagnosis, often distressing 
disease (Kavanagh and Broom 1997) (Karasz, McKee and Roybal 2003).   
 
However, in contrast to the previous participant’s account, others recognised that some 
patients want additional information about their condition, with some clinicians going 
                                                 
2
 CIN = Cervical intraepithelial neoplasia (also commonly referred to as cervical precancer) 
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on to provide explanations of how they sought to address these needs.  This often 
involved the use of alternative forms of media:   
 
We’ve got printed leaflets…and we’re also doing a survey on how many 
patients use the internet.  I do talk about using the internet to get information 
with patients for a variety of things. 
OMFS Cons 2 
 
Quite often as well [as] writing to the GP, I’ll write to the patient, and that letter 
will contain the right language, so if they are going to sit and Google it, they get 
the right answer. 
OMFS Cons 11 
 
Although the examples given above highlight that other sources of information may be 
provided or suggested, where patients do seek clarification relating to their disease an 
obvious source of further information may be the clinicians themselves.  However, 
studies investigating patient participation during the clinical encounter (in the form of 
verbal communication) indicate patient involvement is low (Bensing et al., 2006).  
Other research suggests that patients may leave the clinical encounter without 
discussing all their pre-visit concerns, the so called ‘unvoiced agenda’ (Barry et al., 
2000), which suggests that, for many patients, accessing information from their 
clinician alone may not satisfy all their information needs. 
 
With this in mind, it was postulated that barriers may exist which prevent optimal 
communication between the clinician and the oral precancer patient.  If we consider the 
concept of the ‘unvoiced agenda’,  it has been reported that patients will often fail to ask 
their clinicians for the information they want, particularly, when the questions may 
reflect non-biomedical folk beliefs or  negative feelings that patients have towards 
themselves.  For  example, negative feelings of guilt may act as a barrier when seeking  
information from a clinician  if the patient feels they may have in some way contributed 
to the disease process though their behaviour (Karasz, McKee and Roybal 2003).   This 
could certainly be applied to precancer patients who are smokers.   
 
A further potential barrier to patient-doctor communication was considered, that of a 
possible power imbalance between the patient and the clinician.  As Bryant et al., state, 
this is a complex aspect of the doctor-patient relationship which may encompass factors 
such as education, income, culture, gender  causing those from different backgrounds to 
respond to someone in a position of authority in a number of different ways (Bryant, 
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Bednarski and Gafni 2006).  The idea that patients may see such authority as a barrier to 
communication was discussed with the clinician group, for example with the participant 
below where he was asked if he felt intimidation was a barrier in doctor-patient 
communication: 
 
I: Do you think that people are ever intimidated by health care professionals, in 
terms of finding it difficult to ask for further information? 
IV: Almost certainly yes. 
I: And how do you deal with that? 
IV: It depends really.  We obviously write to the referring practitioner and we’ll 
tell patients if they want further information they can ask.  Do we have a 
dedicated service where we have time to give formal counselling with nurse 
pracs and people like that? No we don’t. 
OMFS Cons 1 
 
Where this participant states he is aware that patients may find it difficult to request 
additional information from their clinician, he also seems not to fully address this issue 
within his practice.  For example, telling patients that they can ask for further 
information does not necessarily lift the barrier that prevented them from doing so in the 
first place.  
 
6.2.2  Other approaches to communicating additional information 
 
Accepting that patients may have information needs that cannot be met by their 
clinician alone, the provision of additional information or guidance towards accurate 
supplementary sources of information was further explored: 
 
I: Do you specifically point them in the direction of any further information? 
IV: No I don’t actually…it’s a very interesting thought and I think that it might 
be more valuable for us to develop a literature pamphlet with some sensible 
website address and things.  I hadn’t thought of that actually…it’s a good area 
for some work.  Because, of course, you don’t know what, we live in an era 
where people, when they have a significant diagnosis, a lot of them will go 
straight on the website and, of course, it’s a minefield.  There are all sorts of 
things, usually American, and usually trying to flog something.  So I think it’s a 
good point actually.  
OMFS Cons 8 
 
Although this participant states that in his current practice he does not provide his 
patients with any supplementary information, on considering the matter further he 
mentions the two most common sources spoken about by the clinician group, namely 
pamphlets or leaflets and the internet. 
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Beginning with the internet, it became apparent that a number of the participants had 
reservations about suggesting their patients use the internet as reliable form of 
information on their disease and, as a result, it was often viewed in a negative light: 
 
I know that quite a few of them do it and I actually warn them against it 
sometimes.  I warn them in particular about if they Google for things worldwide 
and particularly in countries liken North America, that information contains 
thereon, may not be accurate and I advise them that healthcare is a business 
particularly in countries like North America, so to be careful what they read.   
OMFS Cons 11 
 
The ones that have Googled, I find have frightened themselves…I don’t find 
they come across helpful information easily. 
OMFS Cons 10  
IV: We don’t recommend them [using the internet], because the information 
uncut is actually…can be alarming, misleading, so we don’t recommend people 
go to the internet. 
I: Would you say that explicitly to the patient 
IV: No, only if they ask 
OMFS Cons 1 
 
It appeared that the negative attitude often expressed towards internet use may, at least 
in part, be attributed to a personal lack of knowledge on the nature of the information 
available on the web: 
 
I’m not particularly aware of any resource that, you know, there is for people 
with pre-malignancy which is perhaps a gap in the market if you like, because, 
what I do always say to patients is look, you know, the internet is a great thing, 
you can learn an awful lot from it, but there’s also an awful lot of 
unsubstantiated rubbish on it, so you need to be careful what you look at. 
OMFS Cons 9 
 
As well as the internet, the provision of supplemental written information was 
frequently discussed in relation to assisting the patient with access to further 
information on their condition. This took various formats from the provision of locally 
developed leaflets through to personalised correspondence which included the 
individual diagnosis and summary of the condition: 
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I mean, in cancer practice now it’s a measure that we must offer them a copy of 
the letter to the GP, so they all get offered that anyway, but that’s not necessarily 
a helpful letter for them, so I always offer them a letter to go with that, which 
carries explanation…this is what we talked about, this is what you had, this is 
the diagnosis, this is what we need to do; so that kind of thing is very helpful I 
think. 
OMFS Cons 11 
 
The concept of a summary letter personalised to each patient is not a new concept, and 
although not routinely carried out by the clinicians in this study, patient letters 
specifically designed to summarise key information tailored to the individual  has been 
carried out elsewhere in medicine with apparently successful results (Hallowell 1998).  
In addition, it would seem, that written material on a patient’s condition may be useful 
in enhancing patients’ recall of the information provided to them during a consultation 
even when it is not in the format of a personalised letter (Chan et al., 2002). 
 
Although this might suggest that written material would be of benefit to the majority of 
oral precancer patients, it is important that the impact of ‘health literacy’ is considered. 
Individuals with restricted health literacy are defined as being disadvantaged in their 
capacity to obtain, process and understand both written and verbal health related 
information (Davis et al., 2002).  Health literacy is recognised as a potential barrier in 
the delivery of efficacious health care (Berkman et al., 2011) and may be associated 
with poorer interpretation of health messages. The impact of health literacy clearly has 
the potential to impact on more than just the patient’s interpretation of a letter or leaflet, 
however, focusing on this format of information provision, the potential problems with 
providing leaflets or letters to oral precancer patients as a result of reduced literacy was 
something that was hinted at by one of the clinicians in the study: 
  I think that might be an area that I would like to work at but I’m still finding it 
hard.  It’s easier to explain to the patients and, ideally, relatives, when they’re 
there but [I’m] aware that the average reading age for head and neck patients is 
about 11.  So written information, you can never be sure what they are actually 
going to do it. 
OMFS Cons 4 
The patient above suggests that the average reading age of his precancer patients is a 
barrier to him producing supplemental information for them.  He goes on to describe 
how he has had limited success in the past producing leaflets on treatment for oral 
cancer patients for the same reason.  However, he finished by saying that if he felt that 
138 
 
ultimately it was something that would be of benefit to his oral precancer patients he 
would consider developing something for them.  Other participants had less specific 
reasons for not providing written material to their patients: 
 
Actually writing things down and having them, giving them information sheets, 
I don’t do that…but it’s probably because I just haven’t got round to it, not 
because I feel strongly against it. 
OMFS Cons 3 
 
However, this participant demonstrates that even where resources were available, they 
were not always utilised: 
 
We have a written information sheet which is in the clinic which was created 
some time ago…I haven’t ever used it personally 
OMFS Cons 5 
 
Alongside the participants’ discussion of the modalities of information provision, there 
was a sense, from some participants, that despite their best efforts, some precancer 
patients may not always fully comprehend their disease.  At times, this appeared to 
leave the participants with a feeling of dissatisfaction/frustration. 
 
I think you wonder about [patients holding back from asking questions] all the 
time and at every consultation. I always specifically ask, but clearly it doesn’t 
make any difference…I don’t know what else you can physically do because 
obviously we can only ask ‘is there anything that you want to ask?’ and if they 
don’t feel they can, that’s sad.  But I don’t know what I can do about that. 
OMFS Cons 8 
 
And I like to think that, you know, I’ll put [the concept of oral precancer] across 
in words of one syllable, but yeah, I guess you never know what patients are 
taking in. 
OMFS Cons 10 
 
The results of this section have demonstrated that, at present, there are a number of 
limitations in the way information is provided to patients who have oral precancer.  
Where the clinician remained the primary source of information, it was acknowledged 
that other sources may be beneficial.  Participants specifically spoke of the potential 
benefits of written information (leaflets or personalised correspondence); however, such 
resources were not always available or were yet to be developed.  The internet was 
another alternative patient information source which generated a lot of discussion.  
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However, there was a lack of knowledge noted in relation to the availability of reliable 
web sites and, in some cases, a negative feeling towards patients seeking information 
via the internet out of fear of them discovering incorrect or distressing information.   
 
6.3  Challenges associated with addressing risk factors 
 
Another key area of discussion to arise from the clinician based data was that of 
broaching the subject of risk factors for oral precancer with patients.  Such discussions 
focused on the approaches clinicians took when explaining the relevance of specific risk 
factors (specifically tobacco use and alcohol consumption) and the impact of these 
factors on disease genesis and progression.  
 
Patient health related behaviours are significant in those with oral precancer specifically 
as the literature has demonstrated that there is an association with tobacco and alcohol 
use and the development of oral precancer, with tobacco use being more strongly 
implicated.  Furthermore, these two factors are also the primary risk factors in oral 
cancer development and it is believed that an individual with oral precancer who 
continues to smoke and/or drink alcohol is at a greater risk of their disease developing 
into oral cancer.  On the other hand, importantly, the literature has also indicated that 
some patients with oral precancer can achieve complete resolution of their lesion(s) if 
these habits are eliminated  (Gupta et al., 1995), which in turn reduces their risk of oral 
cancer.  
 
6.3.1  Smoking as a risk factor  
 
Smoking is believed to be the most significant risk factor in oral precancer, with 
premalignant lesions occurring up to six times more frequently in smokers compared to 
non-smokers (Dietrich, Reichart and Scheifele 2004).  However, smoking is clearly not 
only a risk factor for oral precancer but a leading cause of preventable mortality and 
morbidity in the UK (1988).  This has long been recognised, and as a result of the 
government publication, ‘Smoking Kills: A white paper on tobacco’, major investment 
has resulted in a number of national  initiatives including  public awareness campaigns, 
a ban on tobacco advertising as well as the more recent smoking ban in enclosed public 
spaces.   Yet, evidence would suggest that, in order to be effective, measures aimed at 
health related behaviour change need to be addressed at population and community 
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levels, using a combination of measures as described above, alongside a number of 
tobacco control initiatives (Ramseier et al., 2010).   
 
One way in which clinicians and other health care professionals can play their part has 
been highlighted by the National Institute for Health and Clinical Excellence (NICE) in 
the form of guidance on brief interventions and referral for smoking cessation for 
patients who continue to smoke (NICE 2008).  These guidelines outline the obligation 
health care professionals in the UK have, not only to enquire about patients’ smoking 
habits but to offer intervention.  This guidance recommends the use of brief 
interventions which are described as ‘opportunistic advice, discussion, negotiation or 
encouragement’.  The NICE guidance includes specific advice aimed at hospital 
clinicians (recommendation 5), stating that hospital clinicians should refer people who 
smoke onto an intensive support service as an ideal.   
 
In addition to the NICE guidelines, the independent advisory panel, the NHS Future 
Forum, recently produced guidelines which, amongst other things, recommended that 
each healthcare professional should ‘make every contact count’ (DoH 2012a).  Put 
simply, the guidelines state that every health care professional working within the NHS 
has a role to play in promoting the general public’s mental and physical wellbeing.  In 
practical terms this involves measures aimed at reducing the following 4 key health 
related risk factors: tobacco use, alcohol use, poor diet and a sedentary lifestyle.  This 
reinforces the need to enquire and take action when patients present with any of the 
above risk factors. 
 
6.3.2  Tackling the subject of risk factors with patients 
 
In this study the clinician participants tended to introduce the concept of risk factors for 
oral precancer to their patients at a relatively early stage in the patient journey, often at 
the point of diagnosis. As in this case where the participant is describing his approach to 
communicating the significance of risk factors to his patients: 
 
If it was a potentially malignant lesion or condition, there would be an 
explanation as to what that was [and] whether or not the patient was doing 
anything that might be contributing to this.  There’s the usual thing, obviously a 
lot of these people are or have been heavy smokers and if they are smokers, they 
get the smoking chat. 
OMFS Cons 4 
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Alongside the explanation of the significance of risk factors to their disease, a natural 
progression was for the discussion to continue on to include advice on smoking 
cessation and particularly its role in the management of the patient’s disease.  To this 
end, the participants often described using a strategy of shared responsibility: 
 
I generally say to them, look, well we can do our bit, but there’s a contribution 
you have to make, being responsible for your own health in stopping poisoning 
the area which is causing these changes or likely to be causing these changes in 
the first place.   
OMFS Cons 9 
 
In some cases the onus of responsibility was placed primarily with the patient: 
 
Really it’s up to him to look at this, you know, what he’s doing to the oral 
mucosa.  I’ll try and help. But you know I can’t do anything about it.  And so I 
don’t take point of shouting at him or doing anything, they’re all adults, they all 
know what they’re doing is wrong. 
OMFS Cons 11 
 
Despite the perceived importance of smoking cessation in patients with oral precancer 
there were often difficulties reported when it came to discussing access to smoking 
cessation services.  However, in some cases such services were never discussed: 
 
I: Would you point them toward any support services yourself? 
IV: Only if they ask 
OMFS Cons 2 
 
This approach, however, is clearly at odds with the national guidelines mentioned 
earlier which outlines the duty the clinician has to explain the presence of support 
services and outline what they offer (NICE 2008).  Where support services were 
available, participants suggested accessing them was not always a straightforward 
process and was often reported as something that could not be fully addressed on the 
clinic: 
 
In community care, smoking cessation is available…it’s certainly not done in 
the clinic, other than, the very bland  message that smoking is damaging your 
mucosa and you need to try and stop it.  And that ultimately if you don’t you’re 
more at risk of getting a cancer…Do we engage in smoking cessation in the 
department? No. 
OMFS Cons 2 
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For some this was principally as a direct result of funding issues: 
 
What we do have is a hygienist who’s been trained in smoking cessation, so 
she’s a resource, but we fall into a familiar trap where the primary care trust 
refuse to pay for her time to do that…an enormous frustration since they’re 
already in the building.   
OMFS Cons 11 
 
As a result of these and similar problems many participants advised their patients to 
contact their general practitioner (GP) rather than being able to provide assistance there 
and then.  This is an unfortunate situation especially if it is considered that in smokers 
seeking help, the likelihood of success is greater in those with access to smoking 
cessation specialists (West, McNeill and Raw 2000). 
 
Alongside difficulties encountered with access to services, participants often described 
the perception that patients were frequently resistant to the notion of changing their 
health behaviours (smoking and drinking): 
 
[The patient says] I’ve tried before or x, y and z has just happened in my life…a 
lot of them seem to come up with excuses why they’re smoking and why they’re 
not ready to stop. 
OMFS Cons 10 
 
[some] people are quite resistant and quite reluctant to accept, even if they 
perhaps think internally that it’s smoking, and they will look for other things like 
‘ I remember my dentist was very rough with me one day 20 years ago and I 
think it all happened from there’. Or ‘I had a friend next door who worked in a 
paint factory.  I think it was the stuff he brought home.’  
OMFS Cons 8 
 
In the second example above, the participant seems to be describing a patient who does 
not accept or is unwilling to accept smoking as a potential cause of their disease.  Where 
it is unlikely that a patient would not believe that smoking was detrimental to their 
health in general terms, there is evidence in the literature to suggest that some patients 
with oral precancer do not believe that their oral lesion(s) are related to their smoking 
habit (Bornstein et al., 2012).  This may act as a barrier to smoking cessation, in that the 
patient may not be able to appreciate the specific potential benefit of smoking cessation. 
This is further illustrated in a study by Helgason et al, whose work demonstrated that 
patients who believe that they have disease or symptoms related to smoking are more 
likely to consider stopping smoking that those who do not (Helgason and Lund 2002). 
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In the previous two examples the participants describe how some of their patients 
provided an explanation or an excuse as to why they were not ready to give up smoking.  
However, clinicians also reported cases where patients made is quite clear that, to them, 
the benefits of stopping smoking did not outweigh the risk of continuing: 
 
But a lot of people will say…’there’s no way I can stop smoking’. One 
lady…said to me ‘Don’t talk to me about smoking because I’m smoking 20 a 
day and I’m not going to stop.  And do you have to have your clinic on a 
[specific day] because I play golf [that day] and it’s golfing season’… so some 
people are very resolute in their views.   
OMFS Cons 8 
 
Regardless of the difficulties outlined above, smoking cessation was the main focus of 
risk factor discussions and, although discussed, it was reported that access to alcohol 
services were less well utilised.  A possible explanation for this being provided by this 
participant: 
 
You can access alcohol services, but it’s much less common for us to do that 
with patients.  I don’t know, for some reason, it’s something that we probably 
don’t tackle as a group in the same way we might about smoking, and I suspect 
it’s probably because we all think that smoking is the bigger factor than alcohol 
so, if you stop one, you’d be better off stopping the smoking. 
OMFS Cons 9 
 
Although studies indicate an association between oral precancer and tobacco use, in the 
past, the evidence implicating alcohol as an independent risk factor has not been as 
strong (Dietrich, Reichart and Scheifele 2004).  This may explain why, in the 
management of oral precancer, often less time is devoted to providing alcohol cessation 
advice compared to smoking cessation advice.  However, more recent work, including a 
prospective study by Maserejian et al., has demonstrated the role of alcohol as a risk 
factor for oral precancer both in conjunction with tobacco use as well as independently 
(Maserejian et al., 2006).   
 
In relation to risk factors for oral precancer, tobacco use and alcohol consumption are 
the most significant.  Where the study results revealed that both risk factors were 
usually discussed with patients, the focus of most discussions centred on smoking.   
Frustrations were expressed particularly where access to support services in the local 
area were limited or had been withdrawn.  However, even where access to support 
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services was available personal frustration was suggested by some when describing 
groups of patients who were resistant to the idea of giving up a smoking habit.    
 
6.4  Making treatment decisions  
 
Once a diagnosis of oral precancer is made, a treatment plan will be formulated.  As 
discussed in the previous section, this will usually involve a plan to eliminate known 
risk factors.  In addition to this, decisions will also have to be made regarding active 
treatment of the disease.  This is the focus of the following section. 
 
6.4.1  Options available 
 
Treating patients with oral precancer remains a complex and somewhat uncertain 
process which, despite extensive research, does not have specialty wide agreement 
when it comes to the most effective treatment options (Kanatas et al., 2011).  This was 
something the participants acknowledged: 
 
It remains a subjective decision about  intervention, I’m afraid… we’re looking 
at ways of trying to make that more objective, trying to stratify people into what 
we would regard as being a high risk of malignant transformation and low risk; 
all that’s complex 
OMFS Cons 8 
 
The literature reports a variety of possible options for the management of oral precancer 
(Lodi and Porter 2008), and while current opinion would generally favour scalpel or 
laser excision (van der Waal 2010), survey based data would indicate that clinicians 
employ a variety of strategies (Table 14).  Closer inspection of the data, however, 
reveals that medical management of oral precancer in this country appears to be 
declining, with a significant decrease noted from data published in the late 1990s 
(Marley et al., 1998), (Marley et al., 1996) compared with more recent data (Kanatas et 
al., 2011).  This is perhaps due to a lack of strong evidence to support their use (Lodi et 
al., 2008). 
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Surgical  Medical Other 
Scalpel excision 
 
Topical therapy – e.g. 
vitamin A and derivatives, 
steroids 
 
Watchful 
waiting/conservative 
management 
Laser excision 
 
Systemic therapy - Steroids Mixed methods (a 
combination of 2 or more 
options) 
cryosurgery   
Table 14. Management options in oral precancer 
Adapted from papers by Marley et al., 1996, 1998 and Kanatas 2011 
 
6.4.2  Factors influencing treatment decisions 
 
The vast majority of the professionals interviewed in this study indicated that the 
mainstay of their practice consisted of either intervention to remove the lesion surgically 
(through either scalpel or laser excision), or conservative management, involving 
regular review to monitor the lesion.  In a bid to break down how the clinicians made 
difficult treatment decisions the rationale behind these choices was explored with the 
study group.  Analysis of the data revealed that the participants’ treatment decisions 
were influenced by: 
 
 the degree of dysplasia within a lesion 
 the clinical appearance of the lesion  
 patient lifestyle (with respect to risk factors) 
 reliability of follow up 
 patient preference 
The influence of the degree of dysplasia within a lesion was consistently mentioned by 
the clinicians as the primary consideration when making treatment decisions: 
 
I: and what helps you to guide these decisions 
IV: the degree of dysplasia…and then patient wish 
OMFS Cons 10 
 
Dysplasia and its role in treatment planning will, therefore, be examined first.   
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It has already been discussed as part of the literature review that dysplastic changes may 
be present within oral precancer and, that when examined histologically, the level of 
dysplasia is usually graded as mild, moderate, severe or carcinoma in situ.   Recent 
studies have confirmed a significant increase in the rate of transformation from oral 
dysplasia to oral squamous cell carcinoma depending on the grade, with lesions 
exhibiting severe dysplasia or carcinoma in situ being considered considerably more 
likely to transform (Mehanna et al., 2009).   
 
Significantly, Mehanna et al., also reported where surgical excision of these lesions will 
not eliminate all risk, it apparently decreases the risk of malignant transformation to less 
than half of those that are not excised, leading the authors to suggest surgical excision 
with long term follow up as an optimal treatment plan for patients with dysplastic 
lesions, particularly those with high grade lesions (equivalent to severe dysplasia or 
carcinoma in situ).  With the participants and the literature placing such importance on 
the degree of dysplasia within a lesion it is worth revisiting how dysplasia is identified 
and graded and in particular considering the variability that may exist within this 
process.   
 
In order to achieve an accurate diagnosis in oral precancer, histopathological assessment 
of a biopsy of the lesion is required; however, there are a number of variables within 
this process. Firstly, at the biopsy stage itself, it is important that an appropriate site is 
selected.  This is because a single lesion may exhibit varying degrees of dysplasia 
within it.  The location of the biopsy can be of particular significance to a small number 
of patients with widespread oral lesions. For these individuals  multiple biopsies may be 
required, particularly as the rate of malignant transformation in this group appears to be 
higher than for those with single discrete lesion (Saito et al., 1999).  The limitation of a 
diagnosis on the basis of a biopsy was recognised by the participants: 
 
Well obviously I’m very aware that when you diagnose a patient, that first of all, 
your biopsy only represents the bits that you biopsied so I’m very keen to look at 
the rest of the lesion…if I look at something and say hang on that lesion doesn’t 
look like it should, according to the report, it looks worse, I wouldn’t believe the 
report, I’ll send the patient for more biopsies.  Sometimes you may even pick up 
an early invasive disease where the biopsy said dysplasia 
OMFS Cons 4 
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A second limitation of dysplasia diagnosis is the dysplasia grading process, which is 
recognised as being  somewhat challenging and complex (Poh et al., 2008).  Judgements 
are made by a pathologist on the architectural and cytological changes in the epithelium 
according to established World Health Organisation (WHO) criteria , however, this 
remains a subjective process which has been shown to vary between pathologists 
(Karabulut et al., 1995).  Perhaps as a result of these difficulties associated with 
dysplasia grading, participants often looked for other indicators to help them assess the 
likelihood of an individual lesion progressing to cancer.  To this end, the participants 
frequently stated that they would use clinical appearance as a means of further assessing 
the significance of the patient’s disease, regularly advising surgical intervention if the 
lesion appeared ‘nastier’ than the report suggested: 
 
And if I personally think the lesion looks more significant than the biopsy would 
say, then I wouldn’t just rely on the biopsy, I’d go ahead and do an excision. 
OMFS Cons 7 
 
Where the participant above states that he would excise a lesion based on the 
‘significance’ of its clinical appearance, the literature allows us to examine in more 
detail what specific features of the clinical appearance increase the likelihood of 
malignant transformation.  From their review of the literature, Napier and Speight, 
determined the following appearances as having a higher association with malignant 
transformation: non- homogenous or nodular leukoplakias and erythematous and 
verrucous lesions (Napier and Speight 2008).  
 
Despite mentioning a number of influences during the treatment planning stage, 
including dysplasia grading and clinical appearance, it was clear from the data that in 
the absence of clear guidance, personal opinion concerning the most appropriate 
management for precancer patients had to be based on the individual’s evaluation of the 
available evidence alongside personal experience of managing precancer patients.  
Perhaps because of the disparate nature of such evidence (and perhaps experience) 
participants’ treatment recommendations to patients varied from unit to unit: 
 
In terms of treatment I would usually say that we have a preference to actually 
remove these patches because it is difficult to predict what’s going to happen to 
them. 
OMFS Cons 8 
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If it’s…carcinoma in situ…the most common treatment for that would be laser 
excision…we would not, generally speaking, offer intervention for patients with 
dysplastic lesions as such. The only caveat to that is, if there’s severe dysplasia 
and the lesion clinically looks more than that, then we might be more inclined to 
offer laser excision.   
OMFS Cons 1 
 
As well as reiterating the earlier point that participants often considered the clinical 
appearance of precancerous lesions significant, the second participant here also states 
that he would only tend to recommend surgical treatment to patients whose lesions 
exhibit the most advanced cellular changes.  This is in clear contrast to the first 
participant above who suggests a predilection towards surgery for the majority of his 
patients. 
 
As well as differences of opinion relating to when to intervene surgically, the method of 
intervention too was variable: 
 
I use KTP rather than CO2 [laser], but I always use a microscope, an operating 
microscope, …I just feel more comfortable doing it that way, and  it seems to 
make sense. 
OMFS Cons 9 
 
The point here is not so much that the participant has a different approach to the 
mechanics of his surgery, but that, in the absence of convincing evidence, he is carrying 
out surgery in this way because he feels more comfortable with it.   
 
6.4.3  Influence of the doctor-patient relationship at this stage 
 
Given the difficulties the participants expressed surrounding the factors considered 
when making treatment decisions it was felt that communicating information in relation 
to treatment choices to patients may be a difficult and complex task.  The approach the 
participants took when aiding patients to make informed treatment decisions, including 
the significance of the doctor – patient relationship in this process, was therefore 
explored. 
 
Throughout the patient journey (from initial consultation and beyond) a number of 
clinicians highlighted the effect their professional relationship with the patients had on a 
patient’s management and indeed their overall experience of disease.  The importance 
of this relationship was highlighted particularly when it came to negotiating treatment 
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decisions.  In particular the need to inspire confidence through building up a positive 
rapport with patients was often discussed: 
 
You want to bring them in, have them have confidence in me and our service, so 
that then they buy into our risk stratification, risk reduction mechanism. 
OMFS Cons 11 
 
For example, the quote above demonstrates that this participant felt that it was 
important that patients have confidence in clinicians responsible for their care as a 
means of inspiring confidence in their management philosophy.  The participant below 
takes this further by suggesting that as the patient progresses thorough their disease 
journey, their relationship with their doctor may change, inspiring a deeper level of 
confidence or trust.  He suggests that as a result the patient is more likely to follow the 
recommendations of their doctor, highlighting that the doctor –patient relationship is 
seen as a key factor in the patient decision making process: 
 
And perhaps maybe because we’ve got to know each other better, there is 
perhaps more trust, more understanding, then the decision may change. 
OMFS Cons 8 
Talking about reasons for choosing to intervene surgically following a 
period of monitoring 
 
This section has uncovered the influences involved in making treatment plans for oral 
precancer patients.  It has been revealed that these decisions are variable dependent on 
the individual clinician, their interpretation of the available literature and their personal 
experience.  Finally the results have touched on the influence of the relationship 
between the clinician and their patient when it comes to making treatment decisions, 
including the feeling by some participants that treatment decisions may change over 
time as a rapport is built up with the precancer patient.   
 
6.5  Difficulties encountered when managing patients with oral precancer 
 
The final section of this chapter will deal with a number of issues specific to managing 
oral precancer patients.  It will begin by focusing on the strategy clinicians employed 
when reviewing their patients following treatment.   
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6.5.1  Management issues – How long to review and when to discharge   
 
From a logistical point of view, participants frequently spoke of the difficulties faced 
when planning follow-up and discharge of oral precancer patients.  When exploring 
patient review, the participant responses were variable.  This is perhaps unsurprising 
when the lack of guidance is considered.  One way participants found to overcome this 
difficulty was to approach an oral precancer patient review in a similar manner to that of 
the oral cancer patient, employing a programme of frequent review in the first instance, 
gradually increasing the duration between appointments before finally discharging, 
providing no further disease was evident at the five year mark.    
 
However, this was not a universally employed strategy and, for some, discharging 
patients remained a contentious issue with a variety of factors apparently influencing the 
participant’s decision to discharge a patient: 
 
It’s very difficult to be honest with you.  I probably do it differently for every 
patient who comes through the door. 
OMFS Cons 2  
 
Where the above participant simply acknowledges that planning reviews and 
discharging precancer patients is difficult, the participant below states that he has no 
known mechanism for discharging them.  This leaves patients in a constant cycle of 
review, potentially causing problems for outpatient clinics in that they may ultimately 
become saturated with these patients: 
 
I have got, you know, a few dysplasia patients who have been coming once 
every six months and once every year, you know, for five or six years and you 
think, well what do I do with you.  Watch this space.  Sorry…I mean to be 
honest I have no mechanism for discharging them. 
OMFS Cons 10 
 
Looking to the literature for guidance, a relatively recent article by van der Waal 
recommends that because there is no reliable known predictor of malignant 
transformation in the oral precancer patient, nor evidence to suggest that surgical 
treatment removes transformation risk, lifelong follow up is recommended (van der 
Waal 2010).  Mehanna et al., reiterate this by suggesting that due to the long term risk 
of malignant transformation, patients with oral dysplasia should be reviewed for 
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anything up to 20 years (Mehanna et al., 2009).  This participant demonstrates that there 
is more than simply patient benefit to consider when planning review and discharge: 
 
I mean there’s a great pressure as you know, upon us all now to not keep seeing 
patients in secondary care so, it just upsets the balance for the Managers to get 
all worked up about. 
OMFS Cons 9 
 
I certainly used to then say bring them back in a year just to see what was going 
on but when we get to yearly reviews PCTs don’t like that so we tend to boot 
them back in to practice 
OMFS Cons 3 
 
A number of participants reflected on their patients’ fate following discharge from 
secondary care, with some expressing concern regarding the quality of the GDP that the 
patient would be referred back to.  In some cases the perceived competence of the GDP 
was considered as a contributory factor in the decision making process: 
 
It depends a lot on who they’re registered with.  If they’re registered with one of 
the corporate dental practices and they’re seeing a different dentist every time 
they go, then I might be less likely to discharge them back…I think it’s quite 
important to be able to go back and see the same dentist time and time again. 
OMFS Cons 7 
 
This is an interesting point demonstrating that this consultant values consistency in 
terms of the patient seeing the same clinician, in this case the dentist, each time.  This 
view however, was not upheld by all participants: 
 
You know I consider them responsible dentists and if you’re a dentist you’re 
supposed to be a professional.  And I don’t distinguish, you know; I write them a 
letter, tell them, would they see them regularly.  I don’t think it’s so much the 
dentist, it’s the patient. Because they’re the one who has to turn up. 
OMFS Cons 6 
 
This quote also reiterates an earlier made point that the participants feel that the patient 
has an obligation to take responsibility for their own health which, to some extent, must 
be demonstrated thorough their actions.  For example by a willingness to modify risk 
factors, by  attending their GDP for review following discharge from secondary care 
and ,in some cases, an obligation to carry out their own intra oral examinations: 
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I give them responsibility, I suppose, for checking it and obviously I would 
usually involve their GDP 
OMFS Cons 4 
 
6.5.2  Communicating transformation risk post treatment 
 
Another area of specific difficulty in the management of the oral precancer patient was 
that of the persisting risk of malignant transformation which is known to persist even 
following surgical removal of a precancerous lesion. 
 
The literature would suggest that, regardless of management strategy, there remains the 
risk that patients will potentially develop further precancerous or, indeed, cancerous 
lesions following treatment. I felt it was likely that participants would find this a 
difficult subject to broach: 
 
I think that so much of the reason for doing what we do is designed to try and 
stop that happening, that one, I suppose, doesn’t labour the point that ‘Oh, by the 
way, you might get cancer anyway,’ because it’s not really the thought process 
at the time.  So I don’t know how you… I don’t think I would like to introduce 
or underline that. 
OMFS Cons 8 
 
This is confirmed if we examine the account of the participant above.  However, it 
appears that in finding this concept difficult he avoids, rather than broaches the subject 
with his patients.  Although the following participant suggests that he does address this 
difficult area, he doesn’t appear certain that his methods are effective: 
 
I: Are patients aware, do you think, that there’s still a possibility that changes 
might progress in their mouth even if they are treated? 
IV: I think so.  I mean; it’s a balancing act, isn’t it, between, you know, scaring 
the crap out of the patient and actually getting them to do something… and the 
problem is, what I generally say to patients is that I can’t predict what’s going to 
happen in the future, but you know, what we’re aiming to do is to reduce the risk 
of them getting problems in the future.  
OMFS Cons 9 
 
The example above also highlights the desire the participants had to deliver a positive 
message in that the subject of further disease development is presented to patients as an 
opportunity.  In other words, if patients have risk factors then an opportunity is 
presented to reduce these and therefore reduce the risk of further disease development.  
However, as discussed previously, there are a small group of patients with oral 
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precancer who present with no discernible risk factors and in such cases participants 
expressed an increased level of difficulty managing the situation.   
 
6.5.3  Importance of clinical environment on patient experience and outcome 
 
All participants recruited to the study were oral and maxillofacial surgeons who were 
responsible for the care of patients with oral precancer; however, there were some who 
stated a special interest in the area.  This appeared to be of significance when it came to 
participants expressing their opinions on the importance of the clinical environment in 
which oral precancer patients were seen.  Specifically the set-up of the outpatient clinic, 
where patients attended for their initial consultation and review appointments, was often 
viewed by those with a special interest in oral precancer as a key factor in patient 
management.  Looking in more detail, data analysis revealed that there were a number 
of approaches to the set-up of the outpatient clinics the oral precancer patients attended.  
In general terms patients were seen either on a mixed general maxillofacial outpatient 
clinic or a dedicated oral precancer clinic: 
 
We don’t have a dedicated precancer or potentially malignant clinic, they’re 
reviewed on general clinics 
OMFS Cons 1 
 
 
Our aim here has been to set up a clinic on the first [specific day] of every 
month and send out any patient with a diagnosis of dysplasia onto that. 
OMFS Cons 11 
 
Where dedicated clinics had been set up, participants felt strongly that there were clear 
advantages of providing care in this manner.  These ideas tended to centre around the 
perception that such clinics allowed the clinician to focus on one particular disease 
process, and in doing so, not only provided a more efficient service for patients but also, 
potentially, improved patient outcome, as this participant explains: 
 
the careful, co-ordinated, determined, continuing follow-up, clinical 
examination, re-examination, biopsy analysis of those patients to identify further 
disease or recurrent disease or hints of transformation at the earliest possible 
stage.  And that’s something that’s come, I think, directly out of having a 
dedicated clinic where everything’s concentrated. 
OMFS Cons 8 
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The participant above is quite clear in his views of the benefits of having a dedicated 
precancer clinic.  Although it was not within the scope of this study to determine the 
proportion of specialised versus general clinics in the UK, Kanatas et al.’s study 
examining the configuration of precancer clinics in the UK, reported that 41% of their 
respondents had designated specialist clinics in which the oral precancer patients were 
seen.  It is difficult to suggest this is truly representative of current UK practice 
however, due to the fact this survey of UK based OMFS consultants only had a 56% 
response rate (Kanatas et al., 2011).   However, it is interesting to see the value such a 
high number of consultants place on providing a specialist service specific to oral 
precancer patients.   
 
Returning to this study, for those participants who saw precancer patients on a 
generalised clinic, participants often stated that such a clinic was unnecessary because 
they ‘wouldn’t see enough of them’ or because it was deemed impractical. Although 
some acknowledged that their management of patients may be altered due to the nature 
of their clinical set up: 
 
Because it’s not a dedicated pre-malignant lesions clinic, we probably don’t 
[spend a lot of time discussing risk factors] although I’ll mention it to patients, I 
probably don’t spend as much time talking about it as I should 
OMFS Cons 2 
 
6.5.4  Importance of the clinician on patient experience 
 
Alongside the importance, or lack of importance, given to the clinical set-up, 
participants frequently reported the perceived importance of the clinician the patients 
encountered at the outpatient clinic, which would not always be the participant 
themselves:  
IV: It’s a bit of a hit and miss whether they see me or not…we’ve got one 
associate specialist who will sometimes do it and there’s an SpR3 who’ll 
sometimes do it. 
I: Do you think [who they present to] makes a difference? 
IV: Yes. 
OMFS Cons 11 
 
In the example above the participant describes three different grades of clinician who 
may have contact with oral precancer patients.  Later, this participant also expresses his 
                                                 
3
 Specialist registrar: an individual who is undertaking advanced training in a specific discipline, in this 
case Oral and Maxillofacial surgery (OMFS).  
Staff grade and Associate specialist – a ‘middle grade’ member of staff 
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belief that the specific clinician, rather than grade of clinician, encountered by the 
patient at this stage is significant.  He goes on to explain that as the person with the 
most developed ideas in the department he would be in a better position to assess the 
patient and provide the most accurate and appropriate information where others would, 
more than likely, simply give a basic level of information to the patient before, 
ultimately, referring the patient on to him.   Whilst this participant seems to suggest that 
it is important that patients within this area are seen by him because he is the local 
expert in this field, a number of other participants were less specific, stating the 
importance of the grade of the clinician rather than the individual, implying more senior 
staff were better suited to dealing with precancer patients, perhaps as a result of greater 
levels of training and experience: 
 
IV:  [oral precancer patients] would tend to be [seen by] myself, although we do 
have staff grades and associate specialists who parallel clinics with me.  Some 
might end up on theirs; they wouldn’t end up being seen by an SHO4. 
I: What would be the reason for that? 
IV: That’s a very good question.  I tend to sort of hoard this sort of thing myself, 
okay.  I would be happy with SHOs reviewing obviously benign 
pathologies…giving the results, discharging the patients, but I would very much 
hope that everyone with dysplasia…would end up being seen by somebody 
senior. 
OMFS Cons 10 
The view that SHOs should, ideally, not be involved in the initial aspects of care of the 
precancer patient was a particularly prominent theme and seemed to be of particular 
significance at the initial stages of patient management: 
 
IV: [oral precancer patients would be seen by] either me or one of the registrars 
but not an SHO 
I: Is there a reason why they wouldn’t be seen by an SHO? 
IV: Because I would be very keen to make sure that things are maybe not 
missed, that they’re all seen by people who understand the significance of these 
things, even if I don’t see patients at every follow up, I want to be sure that we 
get the diagnosis and investigations right first time.  
OMFS Cons 4 
 
In particular, when it came to discussing the delivery of a diagnosis:   
 
 
 
                                                 
4
 Senior house officer – a junior member of staff undergoing training in a specific specialty area.  In 
OMFS SHOs often hold a dental degree only, in contrast to the SpR grade. 
156 
 
I: do you think it makes a difference who gives the diagnosis? 
IV: I think it needs to be somebody reasonably senior 
I: why is that? 
IV: I think that the knowledge base of more junior staff these days, frankly, is 
not as good as it once was. 
OMFS Cons 1 
 
SHOs don’t tend to see patients…they’re quite often involved in the biopsies 
and things but in terms of decision making, absolutely not for them…they don’t 
know what they’re talking about. 
OMFS Cons 3 
 
The final section of this chapter has outlined some specific difficulties in the 
management of oral precancer patients.  The contentious issue of when and for how 
long to review precancer patients has been explored, in doing so it has been revealed 
that although, in general, the literature would suggest long term review, in  practice this 
is not always taking place nor is it always practical.  The approaches the clinicians in 
the study took when it came to communicating cancer risk, even after treatment, has 
been briefly examined before finally looking at clinic organisation and the importance 
of the grade or experience of the clinicians involved in patient care.  This uncovered the 
almost universal message within the clinician group that the initial management of oral 
precancer patients is best undertaken by those with a more comprehensive knowledge 
base, usually at a senior staff level.  
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Chapter 7. Conclusions from both studies with respect to the patient 
disease journey  
 
The previous two chapters have examined the results of each study in isolation.  The 
following section will bring together the results of both the patient and professional 
studies, with a view to identifying specific areas of the disease journey at which there 
may be the potential to make improvements in current practice.   
 
As well as critically examining patients’ experiences and understanding of oral 
precancer, analysis of the patient study data allowed their disease journey to be mapped. 
This journey is represented by Figure 3.  This is presented as a theoretical care pathway 
because, at present, there is no formal pathway for oral precancer. Once mapped, this 
journey was then directly related to the clinician based study which allowed 
identification of the following specific areas where opportunities to modify current 
practice and potentially improve patient outcome exist: 
 
 Communicating a diagnosis (including terminology used and risk 
communication) 
 Information needs and means of provision (including barriers to obtaining and 
meeting needs) 
 Behaviour change       
 Management of oral precancer 
 The influence of the clinician and the environment on patient experience 
 
Each of these areas will now be reviewed from the viewpoints of both the patient and 
clinician. Following each discussion conclusions drawn from the study results will be 
made.  
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Figure 3. Oral precancer – the patient journey through care  
Referral from 
primary care 
Biopsy 
Initial consultation 
in secondary care 
Diagnosis 
Conservative 
management 
(+/- behaviour 
change) 
 
Review 
Discharge 
Surgery 
(+/- behaviour 
change) 
Indefinite review 
re-evaluation 
re-assessment following 
surgery 
Continue to 
monitor 
159 
 
7.1  Communicating a diagnosis 
 
The diagnosis was the first aspect of the disease journey where difficulties in current 
practice were identified from both perspectives.  Optimal communication at the 
diagnosis stage is important.  Indeed, studies indicate that unsuccessful communication 
at this stage may potentially result in misinterpretation of the diagnosis and significant 
distress (Kavanagh and Broom 1997) (Gray et al., 2006).  Within the topic of 
communicating a diagnosis two specific areas where there may be an opportunity to 
make positive changes were noted:  
 The terminology used when communicating a diagnosis  
 Efforts aimed at communicating risk 
 
7.1.1  Choice of language 
 
The results from the patient based study revealed that, for many people, communication 
of the diagnosis was an area that caused considerable confusion.  This was influenced 
on some occasions by the choice of language used by the clinician.  Specifically, 
confusion at the diagnosis stage led some patients to believe that they had oral cancer.  
This had the potential to leave the individual feeling ‘devastated’ by the diagnosis.  In 
addition, the study results also indicated that even if patients did not believe they had 
cancer, the uncertainty of an unknown or misunderstood diagnosis could result in worry 
or distress.  These findings are in line with data from studies involving individuals with 
cervical precancer (Bell et al., 1995; Gray et al., 2006; Kavanagh and Broom 1997). 
Furthermore, unclear terms used at the diagnosis stage were found to hinder patients’ 
efforts at seeking additional information in relation to their disease with a potential to 
impact on outcomes. 
 
Focusing specifically on the terms clinicians used to describe their diagnosis, many 
patients remembered the label given, but when questioned further, were not able to 
convey an understanding of it. This fits in with work carried out by Kessels who 
explored patient recall of medical information.  He states that between 40 -80% of 
information provided by health care professionals is forgotten immediately (Kessels 
2003).  In a bid to aid our understanding of why this occurs, Kessels further goes onto 
suggest that factors influencing patient recall may be divided into 3 categories:  
 
160 
 
a) Clinician factors e.g. the use of medical jargon  
b) The mode in which the information is provided 
c) Patient factors e.g. age, level of anxiety and perceived importance of information 
During this section I will focus on the influence of medical jargon and language used 
during a diagnosis alongside their importance. The latter two categories will be 
discussed in more detail in section 2 of this chapter.   
 
The results obtained following analysis of the clinicians’ accounts has revealed that 
providing patients with an explanation of oral precancer often includes the use of 
language that is considered accessible to the patient.  However, the concept of 
accessibility appeared to vary between clinicians with some favouring the use of 
medical jargon only, others ‘lay’ terms only and finally others using a combination of 
the two.  In all cases clinicians were seen to justify their choices on the basis of patient 
understanding, choosing a specific word or a collection of terms which they believe 
patients will understand.  In instances where clinicians chose to use lay or non-medical 
terms, they explained this was because medical terminology is difficult for patients to 
understand.  Yet the resulting ‘lay’ term was not always well understood by patients.  
For example, ‘unstable cells’ was a lay phrase used by some clinician participants.  
However, this was a phrase patient participants frequently remembered but were often 
unable to explain. In this way it can be seen that although the intention with using such 
terms is to aid understanding, there may well be a disparity between the doctor and the 
patient’s perception of what constitutes ‘everyday language’ (Bourhis, Roth and 
Macqueen 1989).   
 
One of the clinicians who provided his patients with both a medical term for their 
condition along with an associated lay explanation stated that he provided information 
in this way so that his patients would not only be able understand their diagnosis in 
simple terms but would also find it easier to seek further information on their disease 
(using the technical term) if they wished.  This point becomes significant when the 
patient results are again considered.  For example, some patients who reported that their 
disease was explained in lay terms only, using phrases such as ‘white patch’, stated an 
awareness that these terms were reserved for patient explanations only and were not the 
‘technical term’ that doctors would use to describe their disease.  However, when 
seeking additional information relating to their disease, the sole use of lay terminology 
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was sometimes seen as a barrier to obtaining useful information.  In particular, using lay 
terminology as a search term on the internet sometimes provided alarming results.  At 
the time of data analysis, I conducted an internet search using the phrase ‘white patch in 
the mouth’ and found, in particular, a number of misleading and potentially distressing 
images (2010).  The results as a whole were wide ranging but most frequently pointed 
towards oral cancer.  Conversely, studies indicate that if medical terms are used for 
internet based information seeking in oral precancer, the information obtained will be of 
satisfactory quality (Alcaide-Raya, Hughes and Warnakulasuriya 2010).  Interestingly 
though, although some professionals acknowledged that patients may seek further 
information on their diagnosis from a secondary source, such as the internet, none of the 
professionals who took part in the study were aware of or had researched potential 
internet based sources of information for their patients. 
 
7.1.2  Communicating risk 
 
The second area of diagnosis communication to be compared between the two groups is 
that of risk communication. Communicating risk in oral precancer is complex.  If we 
consider risk in oral precancer then, first and foremost, the increased risk of oral cancer 
development needs to be addressed (Warnakulasuriya, Johnson and Van der Waal 
2007).  However, we must also consider the risks of management (Goodson et al., 
2012), both conservative and surgical, as well as the behavioural risk factors associated 
with oral precancer and cancer development (Jaber et al., 1999).  Furthermore, if oral 
precancer is considered a chronic condition, which I would argue that for many people 
it is, then the risk of cancer development is persistent and, therefore, the psychological 
effects on the patient may be notable (the negative psychological effect of a precancer 
diagnosis and associated cancer risk has been demonstrated in the wider literature 
(Lerman et al., 1991)).  In this section I will focus on communicating the risk of oral 
cancer development in a patient with oral precancer.  I will compare the methods 
currently employed by the professional study group to communicate risk along with the 
reasons behind these to the patient accounts of how risk communication is received.   
 
Analysis of the data from the clinicians in the study clearly demonstrated that they 
found risk a difficult area to communicate with their patients.  This became apparent 
when the topic of risk was raised, with some participants having difficulty simply 
discussing the topic.  Problems with communicating risk appeared to result from 
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uncertainty associated with both treatment effectiveness and future malignant 
transformation.  Where professionals undertook discussions regarding risk, the data 
revealed a number of approaches: narrative explanation, statistical explanation, a 
combination of the two or not at all.  When risk communication was approached from a 
purely verbal perspective, for example by using descriptive language to communicate 
risk, clinicians described two main approaches.  Professionals either displayed a strong 
desire to provide a ‘positive’ message or alternatively a considered decision was made 
to overplay the risk.  For those wishing to provide a positive message, some participants 
admitted that they would ‘play down’ the risk of cancer development.  This was often 
seen where clinicians stated they were keen to avoid patient upset.  On the other hand 
where a high risk of cancer development was communicated, for example by suggesting 
that oral cancer is a ‘cancer in waiting’, some participants felt that fear of cancer 
transformation could act as a motivating factor to change patient lifestyle.  Using risk in 
this way (as a motivating factor) is acknowledged in the wider literature (Bottorff et al., 
1998) 
 
For those communicating risk statistically there was awareness that this was not always 
the most appropriate format for some patients (Garcia-Retamero and Dhami 2011) and 
that, on an individual level, the value of using statistics to communicate risk was 
limited.   This is, not least, because the ability to synthesise this type of numerical 
information is an inherently difficult task (Lipkus, Samsa and Rimer 2001). Rarely, 
professional participants admitted that risk of cancer transformation was not 
communicated to patients at all.  Although the reasons for this were not explained 
explicitly, failing to discuss cancer risk appeared to be related to a clinicians desire to 
deliver a positive message as well as a personal discomfort with the notion of an 
uncertain prognosis and an inability to provide a curative treatment.  
 
Where the clinician study data indicates that uncertainty can be difficult for 
professionals to deal with, the patient data found that uncertainty was, for some, 
distressing to live with.  Furthermore, patient uncertainty associated specifically with 
the risk of cancer development was present at a number of stages throughout the 
patient’s journey.  Notably the diagnosis, management and review stages.  Possibly as a 
result of interviewing the majority of patients towards the review stage of their disease 
journey, this was the stage at which uncertainty appeared most prominent.   Patients 
often reported that they were uncertain of the risk of cancer development at this stage, 
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particularly where surgery had been undertaken.  Specifically, patients were not always 
sure if surgery had removed the risk of cancer development. With some participants 
wrongly assuming they had been ‘cured’.  In cases where patients recounted discussions 
surrounding risk, the recall was variable and often bore no resemblance to the medical 
literature. 
 
Communicating a diagnosis - Conclusions: 
 Clinicians are providing a diagnosis to their patients using variable approaches, 
often choosing specific terms on the basis of what they consider to be accessible 
to patients, but this is done in a completely subjective way with little or no 
supporting evidence. 
 Some patients have difficulty making sense of their diagnosis; in some cases a 
precancer diagnosis was misinterpreted as cancer.   
 Using lay terminology only to describe a diagnosis of oral precancer was found 
to hinder some patient attempts at information seeking in relation to their 
disease.   
 Clinicians may find risk of malignant transformation a difficult area to 
communicate with oral precancer patients, with some opting not to discuss the 
topic altogether 
 When discussed, clinicians may further confuse the message by either under or 
overplaying the risk  
 Many patients are concerned about the risk of cancer development but are not 
clear what the risk is for them. 
 
7.2  Further information needs and how information is provided 
 
The point on the disease journey where patient participants reported the greatest need 
for information was immediately following their diagnosis.  At this point, much of the 
information delivered about their disease was communicated verbally during a 
consultation.  Unfortunately evidence suggests this is not always the most successful 
method (Thomson, Cunningham and Hunt 2001). Accordingly, I will now consider the 
patient and professional accounts from the point of view of verbal information exchange 
between the doctor and the patient.  During these encounters a number of barriers to 
optimal information exchange were identified.  These include; the patient’s ability to 
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comprehend and request further information and the doctor’s ability and willingness to 
provide information. 
 
7.2.1  Patient factors 
 
The ability of a patient to retain information delivered during a consultation is 
important.  As an example, Ley notes a well-informed patient is not only able to 
demonstrate a better understanding of their disease but is also more likely to adhere to 
treatment plans and express satisfaction with care (Ley 1979).  However, the data from 
the patient study provides evidence that some oral precancer patients are not able to 
retain or comprehend the information provided to them by their doctor.  This was 
explored in the previous section with reference to the use of medical jargon.  The 
literature also puts forward two other factors that may influence patient recall: the mode 
in which the information is provided and patient factors (such as age, level of anxiety 
and perceived importance of the information) (Kessels 2003).  I will now go on to 
examine these factors further with respect to the study data. 
 
Evidence would suggest that written information is better remembered than verbal and 
leads to better treatment adherence (Kessels 2003).  However, written information is not 
a format that all patients will find accessible, in particular those with low levels of 
literacy (Eaton and Holloway 1980).  In the context of health care, health literacy is 
defined as: ‘the capacity of an individual to obtain, interpret and understand basic health 
information and services in ways which are health-enhancing’ (p.5) (Sihota and Lennard 
2004).  By considering this definition it can be appreciated that those individuals with 
poor health literacy may well be at a disadvantage when it comes to both obtaining and 
understanding information relating to their disease.  Indeed studies have suggested that 
low health literacy is associated with a lack of understanding and use of preventative 
services, a lack of knowledge and decreased comprehension, poor compliance rates and 
poor self-reported health (Andrus and Roth 2002).  Whilst it is not possible to say from 
the study data that patients are failing to request further information as a direct result of 
poor literacy or comprehension skills, given that low levels of literacy are common in 
the UK (with over half of the UK population displaying poor reading and 
comprehension skills (1997),  it would be reasonable to acknowledge the likelihood that 
a proportion of oral precancer patients will fall into this bracket.   
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As well as health literacy acting as a barrier to patient understanding of medical 
information, the psychological literature has demonstrated that older people are more 
likely to have problems with memory and recall of medical information compared to 
their younger counterparts (Jansen et al., 2008).  Specifically the volume of information 
has been identified as key feature in information recall, in that when a large volume of 
information is presented at one time, recall is likely to be reduced.  This becomes 
relevant when we consider that, in the UK, oral precancers are more likely to affect 
older individuals (Napier and Speight 2008).  Anxiety too has been shown to affect a 
patient’s ability to recall information provided; for example MacLeod and Cohen report 
that anxious individuals are more likely to ascribe life-threatening interpretations to 
ambiguous statements made by the doctor (MacLeod and Cohen 1993).  However, there 
is also evidence that this may be overcome by the provision of supplemental 
information (leaflets, audiotape etc.).  As a number of the study participants report 
anxiety following their diagnosis, it is possible that the ability of some oral precancer 
patients to retain verbal information is affected by their anxiety.  Furthermore, some 
participants reported finding the hospital environment anxiety provoking in its own 
right.  Anxiety may also be of significance for those who consider a diagnosis of oral 
precancer bad news.  This is because the literature suggests that some patients fail to 
hear further information following the delivery of bad news (Ptacek and Eberhardt 
1996), something which was evident from the patient participant accounts.  
 
As well as barriers to comprehending or retaining information, the patient study data 
revealed that for some individual’s, barriers to seeking further information were also 
present.  Specifically these barriers took the form of:  
 
 A fear of embarrassment 
 Adopting a passive role 
 A fatalistic attitude 
 
Each of these points will now be discussed. 
 
Several participants from the patient study stated that they avoided asking for further 
information about their diagnosis so as not to appear ‘stupid’ in front of their doctor.  
This led some patients to go without additional information with others opting instead to 
go to the internet, family or friends, a behaviour that is seen elsewhere in the literature 
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(Ybarra and Suman 2006).  Whilst seeking information in this way may well be a valid 
and useful experience for some, there was also evidence from the data that, for others, 
the information obtained was, at times, confusing, vast, difficult to comprehend and 
frightening. 
 
By far the greatest barrier to information seeking, however, was that of the patient who 
stated that they preferred to adopt a passive role.  Such patients frequently described a 
desire to put their trust in their doctor, abdicating any treatment decisions to them and 
correspondingly stating that they felt satisfied with the information provided by the 
doctor.  This problem is significant when the white paper ‘Equity and Excellence – 
Liberating the NHS’ is examined.  This document states that patients should be at the 
heart of the National Health  Service, empowered by information and choice (DoH 
2010).  Clearly achieving this goal will be difficult to achieve where some patients 
choose to avoid both actively seeking information and participating in treatment 
decisions. The level of patient involvement put forward in this government document 
represents a shift in the dynamics of the doctor-patient encounter from a historically 
passive role to active involvement in their care.  This active roll may be difficult for 
some patients to adopt and doctors should be aware and respond to this, for example by 
tailoring the consultation to the individuals preference (Brown et al., 2002). However, if 
patients can be encouraged to become more involved this, in turn, can have a positive 
impact (such as increased patient knowledge, satisfaction, adherence to treatment and 
improved outcomes) (Fraenkel and McGraw 2007).   
 
As well as voicing a desire to maintain a passive role, a number of patients repeatedly 
communicated a belief that the development of their disease had been a matter of 
chance.  This fatalistic attitude appeared to impact on their desire to actively seek 
further information about their disease.  These patients qualified their decision by 
suggesting that there was little benefit to seeking additional information as the disease 
trajectory and outcome was essentially out of their hands.  This is unfortunate as it may 
mean that patients with a fatalistic attitude are less likely to access positive information 
about their disease as well as feeling less able to influence disease outcome (for 
example by reducing risk factor behaviours) (Miles et al., 2008). 
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7.2.2  Clinician factors  
 
Moving on from patient factors affecting information seeking, the results of the 
clinician study indicated that doctors employed a number of approaches when seeking 
to address patient’s additional information needs.  To this end, the majority of clinicians 
stated that they provided information verbally although, when questioned further, were 
often not sure of the success, or otherwise, of this approach.  Other clinicians did not 
seek to address patients additional information needs at all, while the remainder 
provided supplemental written information, usually in the form of a personalised letter.  
The significance of personalising written information becomes clear when work such as 
that by Jones et al., is considered.  Their study indicated that patients are more likely to 
find supplemental written information helpful when it is directly relevant to them (Jones 
et al., 2006). Moreover, the importance of accessible supplemental information has been 
recognised at governmental level (DoH 2006) and has prompted recommendations 
relating to the provision of ‘information prescriptions’, which are tailored specifically to 
the individual and include information that is relevant to them personally.  However, 
although information prescriptions have been shown to be of benefit in other areas 
(D'Alessandro et al., 2004), providing this type of information for oral precancer 
patients may be more difficult due to the lack of robust evidence upon which these 
prescriptions should be based. 
 
In addition to the details provided on the specific approaches to delivering supplemental 
information, some professionals indicated they felt the set-up of the clinic also impacted 
on this process.  In particular some suggested that having a dedicated precancer clinic 
facilitates information provision by allowing the clinician to focus on one particular 
disease process.   Although this is an interesting point it is not within the remit of this 
work to ascertain whether this is true and further work would be required to determine 
the relevance of clinical set up in relation to information provision.   
 
Information needs and provision - Conclusions: 
 Patients have varying preferences for supplemental information 
 Barriers are present which either prevent patients comprehending or accessing 
further information 
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 Clinicians approaches to meeting their patients information needs are currently 
disparate and in some cases non-existent. This is a lost opportunity to address 
patients’ needs 
 
7.3  Behaviour change 
 
Health related behaviour change (in this case primarily tobacco and alcohol cessation) 
was a further area in which problems with current practice were identified.  Previous 
chapters have highlighted the importance of tobacco and alcohol use as risk factors in 
the development of oral precancer and oral cancer.  In particular, the roles of smoking 
and, to a lesser extent, alcohol cessation in oral precancer management have been 
examined.  The oral precancer literature stresses the importance of measures aimed at 
stopping or reducing tobacco and alcohol use in the management of oral precancer 
(Warnakulasuriya 2011). However, there is also evidence that despite intensive 
cessation measures many patients continue to use these substances (Hamadah, Hepburn 
and Thomson 2007; Poate and Warnakulasuriya 2006).  As these risk factors are 
thought to be significant, it is vital to investigate how health related behaviour change in 
oral precancer is approached by professionals and received by patients.  This discussion 
will focus primarily on smoking cessation.  Although alcohol cessation was discussed 
with both study groups much less data was generated on the topic.  In an effort to 
determine the reason for this, examination of the patient study results revealed that the 
majority of participants had no recollection of the topic having been discussed.  
 
Looking first at the study of professionals, a number of the participants stated that they 
engaged less in measures aimed at alcohol cessation compared to smoking cessation.  
The justification often cited for this was the perception that alcohol use is less 
significantly associated with oral precancer and therefore efforts aimed at reducing risk 
factors would be better aimed at smoking cessation.  Although the literature supports 
the concept of tobacco as the predominant risk factor in oral cancer and precancer 
development (Reichart 2001) it does not seem justified to omit efforts aimed at any 
other form of behaviour change, particularly where an increased risk of disease 
development has been noted (Maserejian et al., 2006).  However, due to a lack of data, 
the rest of this section will be dedicated to exploring the topic of smoking cessation.    
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As the literature demonstrates that many patients with oral precancer continue to smoke 
following their diagnosis; it would seem that the effect of an oral precancer diagnosis is 
not necessarily powerful enough to elicit a change in risk factor behaviour.  The study 
results will therefore now be examined both from the patient point of view in relation to 
barriers preventing engagement with smoking cessation as well from a professionals 
viewpoint, by exploring how clinicians advise patients on their health related 
behaviours and provide access to appropriate services. 
 
7.3.1  Patients’ experience of behaviour change  
 
Examining the patient accounts revealed that there were a number of barriers to 
behaviour change, in particular: lay beliefs contradicting biomedical information, a 
fatalistic attitude and the influence of social norms.   
 
The study results indicated that patients were more likely to engage in a behaviour 
change when they believed that the effects would be of direct benefit to them.  In 
particular the impetus to stop or reduce smoking and drinking was often seen where 
patients believed that changing these behaviours would improve their oral precancer, 
reduce the chance of future oral cancer development or provide another positive 
lifestyle benefit. There were a number of examples, however, where participants made it 
clear that they attributed their oral lesions to a cause other than that put forward by their 
doctor, for example, as a result of previous dental treatment or following the use of a 
new medication.  It can be appreciated, therefore, that where such beliefs exist, the 
motivation to change smoking or drinking behaviours may be limited.  It was interesting 
to note from the professional data that a number of the clinicians also cited this as a 
barrier in tackling behaviour change with their patients.  Other clinicians, however, 
dismissed the notion that some patients would not accept a link between oral precancer 
and smoking, stating that it is widely accepted in Western society that that smoking is 
detrimental to an individual’s health.  Whilst this may be true, it does not take into 
account the specific link that they are trying to infer between smoking and the patient’s 
oral lesion.   
 
Variations between lay and professional understandings of illness have been identified 
by many (Balshem 1991; Pill and Stott 1982; Popay et al., 1998). However, lay and 
professional understanding of disease processes may not necessarily be completely 
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distinct from one another.  Factors such as, public health campaigns, experience of 
health care systems and  free access to health related information can lead to a situation 
where ‘lay beliefs’ are informed in part by pre-existing knowledge of medical ideas and 
concepts (Shaw 2002).  This may become important not only when patients seek to 
interpret and understand their illness but further may impact on their illness behaviour, 
including modification of behavioural risk factors such as smoking.  Examples of the 
influence of lay understandings of oral precancer have been described in the previous 
chapters.  For example, where one of the patient participants describes how she 
understands her disease to be the direct result of temperature of her food. Her 
description of her beliefs surrounding disease aetiology demonstrates both an awareness 
and a rejection of the biomedical explanation of her disease.  Consequently her efforts at 
behaviour change are directed toward altering the temperature of her diet.   
 
Moving on from the influence of lay understandings of disease aetiology and on to 
another potential barrier in health related behaviour change, it has been discussed that 
there were a number of patient participants who believed they had no influence on their 
disease course and should their lesion change it would be down to luck, fate, or God’s 
will.  It can be seen that such a fatalistic attitude could pose a significant barrier to 
engaging in behaviour change and this was demonstrated with the patient study cohort.  
This is of concern as studies have indicated that patients who adopt such a viewpoint are 
not only less likely to change behaviour but also may be more likely to have a poorer 
prognosis (Niederdeppe and Levy 2007). However, it should be noted that some studies 
have indicated that it may be possible to modify fatalistic attitudes following the 
implementation of an intervention (Powe and Weinrich 1999).  The literature on 
fatalistic attitudes would further suggest that such beliefs are more prevalent in those 
from lower socioeconomic groups.  As oral precancer patients are more likely to belong 
to such groups (Hashibe et al., 2003) this particular barrier to behaviour change may be 
relevant to the oral precancer patient.  
 
In addition to a fatalistic viewpoint the potential relevance of a low socioeconomic 
status again becomes important when the influence of social norms as a barrier to 
behaviour change is considered.  Accounts from the patient study revealed that many 
participants often looked to their immediate social environment as a means of gauging 
what constituted ‘normal’ behaviour. In the context of smoking and drinking alcohol 
participants often compared their behaviour to that of others from within their social 
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group.  This information was then used to enable them to weigh up their perceived risk 
in continuing their damaging health behaviour.  For example, some participants spoke 
of acquaintances who they felt smoke or drank more than them and compared their 
behaviour to that of their own as a means of suggesting that their behaviour, by 
comparison, was not significant or risky.  
 
If we now go on to explore smoking specifically in a social context,  the literature states 
that smoking is strongly associated with socioeconomic status, which in the UK 
(although not in other countries) equates to higher numbers of smokers in the lower 
socioeconomic groups  (Pampel 2002).  Furthermore, smokers from lower 
socioeconomic groups are less likely to respond to tobacco control messages (Frohlich 
et al., 2010).  This disparity has been noted in the government guidance document 
‘Healthy lives, healthy people – a tobacco control plan for England’ (Government 2011) 
which alongside other guidance, recommends that local areas are encouraged to 
provided tailored stop smoking services to those from high smoking prevalence groups 
(including  those from socioeconomically disadvantaged communities).  Because oral 
precancer patients may belong to such groups (Hashibe et al., 2003) it is important to 
consider why such messages are acted upon less often by individuals with low 
socioeconomic status.  To this end, Frohlich et al., have hypothesised that this may be 
partly due to a ‘mismatch’ between, primarily,  middle-class professionals delivering 
tobacco prevention messages to the lower income smoker (Frohlich et al., 2010).  They 
further put forward the belief that persons from the target group (those from low 
socioeconomic groups) should perhaps be actively involved in the intervention process.  
A concept which is supported by others, specifically in the context of social marketing 
as a tool in smoking cessation (Hastings and McLean 2006). 
 
7.3.2  Approaches to behaviour change employed by clinicians 
 
The clinician based study results indicated that the majority of clinicians were 
discussing risk factors with patients, but with varying approaches.  Best practice was 
seen where current guidelines were followed (DoH 2012a; NICE 2008) and included 
advice and encouragement to stop smoking alongside referral to specialist smoking 
cessation services. However, there was also evidence that smoking cessation advice was 
not always optimal.  In some cases it was reported that engaging with smoking cessation 
was challenging because accessing services was difficult, for example in cases where 
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local smoking cessation clinics had been withdrawn.  However, at other times clinicians 
stated that the responsibility to request access to services lay with the patient.  In 
addition, it has also been discussed that the attitude, especially a lack of enthusiasm, of 
the professional has the potential to impact on a patient’s likelihood to change their 
behaviour (Lowry et al., 2004).  This is interesting if we consider the professional data, 
which demonstrated that in some cases little effort was put into messages about the 
benefits of behaviour change.  Professionals sometimes qualified this behaviour of the 
basis of a lack of time.  
 
Behaviour change - Conclusions: 
 Patients accounts reveal a number of barriers which may prevent engagement 
with behaviour change,  specifically these include:  
o Lay beliefs  
o A fatalistic attitude 
o Social norms 
 When broaching behaviour change with their patients, clinicians appear to be 
much less likely to direct efforts towards alcohol cessation, compared to 
smoking cessation 
 Clinicians report not always following current guidance on smoking cessation 
and in some cases are failing to advise patients of available services.  This is a 
lost opportunity to improve health and to improve mortality and morbidity.  
 
7.4  Management of oral precancer  
 
It has been discussed that there are two main approaches to managing oral precancer: 
surgical removal or conservative management.  By looking at both the patient and 
professional accounts of management together it is possible to examine how the patient 
participants experienced precancer management and compare this to how the 
professional participants made decisions about the most appropriate form of 
management for their patients. In this way, in future the decision making process may 
be better informed. 
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7.4.1  Patient experience  
 
By beginning with those who underwent surgical treatment, analysis of the patient data 
revealed that patient experience of surgery is variable, ranging from those patients who 
report a distressing experience to those who cope well with the surgery.  Focusing 
initially on surgery, it was clear to see from the data that this process included not only 
the surgery itself but also the lead up to the surgery, the experience of being in a 
hospital environment, the surgical intervention, as well as the post-operative phase, 
described by one participant as ‘the aftermath’.   
 
As with other aspects of patient experience it is not possible to simply classify patients 
into those who coped well and those who did not.  Instead it is important to examine the 
factors which influenced the patient experience of surgery, both positively and 
negatively.  It is only by doing this that it may be possible to understand and, for some; 
potentially improve the patient experience of surgery.  Analysis of these factors may 
also enable us to reconsider the consent and even the decision making process as a 
whole to ensure better, well informed choices and experience for all precancer patients.   
 
Firstly, looking at those who coped well with surgery, the data demonstrated that a 
positive experience often appeared to correlate with patients for whom their 
expectations of surgery were met.  In addition, where patients had undergone surgery 
for other medical conditions, they often appeared to cope better with their oral precancer 
surgery than those who had not.  Interestingly, some patients who reported a poor 
experience of surgery stated that they would not have opted for surgery had they been 
aware of the nature of the treatment and/or its post-operative effects at the time.  In 
some cases it appeared that a patient’s expectations were affected by their perception of 
a lack of pre-operative information.  Further data analysis was able to show that some 
dissatisfied patients remembered the surgical information being provided to them just 
prior to the procedure and sometimes by someone other than their usual clinician.  
Moreover, it seemed that recall of the information provided at that time was not always 
particularly good.   
As well as surgical management, the results and discussion of the patient study (chapter 
5) outlined the format of conservative management alongside the patient experience of 
it.  Conservative management essentially involves the patient attending an outpatient 
clinic for regular review of their lesion(s).  This may also include regular biopsy and/or 
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photographs of the lesion depending on the clinic attended.  It can be seen, therefore, 
that conservative management and review following surgery often take a similar format; 
however, the patient’s experience will not necessarily be the same.  One feature which 
was seen in the accounts of both patient groups was that they were not always sure why 
they were attending the clinic.  Broadly, there were two main responses to the review 
appointment: some finding it profoundly reassuring, while others sought discharge. In 
both situations though there appeared to be reluctance to ask their clinician for clarity.  
As a result, uncertainty was a prominent theme at this stage. 
 
Patients who felt reassured by their regular appointments often described a persistent 
fear of cancer, further treatment or sometimes even biopsy.  Importantly, this fear was 
not always voiced at the appointment, thus eliminating a possible opportunity for 
reassurance or further information to be delivered by the patient’s clinician.  For those 
striving for discharge, there was often a view that discharge from the clinic was an 
indication of being ‘cured’, with some patients stating they were keen to get the ‘all 
clear’.  However, patient participants also frequently spoke of a lack of clear 
information on when or if they would be discharged.  As a result, some patients looked 
for clues to assess the likelihood of discharge for themselves.   For example, if the recall 
appointments were becoming less frequent this was seen as an indication that their 
disease was less severe and as a result these patients often felt reassured.  This type of 
behaviour, where a patient looks for other indicators instead of asking the doctor 
directly for information has also been described in the cervical precancer literature 
(Martinez 2005).  
 
7.4.2  Clinician experience  
 
When examining the management of oral precancer form the perspective of the clinician 
study group it is helpful to remember that the existing evidence is not robust enough to 
definitively support one management option over another (Lodi et al., 2008).  It is, 
therefore likely that this impacts on clinicians’ treatment decisions.  Indeed the results 
of the clinician study indicate that the decision making process surrounding treatment 
varied between participants with, for example, some participants indicating they would 
only offer surgery to patients whom they considered to have the most advanced disease.  
Further exploration of the decision making process revealed the factors taken into 
account by clinicians when making treatment decisions which included: the grade of 
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dysplasia within the lesion,  the clinical appearance of the lesion, the reliability of 
follow up in general practice and patient preference, with the grade of dysplasia being 
the most frequently cited consideration.    
 
In general terms, current literature on the subject of clinical decision making suggests 
that a decision making process involving both the clinician and the patient equally is the 
optimal model (Elwyn et al., 2010) and policy supports this (DoH 2010).  Moreover, the 
advantages of the shared decision model previously discussed have been cited as: 
improved health outcomes, boost in patient satisfaction with services, increased 
knowledge and understanding of health status and increased adherence to a chosen 
treatment (Edwards and Elwyn 2009). However, the literature also acknowledges that 
this so called shared decision-making process, despite being considered the ideal, will 
not suit everyone (Deber et al., 2007).  Indeed, there was some evidence from the 
clinician data that the decision making process was not always a truly shared decision, 
although the reasons for this were not clear.   
 
As well as difficulties making treatment decisions, patient review and discharge was 
highlighted as another challenging area in oral precancer management.  In particular, the 
clinicians often expressed concern that they had difficult decisions to make when it 
came to choosing when to review patients and when to discharge them particularly 
when deciding on an appropriate time for discharge.  These decisions may be made 
particularly challenging when recent work suggesting review periods of up to 20 years 
or more is considered (Mehanna et al., 2009; van der Waal 2010).  Furthermore, it was 
noted that the professionals who had become consultants more recently expressed 
greater uncertainty with regard to the duration patient review in particular.   
 
Management of oral precancer – Conclusions: 
 Patients experience of surgery is not uniform and may be influenced by a 
number of factors, including their experience of other disease and prior 
expectations of surgery   
 Patients may view conservative management and review positively or negatively 
but in either case they are often associated with uncertainty  
 Clinicians appear to consider the grade of dysplasia within a lesion particularly 
important when making decisions regarding treatment  
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 At present, there is limited evidence of shared decision making in oral precancer 
management 
 
7.5  The influence of the clinician and the environment on patient experience 
 
The previous four sections of this chapter have considered specific points along the 
patient journey at which there may currently be problems in current practice.   The 
following section, however, will examine two factors which may influence a patient’s 
experience throughout their journey through secondary care, namely the clinician and 
the clinical set up/environment.     
 
7.5.1  The clinician – the significance of the individual 
 
Not surprisingly the relationship between the precancer patient and the clinician or 
clinicians they came into contact with throughout their precancer journey often had an 
impact on their experience of their disease and treatment.  When discussing this topic 
with the patient study group there were two key areas that were highlighted as important 
by the group:  
 
 the significance of the individual at the time of diagnosis 
 continuity of care in the post diagnosis phase  
 
Analysis of the data with respect to the significance of the clinician delivering the 
diagnosis revealed that many patients desire to be seen by someone they perceive to be 
experienced and senior, usually a consultant.  For some patients there was a 
dissatisfaction associated with being given a diagnosis by another member of staff.  The 
advantages of being seen by a consultant from the patient point of view included: trust 
in the diagnosis, security that the appropriate action would be taken and feeling that 
they (the patient) mattered. This fits in with the work of Wittmann et al., who, in their 
study involving oesophageal and gastric cancer patients, found that of their sample a 
high percentage of patients felt that their diagnosis should be delivered by a consultant 
(77% of the study sample). Interestingly, only 5% of the junior doctors surveyed as part 
of the same study felt this was appropriate. 
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Furthermore, feelings of trust and confidence appeared to be fostered where there was 
continuity in terms of the clinician who saw the patient. For many patients the relevance 
of seeing the same clinician was that there was a belief that the person would be familiar 
with their case and, in particular, would be able to remember the appearance of their 
oral cavity and/or lesion which, in turn, would allow them to pick up any changes more 
readily.  Interestingly, there was also evidence that, where a positive doctor-patient 
relationship had developed, some patients expressed that they would undergo 
procedures they found unpleasant because of the trust they had in their clinician and 
would therefore feel happy taking their advice as a result of the faith they put in their 
management decisions.  On the other hand, where a lack of faith in the doctor existed, 
patients reported dissatisfaction with care.  This was particularly, although not 
exclusively, evident at the biopsy stage where a perception that the clinician was 
inexperienced led to a loss of faith and an unpleasant experience.   
 
Professionals, however, stated that precancer patients were often seen by a number of 
different individuals.  There was a sense that although patients may prefer to been seen 
by a consultant, it was not always practical to ensure this happened at every visit.  
Instead, consultants often made it a priority to see an oral precancer patient at the 
diagnosis stage, as this was repeatedly deemed the most critical.  There was an opinion 
that junior members of staff should not be involved in the diagnosis or review of the 
precancer patient due to their lack of knowledge or experience; however, they were 
frequently involved in the biopsy stage of management.   
 
In terms of continuity of care, this was best achieved when dedicated clinics were set 
up.  Using this approach meant that patients were more likely to see a particular 
individual on a regular basis.  However, even when using this approach it was 
acknowledged that it would be difficult for the consultant specifically to spend time 
with each individual and that sometimes another member of the team would be involved 
in the patient’s care.  Some consultants felt that the benefit of establishing a positive 
relationship with their patients over time was that they were more likely to ‘buy into’ 
their management strategies.  As noted above, this seemed to be happening in some 
cases.   
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7.5.2  The environment – the significance of the clinical set up 
 
From the clinician point of view it has been discussed that there are two general 
approaches to organising clinics for precancer patients:  by managing them on a 
specialised clinic or by incorporating them onto mixed outpatient clinics. The available 
literature would suggest, that in the UK, patients with oral precancer are frequently seen 
on specialist as opposed to generalist clinics (Kanatas et al., 2011).  When study 
participants from the clinician study stated that they had set up specialist clinics, there 
were clear ideas surrounding the benefit of organising a clinic in this particular way. 
Specifically, there was a perceived benefit to the clinician on focusing purely on one 
disease process during a clinic; this was thought to allow a consistent approach, with 
targeted messages, and on occasion, the use of new technologies and potential for 
patient involvement in research.  When clinicians saw patients on mixed outpatient 
clinics the majority reported that this was satisfactory, however, some admitted that due 
to the disparate nature of the mixed clinics there was, at times, a tendency not to spend 
as much time focusing on health behaviour messages such as smoking cessation.   
 
Compared to the clinician data the topic of clinical set up in the patient data was much 
less prominent.  Where patients did complain about the clinical set up it was usually due 
to a dislike of being in a hospital environment or a lack of flexibility with appointment 
dates or times.  On occasion, patients attending mixed clinics spoke of their shock when 
faced with others who had visible facial disfigurements but chose not to voice their 
concern with clinicians. On the other hand, patients reported satisfaction with the 
clinical set up when it was well organised and they were seen on time.  
 
The influence of the clinician and the environment on patient experience  - 
Conclusions: 
 Patients wish to be seen by a senior doctor (usually a consultant) at the time of 
their diagnosis and subsequently value continuity as part of their continuing care 
 Clinicians reported that oral precancer patients will not always see a consultant 
or indeed the same clinician at each appointment 
 Clinicians often feel that the organisation of the clinic may impact on patient 
experience, particularly in terms of delivering health messages 
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This chapter summarises the work of both studies.  This is facilitated by the use of a 
map outlining an oral precancer patient journey through a health care system which 
enabled identification of four specific areas at which current practice may benefit from 
an intervention, namely: communicating a diagnosis, meeting patient information needs, 
facilitating behaviour change and decisions concerning treatment options.  In addition 
the influence of the clinician and the clinical environment on patient experience (which 
is present at multiple stages of the patient journey) has also been described.  The 
following chapter will go on to make final conclusions with respect to the studies aims 
and objectives as well as providing recommendations for changes in practice and future 
research.  
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Chapter 8. Summary, recommendations for practice and further work 
 
8.1 .Summary 
 
This work was conducted as a result of a perceived disparity in oral precancer patient 
care, a lack of research within the field of patient experience in oral precancer and a 
desire to improve the patient experience.  
 
The aim of this project was, therefore, to investigate both the patient and professional 
experience of oral precancer with a view to identifying opportunities to improve patient 
care.   
 
With this in mind, this thesis reports on two studies the first of which sought to examine 
critically patients’ experiences of oral precancer with a view to: 
1. Gaining an insight into the understanding patients have of their disease 
2. Exploring what patients recall of the information they receive in relation to their   
disease and their views of the medium through which information was given 
3. Exploring the impact of the diagnosis on the individual’s life and health related 
behaviours 
4. Exploring patients’ views of their ongoing clinical management 
 
The results of this study indicated that: 
1. Patients’ understanding of their disease is variable with some patients finding 
their diagnosis particularly difficult to make sense of.  Specifically the 
terminology used is shown to impact patient understanding and subsequent 
information seeking.   
2. Patients are often able to recall a term given to them to explain their diagnosis, 
but are not always able to make sense of it.  Some patients are aware that they 
are not able to recall the entire conversation with their clinician, which is often 
the primary means of disease specific information delivery. 
3. Being diagnosed with oral precancer does not produce a uniform response: for 
some individuals the diagnosis is devastating, for others the impact is less.  The 
response appears to be dependent on a number of variables, in particular the 
influence of past or concomitant disease is noted.  
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4. The experience of oral precancer management varies and is dependent on a 
number of factors, including the mode of management.  However, meeting 
expectations is a prominent theme at this stage. 
 
The second study aimed to investigate oral precancer from the clinicians perspective, in 
particular the objectives of this study were: 
1. To determine how the diagnosis of oral precancer is explained to a patient 
and to ascertain how concerns are addressed. 
2. To determine if behaviour change, specifically modification of risk factors, 
is considered an important factor in the management of oral precancer and if 
so what action is taken to assist patients with this 
3. To determine the how decisions are made relating to management options 
for patients with oral precancer.   
 
The results of this study indicated that: 
1. A diagnosis of oral precancer is often explained to a patient using terminology 
that the clinician feels the patient will understand and in many cases this 
involves the use of lay terms. At the time of diagnosis there may be concerns 
pertaining to the risk of malignant transformation which can be difficult to 
address and are, sometimes, avoided.   
2. Efforts at health related behaviour change are concentrated around smoking 
cessation, however, current guidance is not always followed and in some cases, 
clinicians feel that it is the patient’s responsibility to request access to services.  
3. Decisions relating to management in oral precancer appeared to be complicated 
by a lack of clear clinical guidance and were often made primarily on the basis 
of the grade of dysplasia within a lesion. 
 
In addition to the conclusions listed, the analysis of the studies allowed the patients 
journey through care to be mapped which enabled several points along the journey to be 
identified at which point there are problems with current practice.  These will now be 
outlined in the next section: recommendations for practice and further work. 
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 8.2  Recommendations for practice 
 
8.2.1  Communicating a diagnosis of oral precancer 
 
The results from both studies provide evidence that when deciding on an approach to 
communicating a diagnosis, particular attention should be paid to the terminology used.  
Clinicians should be aware that the choice of terms they use are likely to directly impact 
on patients understanding of their disease and that patients will not always interpret the 
diagnosis as clinicians intend.  In addition, terms used to describe oral precancer at the 
diagnosis stage may be used by patients to seek further information and clinicians 
should consider this when deciding on the most appropriate language to use. 
 
8.2.2  Addressing patients information needs 
 
There is evidence that patients do not recall all of the information given to them 
verbally by their clinician and may require additional information about their disease.  
In addition, the patient study results also demonstrate that factors such as a fear of 
embarrassment, adopting a passive role and a fatalistic attitude can create difficulties 
pursuing additional information directly from their doctor.  Clinicians should be aware 
of this and consider how best to support their patients’ needs.  In particular, there is 
need for high quality, accessible, reliable supplemental information resources.  
 
8.2.3  Facilitating behaviour change 
 
Tobacco use and in particular cigarette smoking is a risk factor for the development of 
both oral precancer and oral cancer.  Clinicians should be ensuring that patients are 
aware of and have access to smoking cessation services.  It may be helpful for clinicians 
take more decisive steps to encourage patients to engage more with smoking cessation, 
specifically by tailoring the message to the individual. 
 
8.2.4  Making treatment decisions 
 
Although decisions made regarding treatment options in oral precancer are difficult 
without clear evidence-based guidance, the patient study results indicate that managing 
patients’ expectations is an important aspect of this stage of their disease journey and 
may help to improve patient satisfaction with care.  
 
183 
 
8.2.5  The doctor-patient relationship 
 
Finally, throughout their journey, patients often appear to place importance on the 
relationship with their doctor placing a particular emphasis on trust in their clinician and 
consistency.  It may be helpful for clinicians to be aware of this when organising clinics 
for oral precancer patients.   
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8.3  Further work 
 
Clinicians often communicate a diagnosis of oral precancer using terminology they 
believe patients will understand but the evidence from this study suggests that the 
terminology used can be problematic.  Further work needs to be done to unpick the 
meanings patients attach to particular words in order to determine which terms should 
be used during an oral precancer diagnosis.  This would enable the development of 
clearer guidance for clinicians on the delivery of a precancer diagnosis.   
 
The results of the clinician study suggest that clinicians often fail to facilitate further 
patient information seeking because either they do not have adequate resources directly 
available (for example leaflets on the clinic) or because they are not aware of potential 
resources (for example, appropriate internet based information). This may mean that 
such resources may need to be developed or identified.  Clinicians should be able to 
direct patients to the best available resources for their patients in order to guide them 
toward meaningful additional information.  This is of particular importance when it is 
considered that patients may not feel able to access further information from their 
clinician directly. 
 
Many of the uncertainties in oral precancer stem from a lack of robust evidence, in 
particular in relation to likelihood of malignant change and effective treatments.  
Further work is required in relation to both predictors of malignant change and 
treatment effectiveness in order to allow the production of detailed national guidelines 
for clinicians. In this way treatment practices may be standardised and discussions 
surrounding risk of future disease may be easier.  
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8.4  Final summary 
 
This thesis adds to the literature in that it explores and describes the experience of living 
with oral precancer and in doing so offers the reader a deeper understanding of the 
potential impact of an oral precancer diagnosis. It is intended to allow the reader to 
appreciate the factors that may prevent an individual with oral precancer from 
questioning or seeking further information from their clinician.  Moreover, this work 
unpicks potential barriers to an individual fully engaging in treatment decisions or 
health related behaviour changes.  In addition, this work highlights difficulties 
associated with managing oral precancer patients from the perspective of the clinician 
particularly where treatment decisions are based on a limited evidence base.   
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Appendices 
Appendix A – Study protocol 
 
 
 
 
PATIENT AND PROFESSIONAL VIEWS AND 
EXPERIENCE OF ORAL PRECANCER 
 
 
Protocol 
 
 
Principal Investigator: 
Miss Rachel Green 
 
 
 
Summary of protocol 
 
This document outlines a project to investigate the patient’s and 
professional’s views and experience of oral precancer. 
 
Contents 
 
a) Introduction………………………………………………………….2 
b) Background……….…………………………………………….…...2 
c) Aims and objectives…………………………………………………4 
d) Method…...….…………………………………………...……….....5 
e) Enrolment criteria……...…………………………………………....7 
f) Human subject considerations……..……………………….………7 
g) Adverse Events……………...………………………………………7 
h) Study records………………………………………………………...7 
i) References………………………………………………………..….9 
 
 
187 
 
 
a) Introduction 
 
The purpose of this study is to gain a deeper understanding of oral precancer from the 
patient and professional perspective.   
 
During the initial stages of the study we will work with patients who have been 
diagnosed with oral precancer.  Using qualitative interview techniques we will explore 
the patient’s experiences of diagnosis and will further investigate the patient’s thoughts 
and feelings toward their illness and is management. Furthermore, we will investigate 
the impact of their experiences on lifestyle and specifically health related behaviour. 
Through this process we want to gain a deeper understanding of how these individuals 
experience their disease and treatment. 
 
This study will go onto explore views of experience and management of oral precancer 
from the clinician’s perspective.  This phase of the study will target clinicians closely 
involved in the care of oral precancer patients. It will be informed by the earlier 
interviews undertaken with patients and, in particular, will investigate communication 
surrounding disease diagnosis and treatment.    
 
We believe the study will provide important insights into patient experiences and 
understandings as well as clinical practice, which will help to manage this complex 
group of patients more effectively.    
 
b) Background 
 
What is oral precancer? 
Oral precancer, also known as oral premalignancy or potential malignancy, is a term 
used to describe an oral lesion which may precede oral cancer. Potentially malignant 
disorders, such as leukoplakia, erythroplakia and speckled leukoplakia typically present 
in the mouth as predominantly white, red, or mixed white and red mucosal lesions.  
These precancers are labelled as such because it is recognised that they disorders in 
which dysplastic or frankly malignant changes occur with a higher degree of frequency 
as compared to normal oral mucosa (Brennan et al., 2007). 
 
Dysplastic change represents one of the various prognostic indicators of malignant 
transformation (Brennan et al., 2007) and is generally regarded as heralding malignant 
change (Scully 1995).  Dysplasia is graded by convention as mild, moderate or severe.  
With evidence suggesting that severe dysplasia has a higher potential for future 
development of malignancy (Rodrigues.V.C 1998). 
 
Prevalence and transformation of oral premalignancy  
Collective data on the prevalence and transformation of oral premalignant lesions is 
limited.  Leukoplakia is the most common and best known oral precancerous lesion 
(van der Waal et al., 1997).  The prevalence of leukoplakia documented varies and has 
been reported as ranging from 1.0% to 5.0% in the general population. (Lodi.G 2006)  
With malignant transformation into squamous cell carcinoma occurring in 4.4%-17.5% 
of leukoplakias (Rodrigues and Tuomainen 1998).The prevalence of erythroplakia is 
less than leukoplakia, however, most authors conclude that erythroplakia has a higher 
potential for malignant transformation.   
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Published data suggests the percentage of oral cancers in Europe and the USA which 
arise from precancerous lesions or conditions to be somewhere between 16.0 and 
62.0%.  However, work carried out in India has suggested that in this region 80.0% oral 
cancers were preceded by oral pre-cancerous lesions or conditions.(Gupta et al., 1989) 
 
How is oral precancer currently treated ? 
To date there are no widely accepted protocols for the management of potentially 
malignant oral lesions.(Lamey 1993) Survey based work targeting oral medicine and 
oral and maxillofacial surgeons highlighted significant differences in management 
options both within and between these two practitioner groups (Marley.J.J 1998). In 
general terms precancerous lesions exhibiting severe dysplasia tended to be managed in 
a more aggressive, often surgical manner.  However, it was recognised that until a better 
understanding of the natural history of these lesions is achieved there will always be a 
degree of uncertainty as to the efficacy of any particular approach to treatment (Marley 
et al., 1996).  
 
What is the significance of oral premalignancy ? 
The significance of oral premalignancy is clearly its potential to undergo malignant 
transformation to oral squamous cell carcinoma. The concept of this two-step process of 
cancer development in the oral mucosa is well-established (Reibel 2003).  Significant 
mortality and morbidity are associated with squamous cell carcinoma which continues 
to have poor survival rates at five years post diagnosis.  
 
It is recognised, however, that not all premalignant lesions will progress to oral 
squamous cell carcinoma.   
 
What are the associated risk factors and health related behaviour in oral premalignancy? 
Risk factors for the development of oral squamous cell carcinoma are well documented.  
The two best known are tobacco smoking and alcohol consumption.  These behaviours 
have long been implicated in oral squamous cell carcinoma development and research 
confirms that these too are highly important risk factors for oral premalignancy (Jaber 
M.A et al., 1999).  It would appear that risk of disease development is dose dependant 
and that a combination of the two habits further increases disease risk.  Importantly, 
however, it has been shown that regression of oral premalignant lesions may occur if 
such habits are discontinued (Gupta et al., 1995).  
 
What do we know about oral precancer from the patient perspective? 
At the present time, there is no information in the literature relating to oral precancer 
from the patient perspective.  Patients’ perceptions and their response to the diagnosis 
of oral precancer are critical, as the response of the patient in terms of how they change 
their risk behaviours is likely to be fundamentally important to outcome.  It is for this 
reason that this study aims to explore this patient group in more detail.  If we can 
establish how patients understand the message and respond, then we may be better able 
to manage this diverse group of patients.  Work looking at a different type of precancer 
(cervical precancer) suggests this group of patients often have a poor understanding of 
what their diagnosis means, leading to distress, confusion and dissatisfaction with care 
(Karasz, McKee and Roybal 2003). Despite different demographic profiles, could 
parallel exist between this group and our oral precancer group? 
 
What do we know about oral precancer from the clinician perspective? 
Work in the literature relating to oral precancer primarily focuses on the possible 
management options for these lesions.  Views of UK based practicing clinicians 
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involved in the care of oral precancer patients has been restricted to quantitative 
information relating to investigations and managements undertaken.  Through clinician 
based interviews we wish to explore the professional experiences of working with 
patients who have oral precancer, information that it is not possible to gain through 
quantitative research. 
 
c) Aims and Objectives 
 
Aim 
To investigate both patients and professionals experiences of oral precancer with a view 
to identifying opportunities to improve patient care  
 
This will be achieved through two separate but related studies.   
 
Study A objectives 
This study will critically examine patients’ experiences and understanding of oral 
precancer through a series of qualitative semi-structured interviews.  The study’s 
objectives are: 
 
6. To gain an insight into the understanding patients have of their disease 
7. To explore what patients recall of the information they receive in relation to 
their   disease  
8. To explore their views of the medium though which information was given 
9. To explore their views of their ongoing clinical management 
10. To explore the impact of the diagnosis on the individual’s life and health related 
behaviours 
 
Study B objectives 
Study B will look at oral precancer from the clinician perspective using qualitative 
semi-structured interviews.  The study’s objectives are: 
 
4. To determine how the diagnosis of oral precancer is explained to a patient and to 
ascertain how concerns are addressed. 
5. To determine the how decisions are made relating to management options for 
patients with oral precancer.   
6. To determine if behaviour change, specifically modification of risk factors, is 
considered an important factor in the management of oral precancer and if so 
what action is taken to assist patients with this 
 
 
d) Method 
 
Overall design 
 
Study A will involve an oral precancer patient group and will use semi-structured 
qualitative interviews to identify important aspects of their experiences following the 
diagnosis of oral precancer 
 
Study B will target clinicians involved in the care of patients with oral precancer.  
Again, using semi-structured qualitative interviews will explore the clinicians 
perspective of areas of importance highlighted by the patient group. 
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Study A 
Purposive criterion based sampling will be used to identify a group of patients to 
participate in qualitative semi-structured interviews (Table 1) 
  
Table 1. Patient interview criteria 
 
Criteria Details 
Gender Male 
Female 
Age 18 - 40 years 
40 + years 
Management No active treatment (KUO) 
Currently receiving treatment  
Previous treatment received - further   
disease diagnosed following treatment 
Previous treatment received - no further 
disease diagnosed since treated 
Multiple areas of disease  
Location Newcastle 
Sunderland 
Risk factors Smoker 
Drinker 
Smoker and drinker 
Never smoker and never drinker 
 
 
Patients will be recruited using these criteria to ensure that patients with different 
experiences of disease diagnosis and management are recruited therefore allowing a 
broad range of views to be obtained  
 
A semi-structured interview method will be used to allow for adequate insight into the 
patient experience as it provides an opportunity for detailed investigation of individual’s 
personal perspectives. (Ritchie and Lewis 2003) Data collection and analysis will occur 
concurrently until data saturation, that is until no new ideas or themes arise from the 
data (Glaser 1965). From experience we expect saturation to occur at around 20 
interviews (Durham et al., 2007). 
 
20 patients will, therefore, be recruited from two geographical locations – Oral and 
Maxillofacial outpatient clinics in Newcastle and Sunderland.  Patients will be provided 
with a full verbal explanation of the research and its purpose along with an information 
sheet, and an accompanying reply and consent form. If patients wish to participate they 
will be contacted by telephone or post to arrange a meeting. Once consented to 
participate, individual semi-structured interviews will be conducted by a trained 
researcher (RG) at a time and location convenient for the participant.  A topic guide will 
be used to facilitate the interview process. The topic guide will be informed by the 
literature, clinicians with an experience of diagnosing and treating oral precancer as 
well as by colleagues with extensive experience of qualitative research data collection 
techniques. It is anticipated that the topic guide will evolve as the interview process 
progresses and new themes are identified. The interviews will be recorded digitally and 
transcribed verbatim, once the transcripts have been checked for accuracy the original 
191 
 
recordings will be destroyed. In line with Data Protection and Research Governance all 
information pertaining to individuals will be anonymised.  All transcripts will be stored 
on a secure password protected computer network, and any hard copies will be stored in 
a secure locked private office. 
 
Analysis 
Data collection and analysis will occur concurrently to allow for issues which arise in 
earlier interviews, to be explored in more depth in subsequent interviews. In addressing 
the specified research objectives, the study seeks to examine the relative influence of: 
interpretation, communication, life impact. Thematic analysis, based on the ‘constant 
comparative method’ (Glaser 1965) will be employed. The validity of data 
interpretation will be ensured by independent coding and cross-checking by at least two 
members of the research team.  Data analysis will take place at Newcastle University. 
 
Study B 
Purposive criterion based sampling will be used to identify a group of professionals to 
participate in qualitative semi-structured interviews (Table 2) 
 
Table 2. Professional interview criteria 
 
Criteria Details 
Gender Male 
Female 
Designation 
 
Consultant  
Specialty  
 
Oral and Maxillofacial Surgery 
 
Location Variety of locations UK wide 
Working environment  Teaching hospital 
Large regional unit 
District general hospital 
 
 
Professionals will be recruited using these criteria, this will ensure, in a similar manner 
to the patient based study, that a broad range of views will be obtained. 
 
Professionals will be provided with a explanation of the research and its purpose along 
with an information sheet and an accompanying reply and consent form. If professionals 
wish to participate they will sign and return the consent form provided. Once consented 
to participate, individual semi-structured interviews will be conducted by a trained 
researcher (RG) at a time and location convenient for the participant.  Telephone 
interviews will also be offered to this group.   
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d) Enrolment Criteria 
 
The following inclusion and exclusion criteria will be applied to recruit participants to 
the study. 
 
Study A Inclusion criteria Exclusion criteria 
 A diagnosis of oral 
precancer 
Refusal to participate 
 Willingness to take part in 
interview process 
Under 18 years of age 
 Able to provide informed 
consent 
Unable to consent 
 
 
 
Study B Inclusion criteria Exclusion criteria 
 Professionals involved in 
the care of patients with oral 
precancer 
Refusal to participate 
 Willingness to take part in 
interview process 
 
 
e) Human Subject Considerations 
 
Participant Confidentiality - Participants will be assured of confidentiality throughout 
the research process.  Records will be assigned an identifier code, the solution to which 
will be known only to the principal investigator.  In addition, a confidentiality 
agreement is in place with the transcription company. 
 
Participant comfort - Participants will be invited to take part in the interview process at 
a place and time convenient to them.  In study A, in order to allow patient participants 
to feel comfortable during their interview a choice of location, which is non-clinical, 
will be made available.  
 
f) Adverse Events 
 
It is not anticipated that there will be any adverse effect on the participants as a direct 
result of contributing to the study.  However, if any clinical questions are raised during 
the course of the interview process by patient participants in study A, the participant 
will be referred back to the staff involved in there clinical care for appropriate advice.   
 
g) Study Records 
 
All records will be the responsibility of the principal investigator.  The digital 
recordings will be wiped following transcription.  Written records will be stored in a 
private locked office and computer records will be kept on a password protected, 
University owed computer.  Following completion of the study records will be kept 
securely for a period of 10 years. 
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Appendix B.  Ethical approval 
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Appendix C – Ethical approval for substantial amendment 1 
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Appendix D – Ethical approval for substantial amendment 2 
 
 
 
National Research Ethics Service 
County Durham & Tees Valley 2 Research Ethics Committee  
The Tatchell Centre 
University Hospital of North Tees 
Piperknowle Road 
Stockton-on-Tees 
TS19 8PE 
 
Tel: 01642 624164 
Fax: 01642 624164 
 
15 February 2010 
 
Miss Rachel A Green 
Clinical Fellow 
School of Dental Sciences 
Newcastle University 
Framlington Place 
Newcastle-Upon-Tyne 
NE2 4BW 
 
Dear Miss Green 
 
Study title: Patient and professional views of experience and 
management of oral precancer 
REC reference: 08/H0908/77 
Amendment number: 2 
Amendment date 31 January 2010 
Reason for substantial  Addition of recruitment via post 
Amendment request: 
 
The above amendment was reviewed on 12 February 2010 by the Sub-
Committee in correspondence. 
 
Ethical opinion 
 
The Members of the Committee taking part in the review gave a favourable 
ethical opinion of the amendment on the basis described in the notice of 
amendment form and supporting documentation. 
  
Approved documents 
 
The documents reviewed and approved at the meeting were: 
 
 Document  Version  Date  
Letter of invitation to participant  1  31 January 2010  
Protocol  5  31 January 2010  
Notice of Substantial Amendment (non-CTIMPs)  2  31 January 2010  
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Appendix E.  Patient information sheet 
 
Attendance at an Oral and Maxillofacial outpatient clinic – 
Patients' views and experience of care 
You are being invited to take part in a research study.  Before you decide if you want to 
take part it is important for you to understand why the research is being done and what 
it will involve.  
 
Please take time to read the following information carefully and discuss it with others if 
you wish.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
 
What is the purpose of the study?  
This study will ask people attending an out-patient oral and maxillofacial clinic about 
their experiences of care in this setting.  It is designed to explore how people feel about 
their mouth condition and their treatment.  We will do this by talking to a number of 
patients who attend this type of clinic.  It is hoped that this information will be used to 
provide future patients helpful information and manage them more effectively.   
 
Why have I been chosen for the study? 
Over the last few months or years, you have been treated at Newcastle General Hospital.  
We would be interested in hearing about your experiences. Altogether 20 patients who 
attend this clinic will be invited to participate.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part in this study. If you do decide to take 
part you will be given this information sheet to keep and be asked to sign a consent 
form. If you decide to take part you are still free to withdraw at any time 
 
What will happen to me if I take part? 
If you decide to take part a researcher will contact you to arrange a convenient time for 
an interview.  Think of this as an informal discussion.  This discussion will take around 
1 hour. This is all the time we ask of you to take part in the study.   
 
There is a quiet room available for this discussion next to the clinic you normally 
attend, if you prefer the discussion may be carried out away from the hospital in your 
own home. The researcher will record the discussion on a small portable digital 
recorder. This is to make sure that we don’t miss anything important that you have to 
say. 
 
What do I have to do? 
If you wish to take part please fill out and return the enclosed from.  Once we have 
received this form from you a researcher will contact you to organise an interview. 
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What are the possible risks of taking part? 
There are no perceived risks in taking part in the study.  However, some people may not 
feel comfortable discussing their mouth problems in front of others. 
 
What are the possible benefits of taking part? 
It is hoped that the information that is gained from this study may give us a greater 
understanding of the issues people face when attending these clinics for diagnosis or 
management of oral conditions.  We cannot guarantee that your participation in this 
study will be of direct benefit to you.  
 
What will happen to the recordings and written copies of the interviews? 
The information we collect from the interview will be transcribed (a written copy made) 
and analysed by the research team.  This information is treated as confidential and the 
written copies of the interviews will be made anonymous so that it will not be possible 
to identify you as an individual from these written copies.  These copies will be stored 
securely in a locked filing cabinet and no one outside the research team will have access 
to your information.   
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw at any time without giving a reason.  A decision to withdraw, 
or a decision not to take part, will not affect the standard of care you receive in any way. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researcher who will do her best to answer your questions (contact telephone number 
0191 2228396).  If you remain unhappy and wish to complain formally, you can do this 
through the NHS complains procedure. Details can be obtained from the hospital.  
 
Will my taking part in this study be kept confidential? 
Yes.  All information that is collected about you during the course of the research will 
be kept strictly confidential.  The written copies of the interviews will have your name 
and address removed so that you cannot be recognised from it.   
 
Who is organising and funding the research?  
This study has been organised by the School of Dental Sciences - Newcastle University. 
 
Who has reviewed the study? 
The study has been reviewed by County Durham and Tees Valley 2 Research Ethics 
Committee.    
 
Researcher Contact for Further Information 
 
Miss Rachel Green 
Newcastle University 
Framlington Place 
Newcastle upon Tyne  
NE2 4BW    Tel: 0191 2228396 
 
198 
 
Appendix F.  Professional information sheet 
 
Professional views and experience of oral precancer 
You are being invited to take part in the above study.  
 
What is the purpose of the study?  
This study builds on work being undertaken with patients who have been diagnosed 
with a potentially malignant oral lesion.  That study looked at views and experience of 
oral potential malignancy from the patient’s point of view.   
 
We are now planning to conduct a study to find out professional views of the same 
condition.  Specifically we are interested in information surrounding diagnosis, risk 
factors and treatment options and practices.  We are interested in speaking to a variety 
of professionals involved in the care of these patients.  It is hoped that the information 
gained from the study will be used to provide future patients helpful information, 
enabling them to be managed more effectively.   
 
Why have I been chosen for the study? 
As someone who is involved in the care of people with oral premalignancy, we would 
be interested in hearing your views. Altogether 20 clinical staff will be invited to 
participate.  
 
Do I have to take part? 
There is no obligation to take part.  If you decide to take part you are still free to 
withdraw at any time 
 
What will happen to me if I take part? 
If you decide to take part a researcher will contact you to arrange a convenient time for 
an interview.  This is usually done over the telephone.  However, it may be possible to 
arrange an alternative location depending on your location.  This discussion may take 
around 1 hour. The interviews will be audio recorded.  This is all the time we ask of you 
to take part in the study.   
 
What do I have to do? 
If you wish to take part please fill out and return the enclosed from.  Once we have 
received this form from you a researcher will contact you to organise an interview. 
 
What will happen to the recordings and written copies of the interviews? 
The audio recordings will be transcribed to aid data analysis.  The transcripts will be 
anonymised, so that it is not possible to identify you.  All information will be stored 
securely, with no one outside the research team having access to your information.  
 
Who is organising and reviewed the research?  
This study has been organised by the School of Dental Sciences - Newcastle University, 
it has reviewed by County Durham and Tees Valley 2 Research Ethics Committee.    
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Appendix G.  Topic guide for patient interviews 
  
Opening question 
“Just to get things started, can you tell me a little bit about yourself, your age, family, 
job that sort of thing?” 
 
SECTION 1.  EXPERIENCE OF CARE  
 
 Understanding of disease  
What has your doctor told you about your condition? 
What do you understand by your diagnosis?   
Was there anything you didn’t understand about what you were told? 
Was there anyone else who gave you any information about your diagnosis? 
How do you feel about the way you were given your diagnosis? 
In your opinion, could this have been improved in any way? 
Did you have any questions for your doctor at the time? 
Did you feel satisfied with the answers you received? 
Who do you think should give you this information? 
Did you look for information outside of the clinic (for example, from friends and family 
or sources such as the internet)? 
Was it helpful? 
Did your doctor give you advice about looking for further information? 
 
 Treatment 
Have you received any treatment for your condition? 
If yes –  
How did you decide that this treatment that was best for you? 
Looking back do you feel at the time you understood what these treatments would 
involve? 
Who explained what would happen to you?  
Can you tell me what you were told? 
Is there anything that could have been improved about the explanation of the treatment? 
Who do you feel is best to give this information? 
Is there anything you would change about your treatment?  
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If no - 
How did you decide that this type of management was best for you? 
Can you tell me what you were told? 
Looking back is there anything that could have been improved about the explanation of 
this type of management? 
Who do you feel is best to give this information? 
How do you feel about this choice of management now? 
 
SECTION 2. IMPACT ON EVERYDAY LIFE 
 
 Affect on day to day living 
Do you find that having this disease makes any difference to your life? 
Do you feel that you are prevented from doing normal things because of it? 
Does having this disease mean that you don’t do anything that you used to? 
Have you told your friends and family about your mouth condition? 
How did you explain it to them?  What did you say? 
How did they react? 
 
 Behaviour changes 
Did your doctor make you aware of anything you can do to improve your condition?  
(particularly smoking and drinking?) 
What did they say to you? 
What did you feel about this advice? 
Did you believe it? 
Have you made any changes to your lifestyle since receiving this diagnosis? 
If yes – 
Did you find these changes easy? 
Was there any support available to you to help with these changes? Did you use it, was 
it helpful? 
Did someone tell you about support services? Who? 
If no - 
Why not? 
 
Please note this is sheet is for guidance only 
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Appendix H.  Topic guide for clinician interviews 
 
Opening question 
“Just to get things started, can you tell me a little bit about your involvement in the 
management of patients with oral precancer?” 
 
SECTION 1. DIAGNOSIS OF ORAL PRECANCER  
What terminology do you use to describe oral precancer or potential malignancy? 
If I was a patient with oral precancer how would you explain the diagnosis of oral 
precancer to a me? 
Do you think it is a difficult diagnosis to explain? 
Do you think patients understand their diagnosis? 
Other than yourself, are there any other sources of information you recommended to 
patients? 
Do you think it makes any difference who delivers the information to the patients?  
 
SECTION 2. EXPERIENCE OF BEHAVIOUR CHANGE 
How do you broach the subject of risk factors with patients? 
How do patients react to this? 
What steps are taken to assist patients with changes in their behaviour? 
What help is available at the clinic? 
What sources of help do you employ? 
What do you see as the main obstacles to patients changing their behaviour?  
Do you think it is part of your role to provide this sort of information?  
 
SECTION 3. MAKING TREATMENT DECISIONS 
What management options do you offer to patients with oral precancer? 
What influences your decision? 
How do you support patients to make treatment decisions? 
How do you feel patients cope with the management option of: 
 Watchful waiting 
 Medical management 
 Surgical management 
 
Please note this is just sheet is for guidance only 
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Appendix I.  Presentations  
 
This thesis contains research which has been presented at the following academic 
conferences: 
 
Patient (mis)understanding of oral potentially malignant disorders 
Association of British Academic Oral and Maxillofacial Surgeons  
Cardiff  11/11/10 
(Awarded second prize in the verbal presentation category) 
 
Understanding patient views and experiences of oral precancer 
International Association of Dental Research 
Barcelona, Spain 16/07/10 
R. Green, C. Exley, P.J. Thomson, J. Steele.  Understanding patient views and 
experience of oral precancer, J Dent Res 89 (Spec Iss A): 2571, 2010 
(www.dentalresearch.org)* 
 
Understanding the transition from primary to secondary care: experiences of 
patients with oral precancer 
British Association of Oral and Maxillofacial Surgeons 
Nice, France 23 /06 /11 
R. Green, P.J. Thomson, C. Exley, J.G. Steele. 2011. Understanding the transition from 
primary to secondary care: experiences of patients with oral precancer. British Journal 
of Oral and Maxillofacial Surgery 49, Supplement 1(0):S60  
 
*Cited in Thomson, P.J. (Ed.). 2012. Oral Precancer: Diagnosis and Management of 
Potentially Malignant Disorders: Wiley-Blackwell 
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Appendix J. Tables detailing study sample groups 
 
Patient participant variables (Study A) 
Gender Male Female 
 14 14 
Age Over 40 Under 40 
 27 1 
Risk factors (tobacco use/alcohol consumption) Present Not present 
 26 2 
Management Surgical  Conservative 
 21 7 
Location Newcastle Sunderland 
 16 12 
 
 
Clinician participant variables (Study B) 
Gender Male Female 
 11 0 
Designation  Consultant (for over 10 
years) 
Consultant (for under 10 
years) 
 6 5 
Specialty 
 
OMFS Other 
 11 0 
Work 
environment  
Teaching hospital District general hospital 
 5 6 
 
*although part of the sampling criteria, the exact location of each participant is not 
documented to protect the anonymity of the participants.  
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